incivo works by stopping the virus from multiplying in the body . inciva is used to treat chronic hepatitis c infection in adults ( including those of 1865 years of age ) in combination with peginterferon alfa - 2b , ribavirin and telaprevir , which are medicines called ns3 - 4a protease inhibitors . the nn3 -4a proteace inhibitor is a natural antibody that helps to protect you from hepatis b virus . pegInterferon atfa and rib virin are the active ingredients of inciVO . what is chronic : incive is used for treating chronic hempatiti c disease in adults . it is used in addition to long - term patients with chronic hc infection who have not previously responded to an
do not take incivo : - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). - when taking peginterferon alfa and ribavirin because of their constraints ( e . g . pregnancy precautions ), you should not take either inciva in combination with pegInterferon atfa or rib avirine . in this case , your doctor may decide to reduce your dose of inciVO . take special care with incive - do not use incivre with pegginterferone alf - 2b or ravir in combination . tell your doctor if any of these apply to you . you must not take the following medicines if your doctor considers that the combination of icivo may be more suitable for you - severe side
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will prescribe the appropriate dose regimen . the recommended dose regimen is 3 to 6 tablets daily . this can be taken with or without food . it can be given as 3 to 8 tablets daily with or with food , preferably in the morning . use in children and adolescents the recommended dosage regimen is 6 tablets per day . for patients with both hepatitis c virus infection and human immunodeficiency virus infection , who are not taking efavirenz , the recommended dosing is 3 tablets per week or 8 tablets per night . in this case , your body will absorb more incivo than it should . you should swallow the tablets whole with water . do not chew or break the tablets . if the recommended daily dose is 60 mg / 
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : tell your doctor straight away if you get an itchy skin rash which starts out as a rash on its own . the rash may progress to a more severe form or if the re has other symptoms that may contribute to the rashes being severe . for a severe skin reaction , see your doctor immediately . in case of a skin r , tell your physician immediately , as your rash might become severe or life - threatening . other symptoms of  a sudden rash include : fever , tiredness , swelling of the face , and swelling of lymph glands . it is a wide - spread rash with peeling skin , fever . flu - like symptoms , painful skin and / or painful skin . these
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . incivo tablets should be stored in the original bottle and keep the bottle tightly closed in order to protect from moisture .
what incivo contains - the active substance is telaprevir . each tablet of inciVO contains 375 mg of tel apreVir . -the other ingredients are : tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrously , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , the talc , titanium dioxide ( e171 ), and iron oxide yellow ( е172 ). what ivo looks like and contents of the pack film , capsule - shaped , yellow caplet - colored tablets , debossed with " gsi " on one
the active substance in zinbryta is daclizumab beta , a monoclonal antibody . this antibody is designed to recognise and attach to a specific target substance in the body . what zinbyta can be used for zinberyte is used to treat multiple sclerosis in adults . it is used as an antidote for ms that has not responded to therapy after two mds treatment and is not responded or cannot be used on its own . other treatments can cause inflammation and weaken the protective sheath around the nerves ( central nervous system ), including the brain and spinal cord . when this loss of myelin is called demyelINation , it is called amyelinating . people with relapsing m , who have repeated attacks ( relapses ) and who have
do not take zinbryta - if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . warnings and precautions talk to your doctor or pharmacist before taking zinberyte : - you have liver problems . your doctor may need to change your dose . talk to you doctor before taking your first dose of zinbirryt : you have any other autoimmune disorders . you are taking any other medicines , including herbal supplements . do not give yourself the chance to take any medicines or supplements because they may increase your risk of liver side effects . these medicines may not be suitable for you . take special care with zinberrytta tell your doctor if any of these apply to you : depression or have had in the past a seriously infection ( such as pneumonia ) or tuber
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much zinbryta to use the usual dose of zinblita is 150 mg . your doctor will decide how much you need . if your doctor decides to carry out a blood test to check how well your liver is working , the usual starting dose of the two doses of  Zinbrytra is 40 mg , depending on the results of this blood test . you will have a test to make sure that you have the correct dose . injecting zinburryte yourself zinbirryt , usually injected under the skin in your thigh , stomach or back , or in your upper arm . instructions for injecting the medicine at the end of this leaflet 7 . before injecting your first dose of your first injection of
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this is very common . tell your doctor straight away if any of the side effects get serious . your doctor may decide to temporarily or permanently stop your treatment . serious side effects liver problems . common ( may affect up to 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ) problems with your skin or the whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( may effect up to1 in 100 people ). severe inflammation of the liver may cause death . please tell your physician immediately if your symptoms get worse or if they get worse . they could be serious and could be life -
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled sYringe in original package in order to protect from light . when needed , a new syedringe / pen may be stored in ' a fridge at a temperature not above 30 oc . zin brypa s / pens may be kept at room temperature up to 30 , or kept at rooms temperature upto 30 . once thawed , do not put the pen back in the refrigerator . you can put zin Bryt
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg daclizub beta in 1 ml . every pre – filled pen contains 150 micrograms daclizab beta inside 1 metre . the other ingredients are sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 under ' zin Bryte contains sodium '). what zbrytoa looks like and contents of the pack zinburryt consists of a colourless to slightly yellow , round , flat , bevelled edge , pre . filled pen with an attached trigger rod . one pre , multipack , or multipack of 10 . not all pack sizes may be marketed .
wilzin belongs to a group of medicines known as metabolism products . wilszin is used to treat willson ' s disease , a rare inherited defect in copper excretion in the liver . it affects the white cells in the eyes and in the brain . this results in liver damage and neurological disorders . the intestine is damaged , damaged and leaking from the food pipe , leading to its further accumulation in the body . your doctor has prescribed wilezin for you because you have wILSON '
do not take wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilszin . take special care with wILzin willzin should be used during initial therapy . tell your doctor if signs and symptoms suggest that you have wlson ' s disease and are currently taking another anti - copper agent ( penicillamine ). warnings and precautions talk to your doctor before taking wulzin : if for any reason you are currently being treated with another anti- copper agents , such as peniciillamine . willetzin may temporarily be used for the initial treatment in combination with other anti , copper agents such as st . penicilamine , if your symptoms do not improve after the treatment . your doctor will take samples of blood and urine to check that you are receiving sufficient treatment and that monitoring
always take wilzin exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the different dose regimens are available for adults and children . adults the recommended dose is 25 mg or 50 mg taken once a day . your doctor may prescribe 1 mg of wilszin or 50 milligrams ( 2 mg ) of witzin per day , or 25 mg taken twice a Day ( 1 mg ), or 50 micrograms in the morning . alternatively , your doctor will prescribe 2 mg of the willetzin 25 mg and 1 mg twice - daily dose of a 50 mg dose , taken once daily or 2 mg twice daily . if your doctor prescribes wILzin 25 milliliters ( 1 to 6 mg / day ) take 1 mg once daily , with or without food . take 1 tablet
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect affects1 to 10 Users in 1 , 000 ) rare ( affect 1 to 5 users in 10 to 10 user in10 ,000 ) very rare ( effect occurs in less than 1 patient in 10 who receives 10 ,00 ,0000 ) not known ( frequency cannot be estimated from the available data ). wilszin intake may cause gastric irritation during treatment . you may experience changes in blood tests , such as an increase in some liver and pancreatic enzymes , and a decrease in blood red and white cells . reporting of side effects 9 if you get any side effects talk
keep out of the reach and sight of children . do not store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( corresponding to 83 . 92 mg of Zin acetate dihydrate ) or 50 mg of gold ( indicating zinc ). each hard hard capsule of 167 .84 mg contains zinc accetate dihydrat , magnesium stearate . the capsule shell contains gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( 8000 ) and blue ink . what ilzin looks like and contents of the pack wilszin 25 mg hard capsules are blue and white and engraved with ' w100 ' on one side and ' 50 ' off the other . on the printing ink is black iron oxide ( encoding with shellac ). what ailzin look like and content of the package wILzin 25
biktarvy contains the active substances : bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor ( irti ) emtricitabine , which is an antiviral medicinal medicine known only as a nucleoside reverse transcriptasing inhibitor ( nortis ) 10ofovir alafenamide , another antirétroviral medication known as  a nuclear nucleonide reverse transcript asse inhibitor ( nutrta ) biktarivy is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection in adults , adolescents and children of all ages . hiv is a type of hiv that can cause an increased risk of your immune system . this will strengthen your immune systems and reduce
do not take biktarvy if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide , any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if the above applies to to you ( or you are not sure ), talk to your doctor before taking biktarivy ( see also section " taking biketegravar ") if your doctor has told you that you are taking any of these medicines : - rifampicin , which may be used to treat some bacterial infections such as tuberculosis - saint john ' s wort ( hypericum perforatum ), which is a herbal remedy used for depression and anxiety . warnings and precautions talk to
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . - do not take antacids ( to prevent stomach ulcers , heartburn or acid reflux ) because biktarvy contains the following active substances : aluminium , magnesium hydroxide mineral supplements and vitamins , minerals , and magnesium , iron , etc . see section 2 for further information on these medicines . how much to take if your doctor tells you to take biktarivy if : you are on dialysis . taking bikgarvy while on di alysis your doctor may decide to keep you under closer observation or change your dose if necessary . take your tablet as soon as you can , in case you have missed a dose . you may have to take another tablet of bik
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you should tell your doctor immediately : - inflammation or infection . in some patients with advanced hiv infection , signs of opportunistic infections ( infections that occur in people with a weak immune system ) may occur . it is important to tell your healthcare professional if there are symptoms of inflammation from previous infections or if hiv treatment is not working properly . these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . some patients may have autoimmune disorders , in which the immune system attacks healthy body tissue . this is particularly common in patients taking medicines for hiv disease . the frequency of these events is not known .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the seal and the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . keep the container tightly closed in order to protect from moisture .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktarivy tablet contains bictategravir sodium equivalent to 50 mg bictabegraVir , 200 mg emptricit abine et alafatenamide fumarate equivalent to 25 mg ten ofovir altafène . the other ingredients are tablet core microcrystalline cellulose , criscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , and talc . printing ink : shellac , iron oxide red (  e172 ), iron oxide black ( gilded ) shellacent , red iron oxide yellow (
novonorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panceras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonourm is used to control type 2 diabetics as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . yes , novonorgm can also be given with metformin , another medicine for diabetes . it is important to continue to follow the advice on diet and exercising from your doctor , pharmacist or nurse .
do not take novonorm if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). if your doctor has told you that you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). warnings and precautions talk to your doctor before taking novonourm : if - you have a severe liver disease . in particular , you may be taking gemfibrozil ( a medicine used to lower increased fat levels ) 47 if any of these apply to you . liver problems . your doctor will decide if novonmorm is suitable for you if there is a risk for moderate liver disease ( see section 4 ). there is little information available on the use of novonorgm in patients with a severely liver disease and if patients with kidney problems ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablets with a glass of water immediately before or up to 30 minutes before each main meal . your doctor may increase your dose to 4 mg once daily up to a maximum of 30 mg once per day , up to 16 weeks . if your blood sugar is too low , you may get a hypo . don ' t stop taking novonorm unless your doctor tells you to . as you will find this information so it is important to keep following your diet and exercise plan while taking novovonormus . do not stop taking this medicine unless you have discussed this with your healthcare provider . you should not stop your treatment without your doctor 's advice as this may increase the risk of
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most frequent side effect is hypoglemia which may affect up to 1 in 10 people ( see a hypo in section 2 ). hypogycaemic reactions are generally mild / moderate but may occasionally develop into hypogliescaem unconsciousness or coma . allergy allergy is very rare ( may affect more than 1 in every 10 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be anaphylactic reaction . if you have other side effects talk to your doctor , pharmacist or nurse . the frequency of these reactions is not known ( cannot be estimated from the available data ). most cases are mild and disappear after a few days . in some cases , severe reactions may be life 
what novonorm contains - the active substance is repaglinide . -the other ingredients are microcrystalline cellulose ( e460 ), calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol 85 %, magnesium stearate , meglumine , and poloxamer . the other ingredients in the tablet core are iron oxide yellow ( 0 . 5 mg ), iron oxide red (  2 mg ). what novoororm looks like and contents of the pack novonorg tablets are round and convex and engraved with the novo nordisk logo ( apis bull ). the tablets are 0. 5 mm , 1 mm and 2 mm in diameter . pack sizes of 0 and 5 . 1
pumarix is a vaccine for use in adults from 18 years old to prevent pandemic flu ( influenza ). pandemie flu is essentially a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . the signs of pandelic flu are similar to those of ordinary flu but may be more serious . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarize may not fully protect all persons who are vaccinated .
pumarix should not be given if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the substances that may be present in trace amounts as follows : egg and chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . however , in a pandemic situation , it may be given as a precautionary measure . if this happens to you , you will not be fully protected against the vaccine , and you may require medical treatment . in case you have an allergic response , pumarize may not fully protect all persons who are given this vaccine . warnings and precautions 33 talk to your doctor or nurse before you are given pumarx
pumarix is for use in adults aged 18 and over . pumarize can be given with or without food . a doctor or nurse will administer a similar h5n1 as03 to a child from the age of 18 years . adults the doctor or health care professional will administer the appropriate dose of pumarice to p0 . 5 ml . administer the vaccine at the same vaccination site each year . use in children and adolescents pumarx can be used in children 3 - 9 years of age . there are limited data in children from 3  17 years of birth . no data are available for children and teenagers . how pumarizer is given pumaris will be given as an injection into a muscle . this will usually be in the upper arm . follow your doctor ' s instructions about when and how to use this vaccine .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may cause you to have dangerously low blood pressure . if this is not treated it may lead to shock . your doctor will have emergency treatment ready to use . other side effects very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles , joint pain common ( might affect up to 1 in 100 people ) redness or swelling where the injector is given fever sweating shivering diarrhoea feeling sick uncommon ( may effect up to1 in 100 persons ) runny nose uncommon ( might effect upto 1 in 1000 people ). it is not known how often these side effects occur . very common : may affect upto1 in 10 children flu like symptoms , including nausea , vomiting , chills , feeling weak or
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . do not freeze . after the vaccine has been mixed , use the vaccine within 24 hours and do not store above 30 .
what pumarix contains active substance : split influenza virus , inactivated , containing antigen * equivalent to : a / vietnam / 5 / 2005 ( h5n1 ) like strain used ( pr8 - ibcdc - 6 ) in 0 . 5 ml dose * propagated in eggs ** expressed in microgram haemagglutinin this vaccine complies with the who recommendation and eu decision for the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvanted with squalene , Dl - tocopherol , polysorbate 80 and all other adjutants are used to improve the body ' s response to the vaccine . other ingredients : sodium chloride , disodium hydrogen phosphate ;
somakit toc is a radiopharmaceutical product for diagnostic use only . it contains an active substance called edotreotide . the powder contains a nuclear medicine equivalent to a supernatant amount of a radiationactive substance called gallium ( 68ga ) chloride , which is equivalent to gallium( 68Ga ] edetreototide at the onset of this procedure . because it contains little radioactivity , it is used to deliver radioactivity to patients where it is needed . gallium is extracted from the needle and injected into one of your body areas , in a medical imaging procedure called positron emission tomography . your pet will be monitored during this medical procedure , somamakit tc will be administered to you as part of dna technology . this medicine allows doctors to
do not use somakit toc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if allergic reaction occurs ( see section 4 , " contents of the pack and other information "). - talk to your doctor before using somamakit tc : - as you may have kidney or liver problems . - have renal or hepatic disease . children and adolescents do not give this medicine to children and teenagers under 18 years of age because of the risk of dehydration . before the examination , please drink plenty of water and drink plenty ( see also section 4 " possible side effects "). warnings and precautions talk to you doctor or pharmacist before using , before using and during treatment with somma kit toc ( see additionally section 28 " possible consequences "). children and young people may
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in specially controlled areas . it will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide on the quantity of somаkit tob to be used during the operation . each volume will consist of 100 mbq ( megabecquerel , the unit used to express radioactivity ). administration of somatakit tc and conduct of the procedure are the responsibility of the nuclear scientist . administration of radiolabelling , somamakit TOc is administered by intravenous injection ( a single injection ). it is administered after the test has
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc . symptoms are warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions , stinging or bruising at the injection site may be associated with ionising radiation associated with the least risk of cancer and hereditary abnormalities . if you get any side effects talk to your doctor or nurse . this includes any possible side effects not listed in this leaflet . reporting of side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . after radiolabelling , the product should be used immediately . if not used immediately, in - use storage times and conditions prior to use are the responsibility the specialist and would normally not be longer than 4 hours below 25 if stored under protection from light . no special storage conditions are expected . radiopharmaciaceutical should be disposed of in accordANCE with national regulations on radioactivity .
what somakit toc contains - the active substance is edotreotide . one vial of powder contains 40 mg of eed dotreototide ( as 10 - phenanthroline ). - other ingredients are gentisic acid , mannitol , formic acid . sodium hydroxide and water for injections . what sommakit tc looks like and contents of the pack somamakittoc is a clear and colourless solution . it is supplied in a glass vial with a black flip - off cap . the vial contains a white powder . somma kit toc is supplied as a single dose in  aglass vial containing yellow flip  - on cap , which makes it easier to inject . each vial delivers a clean
afinitor is an anticancer medicine containing the active substance everolimus . everolim works by slowing down the growth of the tumour and slowing the growth and spread of cancer cells . afinitour is used in adult patients with : hormone receptor - positive advanced breast cancer ( postmenopausal women ) who have not previously been treated with non - steroidal aromatase inhibitors ( ras ), to help control the disease under control . it is also used in combination with a medicine called exemestane ( a steroids aromatise inhibitor ) and hormonal anticancancer therapy . advanced tumours ( neuroendocrine tumours ) that have spread to the stomach or bowels . the tumour is a type of cancer that affects the central nervous system ( central nervous systems ).
you must not be given afinitor if you are undergoing cancer treatment . do not use afinitour if any of the following apply to you . if this applies to you then : - you are allergic to everolimus , sirolimus / temsirolim , or any of those other ingredients of this medicine ( listed in section 6 ). if the above applies to to you ( or you are not sure ), talk to your doctor before you are given afinior . you are also allergic to afinitur . warnings and precautions talk to you doctor before taking afinitoral : you have any problems with your liver or have had any disease which has affected your liver . your doctor may prescribe a different dose of agonyl alcohol ( sugary) substituted with water tablets . for diabetes ( high level of sugar in your blood ) you should
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . take the tablet before a meal . swallow the tablet whole . do not chew , crush or split the tablet . you can take the tablets with or without food . if possible take your tablet at about the same time each day , preferably in the morning . patients with liver problems may need a lower dose of agony . your doctor may prescribe you a higher dose of afinitor ( 5 mg once daily ). your doctor will decide the right dose for you , depending on how you respond to the tablet ( 5 g , 5 ml or 7 . 5 mg ). you may experience certain side effects whilst taking afinitour . stopping treatment with afinitur can stop you from taking afin
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and seek medical help immediately if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . the following side effects have been reported with afinitour : very common ( may affect more than 1 in 10 people ) increased temperature ( chills , signs of infection ) fever , coughing , difficulty breathing , wheezing . these may be signs of inflammation of the lung called pneumonitis .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . open the blister just before taking the tablets . this medicine does not require any special temperature storage conditions . does not use if the package is damaged or shows signs of tampering . only authorized healthcare professionals can take this medicine if their package is in perfect condition . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains the active substance is everolimus . afinitour 2 . 5 mg : each tablet contains 2 , 5 mg of everolim . vueitor 5 mg: each tabletten contains 5 mg ( 1 mg ) of everOLImus  . Afinitor 10 mg - each tablettet contains 10 mg of Everolimus the other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate , lactose monohydrate , hypromellose , and crospovidone ( containing lactoses anhydrous ). what afinior looks like and contents of the pack afinitoral 2 : 5 mg tablets are white to slightly yellowish , round and flat . they have " t " imprinted on one side . the package is a white to off - white , oval 
what laventair ellipta is laventAir ellippa contains two active substances umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what lavantair epte is used for laventAIR elliрta est to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary areas . when used regularly , it can help to control your breathing difficulties .
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using this medicine . warnings and precautions talk to your doctor or pharmacist before using laventAir ellippa : - you have asthma ( don ' t use laVENTair elipta to treat asthma ). talk to you doctor if : you have heart problems or high blood pressure you have an eye problem called narrow - angle glaucoma . you have or have ever had an enlarged prostate , difficulty passing urine or a blockage in your bladder . - your doctor may want to monitor you more closely . your doctor has told you that you have epilepsy . it is not known
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use laVENTair elutions every day , as instructed by your doctor to reduce the effects of symptoms . if your doctor instructs you how to use lavantair ellpt , you can help control your symptoms throughout the day and night . laventAIR ellippa should not be used to relieve a sudden attack of breathlessness or wheezing . to help prevent this sort of attack
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you have any of the following symptoms after taking laventair ellipta stop using this medicine and tell your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) or redness rare side effects may affect less than 1 in 1 , 000 people : swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( collapse ) collapse . these side effects are usually mild and usually disappear after a few weeks . if they do not disappear after several weeks , they could be serious and require medical attention .
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umeclinium broMIDe ) and 22 microgram ( mg ) vilanter ( as trifenatate ) the other ingredient is lactose monohydrate ( see section 2 under ' laventaire ellippa contains lactoses ') and magnesium stearate . what lavantair e . g . contains lactating powder . the active ingredients are lactosed , inhale and inhalate directly into the food pipe . after you have taken lavent air ellimpta , you should not eat the powder
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine attaches to a specific target substance in the body called il - 23 . what tremefyya is used for trempya may be used by adults with certain forms of psoriasis . moderate to severe " plaque ppsorasus " is an inflammatory condition affecting the skin and nails . trefyam works to improve the condition of the skin , including the appearance of nails , and to reduce symptoms such as scaling , dropping , flaking , itching , pain , burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking the medicine . if allergic to any of these , ask your doctor for advice . warnings and precautions talk to your doctor before using tremefyya as it may increase the risk of an active infection . you should have active tuberculosis warnings before you are given trefy , if : you have an infection , or think you have ever had an infection that is serious . your doctor will tell you whether you have tubercusis . patients with tubercularosus ( tb ) have been in close contact with someone with tubersculoses . it is important that you tell your healthcare
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of tremfya is 100 mg ( 1 pre - filled syringe ) injected under the skin ( subcutaneous injection ). this is repeated every 4 weeks for up to 8 weeks . after each injection of TREmfYa , your doctor may decide to increase your dose . if your doctor decides you should not use more trempya than your doctor has recommended , talk to your doctor about other ways to inject trepya . do not try to inject yourself if this happens . you should inject TREMfyya yourself , even if there is no other option . for instructions on how to inject your medicine , please read the section at the end of this leaflet
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical attention : serious allergic reaction - the signs may include : - difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps other side effects talk to your doctor if any of these side effects get serious . some side effects could be serious common ( may affect up to 1 in 10 people ): upper respiratory infections common ( might affect upto 1 in10 people ), including headache and joint pain headaches joint pain feeling weak or tired , feeling tired or feeling sleepy dizziness headache diarrhoea joint pain , pain in the joints , back pain . reporting of side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the pre - filled syringe after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre- filled
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of guzelklumab in 1 ml solution . -the other ingredients are histidine , histine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what TREmfYa looks like and contents of the pack solution for injection : trempya is a carton pack containing one single - dose glass sYringe or a multipack containing 2 ( 3 packs of 1 ) single , dose pre – filled  ssyredes , one pre . questionnaire for medical or healthcare professionals is available . not all pack sizes may be marketed .
the active substance of trepulmix is treprostinil . treprastilil belongs to a class of medicines called prostacyclins . these are substances that bind to blood pressure and relax blood vessels . prostacycleins prevent blood from clotting . the active ingredient in trepmix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ). it is used if you have persistent or recurrent ctes and you do not respond well enough to surgical treatment , and you should improve exercise capacity ( ability to carry out physical activity ) and symptoms of the disease . chronic thmboembrylic pulph is when blood pressure is too high , because the blood vessels in the heart have to work harder to pump blood through them .
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor and do not use trepstINil . warnings and precautions talk to your doctor or pharmacist before taking tre Pulmix : if your doctor has told you that you have a disease called " pulmonary veno - occlusive disease ". this is a condition in which the blood vessels in the lungs become swollen , leading to a higher pressure in the blood vessel between the heart and the arteries . if : you have severe liver disease you have ever had a heart problem , including a cardiac attack ( myocardial infarction ) within the last six months you have any severe changes in heart rate severe coronary heart
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how is trepulmix given and how much should i take ? trepmix is given as a continuous subcutaneous infusion ( injection under your skin ) through a small tube ( cannula ) in your abdomen or thigh . your doctor will decide how many trepelmix tablets you will receive . trepetmix comes with a portable pump . you will need to keep using your treprostinil for as long as your condition keeps getting worse . the pump will keep the infusion line open . in order to reduce the risk of accidental overdose , you will usually receive 1 dose of 2 . 5 mg , 5 mg or 10 mg per day . depending on how you respond to the inffusion
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the hospital or clinic the infected area bleeding or bruising at the site of the induction cause headaches nausea diarrhoea jaw pain common ( might affect up to 1 in every 10 people): dizziness , light - headedness or fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgi ) swelling of feet , ankles or feet dizzitude , trepulmix may cause inability to get or keep an erection . uncommon ( may effect up to one in every 100 people ),: diarryngeal pain , infusion - site reaction ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . trepulmix vials may be stored at room temperature ( up to 30 ) for up to one month without being refrigerated again . for continuous subcutaneous infusion , a single reserve ( syringe ) of undiluted tre Pulmix may be kept at room room temperature for a maximum of 72 hours . this medicine must not be put back in the refrigerator . it must not been used if there are any signs of damage , such as discolouration or other signs of deterioration .
what trepulmix contains - the active substance is treprostinil . treppulmix 1 mg : each vial contains 1 mg of treprastINil ( as sodium salt ). treputmix 10 mg  : every vial includes 10 mg of delamanid ( as salt ) and 10 mg delaMANid (+ treparst inil ) as sodium Salt . the other ingredient is : trepumix 2 . 5 mg - each viall contains 2 , 5 mg of dulcet ( as potassium salt ), 10 mg or 25 mg of cepstnil ( the other ingredients are : sodium salt and trepelmix 5 mg and 5 mg deltinils ( as water and sodium salt in 10 ml ). what TREpulmix looks like and contents of the pack trepur
thorinane contains enoxaparin sodium which is a low molecular weight heparin ( lmwh ). thorginana works in two ways . 1 ) stopping existing blood clots from getting any bigger . 2 ) blocking blood coagulations forming in your blood . thlorinanе is used to : prevent blood  clottings from forming themselves . this helps your body to remove blood flakes from your blood and reduce the risk of blood clats forming within your blood after an operation . it is used in adults who have an acute illness or who have unstable angina ( a condition of heart ) or a heart attack . reduce the chance of blood colliding with your dialysis machine if you have severe kidney problems .
do not take thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include : rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if this applies to you , tell your doctor . you may be allergic to any of these . do not use thoresane in combination with other low molecular weight heparins ( nadroparin , tinzaparin or dalteparin ). if , after you have had a reaction to hepin that caused a severe drop in the number of your clotting cells ( platelets ) . this reaction is known as heparain - in - initiated thrombo
like other similar medicines ( medicines to reduce blood clotting ), thorinane may cause bleeding which may potentially be life - threatening . in some cases the bleeding may not be obvious . if you experience any bleeding event that does not stop by itself or if there is evidence of excessive bleeding ( exceptional weakness , tiredness , paleness ), dizziness / headache or unexplained swelling , contact your doctor immediately . your doctor may decide to keep you under closer observation or change your medicine . patients receiving thorginana may experience a severe allergic reaction ( such as difficulty breathing , swelling of the lips , mouth , throat or eyes ), blockage of a blood vessel by ablood clot . this could cause cramping pain or discomfort . other side effects include : very common ( may affect more than 1 in 10 people ):
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . thorinane pre - filled syringes should be stored in the original package and not frozen . after dilution the solution should be used within 8 hours . this medicine does not require any special temperature storage conditions . use the thoresinana pre  filled  sYringe only once . discard any unused medicine . any discarded medicine must be discarded after thawing . it is recommended that the dilsement times and conditions prior to use are the responsibility of the user .
what thorinane contains - the active substance is enoxaparin sodium . each ml contains 100 mg of eonoxaparain sodium at the date and time of calibration . - each pre - filled syringe with 0 . 2 mL of solution contains 2 , 000 mg of Enoxaprin sodium and water for injections . what torinans looks like and contents of the pack thoriane is a clear to slightly opalescent , colourless type i neutral glass ssyre barrel with fixed needle and needle shield with chlorobutyl rubber stopper and a blue polypropylene plunger rod . it is available in packs containing 2 or 10 pre – filled yringers . not all pack sizes may be marketed .
senstend contains lidocaine and prilocaine as local anaesthetics . senstendu is used for the treatment of lifelong premature ejaculation in adult men . the senstende head is placed in the penis to help with ejculation .
do not use senstend if you are allergic to lidocaine or prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using senstendu . if there is a risk of allergy or sensitivity to local anaesthetics , especially amide - type local anesthesis . tell your doctor or nurse if : you have a genetic disease or other condition affecting your red blood cells ( glucose - 6 - phosphate deficiency , anaemia or methaemoglobinaemia ). in these situations medicine sensitivities and sensitivity can occur . you have severe liver problems . this medicine is not recommended if used on its own . it should only be used once daily . senstendur should not be
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of senstend is 3 sprays ( 3 sprayers of 1 ml ) on the head of the penis . use within 3 hours , or 24 hours when spraying in the air . how much to use the spray container contains an instruction on how to use and how to adjust the pump mechanism . twist the valve to release the medicine as soon as possible to avoid contact with eyes , nose , mouth and ears . before use , the pump must be sprayed 1 time into the foreskin from the head and into the penies . each valve is sprained , actuated by the pressure in the head . if the spray is injected 3 times per week , it should be used within 3 days 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may occur when taking senstend : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection increased pressure in the penis feeling of burning in the back of the penises uncommon ( may effect up to1 in 100 people ). headache local irritation of the throat ( if inhaled ) irritation of part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling of thepenis pain or discomfort in the lining of the pensis itching not known ( frequency cannot be estimated from the available data ) sex drive abnormal ejected male sextortion reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the container in the outer carton in order to protect from light . after first opening : do not store above 25 . throw away the container 12 weeks after first use . use the metal container to puncture , not burn or break it . please read the " instructions for use " provided in the metal containers . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use ; these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . - each ml of solution contains 150 mg lidocasine and 50 mg prilacaine - one spray delivers 50 microlitres which contains 7 . 5 mg lidaine and 2 . 4 mg Prilocaine respectively . what sensTENd looks like and contents of the pack senstendu is a clear , colourless to light yellow cutaneous spray , solution for injection , supplied in an aluminium spray container with metering valve . each pack contains 1 spray container containing 6 . 6 mL or 5 m2 of solution .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melamine that cannot be removed by complete resection in adults ( treatment with surgery ) as adjuvant therapy advanced non - small cell lung cancer , a form of lung cancer that can be advanced in adults advanced renal cell carcinoma , advanced kidney cancer in adults classical hodgkin lymphoma , after having received previous therapies including an autologous stem - cell transplant , or a transplant to a different organ advanced cancer of the head and neck , in adults advance urothelial carcinoma . it is used to control bladder and urinary tract cancer in adult . opine is accompanied by nivolumab , another medicine that suppresses lymphocytes . the active substance in opituitary is 
do not use opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using oppdivo and during treatment : - contact your doctor if : you have problems with your heart such as a change in the rhythm or rhythm of the heartbeat , or an abnormal heart rhythm . you have difficulties with breathing or cough . these may be signs of inflammation of the lungs ( pneumonitis or interstitial lung disease ). - you have diarrhoea ( watery , loose or soft stools ), or any symptoms of inflammation or of the digestive system ( colitis ). you have had a heart problem before , including a chest infection or a lung infection . - your doctor may want to
always take opdivo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the usual dose of oppdivo is 240 mg ( two 2 g tablets ) taken once a day , or 480 mg ( four 4 g tablet ) in the morning . your doctor may prescribe obdivo together with ipilimumab , depending on the treatment , if needed . if your doctor determines that you can receive more opitations or less opindivo than he / she should . for skin cancer , the recommended dose of the recommended starting dose of one g of nivolumab is 1 g nitvolumumabe . the dose of 1 ml of iu / kg is calculated based
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . opdivo may be stored at room temperature ( up to 25 ) for up to 48 hours . from a microbiological point of view , the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nyvolum ab ( 40 mg / mL , 4 mg , 100 mg ) or 10 m / vial ( 100 mg of concentrate , 10 g , 240 mg ), and 24 mg of other nitromab in each . the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " oppdivo includes sodium "). the other ingredient ( s ) are mannitol ( e421 ), pentetic acid , polysorbate 80 , water for injections . what apdiva looks like and contents of the pack obdivo is a clear , colourless to pale yellow to yellow
clopidogrel tad contains clopizigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). cloprigrel todo is used to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboisis , and atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogrell tdd to help prevent and reduce the number of blood and thrombocytes .
do not take clopidogrel tad 30 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . If you suffer from severe liver disease . do not use cloclopidOgrel todd if any of these apply to you ( or you are not sure ), talk to your doctor before taking clopinogrela t d . warnings and precautions if anything happens to you contact your doctor or pharmacist before taking your first dose of clonogreil td : if : you have a risk of bleeding such a mental condition that puts you at risk of internal bleeding ( such as
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if vous have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of cropidogral TAd ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet ( 4 tablet of 75 %) of  Clopidogresl . you should take clopogrell td for as long as your physician continues to prescribe it . contact your doctor,
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , if confused ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include redness , swelling or itching of the face , lips , tongue or throat . some side effects could be serious . tell your doctor if your doctor determines that you have
what clopidogrel tad contains - the active substance is clopogrell . each film - coated tablet contains 75 mg of clopionogrelly ( as hydrochloride ). -the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( е172 ), yellow iron oxide in the film  talc and macrogol 3000 in the movie - coating . what  Clopidogral tard looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 and 14 film  - covered tablets are available . not all pack
tacforius contains the active substance tacrolimus . it is an immunosuppressant . following your organ transplant ( liver , kidney ), your body ' s immune system will try to reject the new organ . tacforyus is used to control your body'  s immunity , enabling your body to accept the transplanted organ , in most cases . your doctor will use tacforis to prevent your body from rejecting the transplant , such as the liver . the kidney and heart , when any previous treatment you were taking was unable to control this immune response after your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking tacforitus . if your doctor thinks you may be allergic to siroli Mus . warnings and precautions talk to your doctor or pharmacist before taking tacfordius as well as if : you are taking any macrolide - antibiotic ( e .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed to you by a doctor with experience in the treatment of transplant patients . make sure that you receive the same tacforius medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different tacrolimus medicine . if the impression that the effect of this medicine is too strong or too weak , talk to your doctor . always take tacforIus exactly as described in this leaflet . you should check with the doctor or nurse if this medicine has been prescribed for you , and that it is the right medicine for you at the right time . the starting dose to prevent the rejection of your transplanted organ will be calculated based on your body weight . initial daily doses of 0 . 10 - 
like all medicines , this medicine can cause side effects , although not everybody gets them . infections you may get infections more easily with tacforius . severe effects may occur , including allergic and anaphylactic reactions . benign and malignant tumours have been reported following tacfory treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis (  a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) and febrile neutropenia ( reduced number of a type of whiteblood cells that fight infection ) have been noted . these changes may be accompanied by a decrease in red cells ( which may lead to abnormal break up ) as well as a reduction in the number of platelets ( which fight infection
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . use all the prolonged - release hard capsules within 1 year of opening the aluminium wrapping . store in the original package in order to protect from moisture .
what tacforius contains the active substance is tacrolimus . tacforinius 0 . 5 mg : each capsule contains 0 5 mg of tacrolivimus ( as monohydrate ). tacforitus 1 mg / kg : one capsule contains 1 mg of troli Mus ( as monohydrate ) in one capsule . tacforimus 3 mg ; one capsule contient 3 mg of of tacrotimus ( As monohydrate
clopidogrel zentiva contains clopizil and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). cloclopidOgrel Zentiva is taken by adults to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboisis , and atherotrothrombotic events ( such as stroke , heart attack , or death ). you should take clopinogrell zenta every day as directed by your doctor .
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you . if your medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain . If you suffer from severe liver disease . do not use cloclopidOgrel
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if vous have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral  Zentiva ( 1 tablet of 300 mg or 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet in the morning and one 75 - mg tablet at the end of treatment of one 75- mg capsule of cropidogresl zetiva
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , if confused ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include redness , swelling or itching of the face , lips , tongue or throat . some side effects could be serious . tell your doctor if your doctor determines that you have
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . clopidogrel zentiva should be stored in the original package in order to protect from light . aluminium blisters : do not store above 30 . store in the Original package in case you are not using clopdogrell zenta , except for all aluminium cartons . this medicine does not require any special storage conditions . no visible sign of deterioration has been observed . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what clopidogrel zentiva contains the active substance is clopigrel 75 mg . each tablet contains clopionogrell ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' cloclopidigrell zentivea contains lactose ' and ' collapsing tablet contains hydrogenated castor oil '): mannitol ( e421 ) and hydrogenated castingor oil in the tablet core and / or microcrystalline cellulose ( cp ), macrogol 6000 and low - substituted hydroxypropylcellulose ( type a ) in the film - coating : lactoses monohydrate ( milk sugar ) hypromellose (  e321 ), triacetin ( е1518 ), red iron oxide ( i )
yttriga is a radioactive medicine . it is used in combination with another medicine with tiny radiation doses to improve the treatment . yittrig consists of a single dose , radiolabelled medicinal product , that contains a trace amount of radioactivity .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yittrig - you must not be pregnant - this is because yettrigga is a radioactive medicine . warnings and precautions talk to your nuclear medicine doctor before using yhttroga . yattrige is not a medicinal product and should only be used as a single dose . it must not only be administered to patients who are able to communicate with each other . you must also read the package leaflet for radiopharmaceuticals . before using this medicine , you will be asked to carefully read the following information : ydtrigy contains radioactive material , which is contained in the package of radioactive medicinal products . children and adolescents yytrigriga is not
your doctor will determine and decide on the correct dose . method of administration yttriga is for oral use . it is recommended that radiolabelling of medicinal products is performed in accordance with national regulation on specific diseases . administration of yTtrig yettrigga is not intended for overdose . your doctor / health care professional will supervise the appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . reporting of side effects 9 . 4 % of patients with yettrigga gets any side effect . talk to your doctor , pharmacist or nurse if : you get any side impacts . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep out of the sight and reach of children . store in the original package in order to protect from light . do not use yttriga after the expiry date which is stated on the label after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . yittrig complies with local regulations on radioactive substances . any unused product or waste material should be disposed of in accordance with local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution for injection contains 1 g of hydrochloric acid ( see section 3 ). what Yttrigga looks like and contents of the pack yTtrig consists of a v - shaped bottom , a colourless type i glass vial , with 10 mL of solution with a flat bottom topped by a silicon stopper and an aluminium seal . the vial is a clear , colourless liquid .
ciambra is a medicine used in the treatment of cancer . ciama is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . in the long term , the combination of ciaba and cistplatin are used for the initial treatment of patients with advanced stage of lung cancer ; ciamba is used to treat patients with lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; in the short term - term stage , it is used as a treatment for patients with stage of long - lasting lung cancer who have had other initial chemotherapy has been used .
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciama ( listed in section 6 ). - for breast - feeding ; you must discontinue breast  - feed during treatment with ciamba . - you have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or hospital pharmacist before receiving ciaba . you have or have had problems with your kidneys . before each infusion of ciembra your doctor will test your blood to make sure that you have enough kidney and liver function and to check that you do have enough blood cells to receive the medicine . your doctor may decide to delay treatment with or stop treatment with this medicine if your blood cell counts are too low . in the event of a possible change in the dose of
ciambra will be given to you in a hospital or clinic . the recommended dose of ciama is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your normal body . this body surface area will be worked out to work best for you . a doctor or nurse will determine your dose and frequency of treatment depending on your blood cell counts and on your general condition . you will have mixed the ciampa powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before use . before you are given ciaba , you will be administered the dose by infusion into one of your veins . it is usually given for approximately 10 minutes . after you are also given a dose of either ciamba in combination with cisplatin : the dose
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : 52 fever or infection ( common ): if your temperature is 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if this happens , tell your doctor . chest pain ( common with a fast heart rate ) can be signs of pain , redness , swelling or sores in your mouth ( very common with allergic reaction ) if it occurs , contact your physician . skin rash ( very commonly referred to as burning or prickling sensation ) fever ( common in children ). skin reactions may progress to widespread blistering more than normal for 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution of pemetrexed should be used immediately after preparation . however , chemical and physical in - use stability of the reconstructed solution has been demonstrated for 24 hours at 2 - 8 and at 15 - 25 . from a microbiological point of view , the resulting product should be administered immediately . any unused solution should be disposed of in accordance with local requirements .
what ciambra contains the active substance is pemetrexed . ciama 100 mg : each vial contains 100 milligrams of pemetreXed ( as pemetrexxed disodium hemipentahydrate ). ciamma 500 mg  : every vialContains 500 milligramms of Pemetrexéd (a pemetreixed diodium dipent ahydrate). after reconstitution , the solution contains 25 mg / ml of pemeterxeed per vial . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for further information on phe adjustment , see section 2 " ciamba contains sodium "
what immunogam is immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) that help protect you from certain infections . immunogam helps to lower the levels of certain types of viruses in your blood . what immunogame is used for immunogam can be used to treat increased levels of human hepatitis b immunoglobularins , such as immunoglobuin g ( igg ) in the blood plasma of screened patients . how immunogam works immunogam reduces the amount of hepatis - b virus in haemodialysed patients whose condition has not improved after vaccination . individuals receiving a heptis
you must not be given immunogam : - if you have ever had an allergic reaction to human immunoglobulins , other blood products or human immunoglycaemia ( iga ) or other blood produits that contain an iga deficiency . in this case you might experience an allergic response to iga or to other iga related products . children and adolescents do not give immunogam to children below 18 years of age because immunogam contains human immunogranulin . the following adverse reactions may occur : chills ; headache ; fever ; vomiting ; allergic reactions , nausea ; arthralgia ( joint pain ); low blood pressure ; moderate low back pain . warnings and precautions talk to your doctor or nurse before receiving immunogam as you may develop antibodies against hepatitis b immunoglobular regularly or regularly , since human hepatis 
the recommended dose of immunogam for vaccination against hepatitis b virus is one dose ( 0 . 5 ml ) per kilogram of body weight . the first vaccine dose should be administered administered by a healthcare professional trained in the use of human hepatis - b immunoglobulin . administration prevention the recommended vaccination dose of heppatiti b is 500 micrograms per kilogram body weight administered every 24 hours for 72 hours . prevention of hematopoietic patients : 500 microgramms per kg body weight ( see section 2 under " warnings and precautions "). seroconversion the recommended dosage and timing of vaccination depend on the type of hbv . if you have hepepatite b or are a hepolitis bovine carrier , the hepathtis
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect affects1 to 10 Users in 1 , 000 ) rare ( affect 1 to10 users in 10 to 10 user in10 ,000 ) very rare ( effect occurs in less than 1 patient in 10 patients in 10 patient in10 and less than1 user in 1 10 , 00 , 1000 ) not known ( frequency cannot be estimated from the available data ). if you experience undesirable effects . during clinical trials with immunogam , the concentration of muscle was increased very commonly ( affect 10 users per 1 . 000 ), but the frequency for these effects was lower . in children ( 10 users / 1 
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the viale in the outer carton in order to protect from light . immunogam should not be used if the solution is cloudy or has particles or deposits . after opening , dispose of any unused solution . medicines should not to be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . one ml of immunogam contain 1 mg or 5 mg of human plasma protein of which at least 96 % is immunoglobulate . - other ingredients are polysorbate 80 . what immunogame looks like and contents of the pack immunogam is a solution for injection in a glass vial . it is essentially a colourless to pale yellow liquid . each pack contains 1 vial of solution .
remicade contains the active substance infliximab . influbimabe is a monoclonal antibody a type of protein that attaches to a specific target ( tnf ) called tumour necrosis factor  ( tnF ). remikade belongs to  a group of medicines called ' ttn4 - blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew 's disease ) ppsorasis . reMICade is also used in adults and children 6 years of age and older for crohn '' s disease or ulcerative colitis . when relicade works , it blocks
do not take remicade : if you are allergic to infliximab or any of the other ingredients of relicade ( listed in section 6 ). if this applies to you , tell your doctor . if your doctor thinks you may be allergic ( hypersensitive ) to proteins that come from mice . check with your doctor before taking reMICade and tell your doctors . do not stop taking . for children and adolescents : you have tuberculosis ( tb ) or another serious infection such as pneumonia or sepsis . you have heart failure that is not well controlled with remaculation . take special care with retinoids tell your dentist if any of these apply to you before taking your first dose of reticulation : tell your nurse or pharmacist before taking the first dose . don ' t
rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), ppsorasis , ulcerative colitis and crohn 's disease the usual dosage is 5 mg for each kg of weight , given once every week . how remicade is given remikade will be given to you by your doctor or nurse . your doctor will prepare the medicine for infusion . the medicine will be diluted and given as an infusion ( drip ) ( over 2 hours ) into one of your veins , usually in your arm . after the third treatment , your doctor may decide to give you another dose of relicade . it is unlikely that you will be treated with more re
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash , hives , swelling of the hands , feet or ankles . you may experience these reactions as well , an allergic response to remitre or to another medicine ( see section 2 ). more signs of allergic side effects that may happen up to 12 days after your injection include pain in the muscles , fever , chills , nausea , vomiting , diarrhoea 
remicade will be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). this medicine can also be stored in the original carton outside of refrigerated storage up to a maximum of 25 for a single period of up to three months . at the end of this three - year period , do not return to refrigerate or freeze . write the new expiry dates printed on the carton including day / month / year . record the date from when removed from the refrigerator in the space provided on the outer carton , when stored in - use storage times and conditions prior to use . relicade should be used as
what remicade contains the active substance is infliximab . each vial contains 100 mg of influbimag . after preparation each ml contains 10 mg of fliximab the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate and dibasic salt phosphatade . what reamicad looks like and contents of the pack reMICade is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white . relicade comes in packs of 1 , 2 , 3 , 4 , or 5 vials . not all pack sizes may be marketed .
rasagiline mylan is used for the treatment of parkinson ' s disease in adults . it can be used together with or without levodopa ( another medicine that is used to treat parkinsons ' disease ). with parkinSON 's disease , there is a loss of cells that produce dopamine in the brain . dopami is essentially a chemical in the body involved in movement control . rasagil mylan helps to increase and sustain levels of dopam in the mind .
do not take rasagiline mylan - if you are allergic to rasagilide or any of the other ingredients of this medicine ( listed in section 6 ). - you have severe liver problems . do not use the following medicines while taking rasagine mylan as it may affect the way rasagile mylan works : - monoamine oxidase ( mao ) inhibitors ( e . g . for treatment of depression or parkinson ' s disease , or alternatively for use with medicinal and natural products containing st . martin 's wort ) - pethidine ( a strong pain killer ). you must wait at least 14 days after stopping rasagigaline myLAN treatment and starting treatment . patients taking mao inhibitors and pethine should be aware that rasagaline myla can cause mild to moderate
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan can be taken with or without food . if your doctor thinks that you may have taken too much rasaginine mylan , contact your doctor immediately . take the rasagil mylan carton and the bottle with you to show the doctor or nurse or pharmacist . how long to take rasagaline myLAN take rasagariline in the morning and evening as prescribed by your doctor 23 you should take rasagamiline Mylan for as long as your physician continues to prescribe it . do not take a double dose to make up for a forgotten dose . just take your next dose at the usual time . it is important that you continue taking rasagigaline
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of placebo are presented below . their frequency is defined as follows : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect affects less than 1 patient in 1 , 000 ) very rare ( affect occurs less than1 patient in 1010 ,000 ) not known ( frequency cannot be estimated from the available data ): very commonly abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) general feeling of being unwell ( including neck pain and chest pain ( angina pectoris ) reporting of side effects 23 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also
what rasagiline mylan contains - the active substance is rasagililine . each tablet contains rasagilliline tartrate equivalent to 1 mg rasagile . - other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maizestarch ; talc , stearic acid what rasaagiline myLAN looks like and contents of the pack rasagiziline tablets are 11 . 5 mg / 6 mg tablets are white to off - white , biconvex tablets of 1 mg . the tablets are provided in blister packs containing 7 , 10 , 28 , 30 , 100 and 112 tablets , in perforated unit dose blisters . not all pack sizes may be marketed .
do not use hulio if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor or nurse thinks you may have a severe infection , including tuberculosis ( see " warnings and precautions "). it is important that you tell your doctor if any of these apply to you . symptoms of infections , for example , fever , wounds , feeling tired , dental problems . if so , tell your dentist . warnings şi precautions talk to your doctor before using hULio as you should tell your doctors if : you have moderate or severe heart failure . you have , or have had , a serious heart condition ( see section 4 ). allergic reaction if allergic reactions have occurred ( with symptoms such as chest tightness , whe
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . for polyarticular juvenile idiopathic arthritis in adults , adolescents and children from 2 to 17 years of age : the usual dose is 10 mg once a day for 30 days . your doctor may decide to increase your dose of hulio to 20 mg once daily . in children and adolescents from 2 months to 17 months of age ( including elderly ), the usual starting dose is 30 mg once weekly . a doctor may increase your starting dose to 40 mg once every week . not applicable in enthesitis - related arthritis in children ( from 6 to 17 year of age with a body weight of 15 kg to less than 30 kg ), your doctor will decide the right dose of the first dose of one tablet . you should take hUL
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require urgent medical treatment . side effects may occur up to 4 months or more after the last hulio injection . seek medical attention urgently . these side effects were reported in patients who have already experienced allergic reaction or heart failure . signs may include severe rash , hives swollen face , hands or feet , trouble breathing , swallowing , pale complexion , dizziness , persistent fever , possibly with bruising or bleeding . tell your doctor as soon as possible if you notice signs and symptoms of infection such as fever ; feeling sick ; being sick , vomiting , nausea and vomiting . this is because it is very important to tell your partner or caregivers that you are taking
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what heulia looks like and contents of the pack hULio 40 mg / ml solution for injection in a sterile solution contains 40 mg of aadhalimumb , and is 0 . 8 mL clear to slightly opalescent solution in  a glass vial with a rubber stopper . hülio is available in packs containing 1 or 2 vials , 1 steril injection syringe , 2 sterility needle , 3 sterILE vial adapter , 4 alcohol
yellox contains bromfenac , which belongs to a group of medicines called non - steroidal anti - inflammation drugs ( nsaids ) that reduce inflammation . yellx is used to reduce the amount of eye inflammation following cataract surgery .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using yelsh : - you have asthma , skin allergy or intense inflammation in your nose that is not controlled with other nsaids . nSaids include acetylsalicylic acid , ibuprofen , ketoprofened , diclofenocide . do not take this medicine if any of those apply to you . topical steroids ( such as cortisone ) may increase the risk of unwanted side effects . talk to you doctor if : you have had bleeding problems in the past . you are taking other medicines that may increase bleeding time . this is because yemophilia may
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop of yellox into your eye ( s ) or your eye( ss ). the recommended daily dose is 2 drops per day . you can take the drops at any time of the day after your cataract surgery . method of administration yellowx is for oral use . use your hands at the same time to apply the eye drops . twist off the bottle cap . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your eyelid with a finger , until the tip touches the eyelid . if it does not work properly , repeat the steps for your other eye .
what bromfenac contains - the active substance is bromfienac . each ml of solution contains brom Fenac ( as sodium sesquihydrate ). each sachet contains 33 mg bromfed . -the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tolbutamide , povidone ( k30 ), disodium edetate and sodium hydroxide to keep acidity levels normal . what bromas looks like and contents of the pack bromfernac is a clear yellow liquid ( solution ) that appears to be a colourless light yellow liquid . it is supplied in a pack containing one 5 mL glass vial with a screw cap .
dzuveo contains the active substance sufentanil , which belongs to a group of strong painkillers called opioids . sufenteanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking d Zuveo and during treatment if : you have any condition that affects your breathing ( such as asthma , wheezing , or shortness of breath ), as d zuveo may affect your breathing . during treatment you have had a head injury or brain tumour . your doctor may need to monitor your heart and circulation ( especially slow heart rate , irregular heartbeat , low blood volume or low blood pressure ). you have moderate to severe liver problems . you have severe kidney problems , as a result of dzveo can affect your kidneys , heart rate
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device should be used only by healthcare professionals trained in giving this medicine . dzuveo must only be prescribed by a doctor experienced in the use of strong painkillers such as sufentanil . how much to take the recommended dose is 30 mg . take the sublingual tablet with the disposable single  dose applicator provided in the carton . to administer the tablet , the tablet must be swallowed whole with half a glass of water . do not crush or chew the tablet as this may affect the amount of medicine that is supplied in the applicators . instructions for use the app is provided in a carton , which is provided with the app . place the tablet under your tongue . allow the tablets dissolve under the tongue and allow to
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical attention : - severe breathing problems , such as slow and shallow breathing . if any of these side effects get serious , or if they continue for a long time , stop taking dzuveo and contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ):  nausea ( feeling sick ),  vomiting ( being sick )  feeling hot . common side effect ( may effect up to 1 in10 people ).  inability or difficulty sleeping . not known ( frequency cannot be estimated from the available data ) feeling tired ,  difficulty sleeping ( insomnia ) and feeling sleepy . uncommon side effects may affect up to1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light and oxygen . this medicine does not require any special temperature storage conditions . please record the date of opening on the viabiliser and the date after exp on the label . if you notice any visible signs of deterioration , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of sufenteanil ( as citrate ). -the other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose , criscarmellose sodium , indigo carmine ( k90 ), stearic acid , magnesium stearrate . what azuveou looks like and contents of the pack the sufenil applicator is a white , round edges , debossed with " sn / l " on one side and " 3 " on the other side . dZveo is available as a single - dose applicators ( labelled [ sublingual tablet ]). the applicant contains one sufENTanil
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body and cannot be treated with surgical treatments . this is if a type of sensitive prostate cancer has spread within the body or cannot be removed by surgical treatment . only patients who produce testosterone can produce a " resistant prostate cancer ". erleda targets the male hormone called androgens which is needed to treat the cancer . androgènes , together with apalutaMIDe , stops prostate cancer cells from growing and multiplying .
do not take erleada if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there is still a possibility you can get pregnant ( see section " pregnancy , breast - feeding and contraception section ").  if any of these apply to you ( or you are not sure ), talk to your doctor before taking this medicine . warnings and precautions talk to you before taking erlesad : if your doctor considers you pregnant or if it is not clear whether this medicine is safe and effective . taking this medicinal medicine , you may get seizures . tell your doctors if or when you are taking any medicines to prevent blood clots ( e .g . warfarin or acenocoumarol ).
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day for one month . your doctor will tell you exactly the dose to take . if necessary your doctor may tell you to take 60 mg twice a week . take erleada about the same time each day . this medicine is taken by mouth and can be taken with or without food . you should take ERleadea with other medicines . it is best to take your tablet with food , and swallow it whole with water . do not chew or crush the tablet . taking erleda while taking ERLEadа while taking other medicines may lower the amount of erlesad . to help you remember to take it , you may find it easier to take the tablet at the same times every day
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and contact a doctor immediately if you have any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk ( often with central blisters ), skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes can be preceded by fever and flu - type symptoms ( toxic epidermal necrolysis ). serious side effects include those listed below . fit , seizure , and fits have been reported in up to 1 in 100 patients taking a erleda . if these effects are not treated they could be fatal . your doctor will check you for side effects before you start taking , or if necessary
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutaMIDe - -the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hyperromellose acetate succinate , magnesium stearate , microcrystalline cellulose and silicified microcrystalline cellulose . the film  - coating contains iron oxide black ( e172 ), iron oxide yellow ( i )), macrogol , polyvinyl alcohol , the talc , and titanium dioxide (  e171 ). what Erleade looks like and contents of the pack erlesad consists of film , film . film  shaped , round , biconvex , slightly yellowish , oval , de
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient fluciclovine . it is used to obtain a picture ( scan ) from your pet ( a pet scan ), if you have previously had treatment for prostate cancer . other tests will be performed to find out whether the presence of prostate specific antigen ( psa ) is present in the cancer , so that an azumin pet scan can be performed if the cancer has responded to the test . the use of aXumin does involve exposure to small amounts of radioactivity . your pet scan will give your doctor information about the location and the kind of cancer the pet scan you have . you should discuss the results of the test with the doctor that requested the scan . use of this procedure with the radiopharmaciaceuticals does involve exposed to small amount of
do not take axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking aXumin as it may cause kidney problems . if your doctor thinks you may be following a low sodium diet , ask your doctor for advice . you should not take this medicine after the expiry date which is stated on the blister and the carton after the injection . the usual dose of azumin is one scan . it is recommended that you take it at least 4 hours before the apumin scan , and at least four hours after the scan ; however , you should take your usual medicines as prescribed by your doctor . drink plenty of water during the latest 60 minutes after the apoxumine injection , so you should avoid urin
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in specially controlled areas . this medicine will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . dose the nuclear medicine doctor supervising the procedure will decide on the quantity of aXumin to be used and will calculate the quantity to be administered depending on the required quantity . the quantity depends on the product being measured as 370 mbq ( megabecquerel , the unit used to express radioactivity ). administration of  azumin and conduct of the procedure a xummin is given into a vein by injection with a flush of sodium chloride solution before administration . duration of the operation
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies side effects were uncommon ( may affect up to 1 in 100 people ) and were not long - lasting . if you experience any of these , stop using the medicine and tell your doctor immediately . the most frequently reported side effects of axumin ( may effect up to1 in 100 patients ) were pain , rash , altered taste in the mouth , and altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects 9 if your doctor gets any side effects talk to your nuclear medicine doctor . these side effects are listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . axumin must not be used after the expiry date which is stated on the label after exp .
what axumin contains - the active substance is fluciclovine . aixumin 1600 mbq / ml the active substances are 1600 iu ( 1600  g ) flucclovine and 16000 ius ( 1600 to 16000 international units ) of aexumin . 3200 ii / 1 : each tablet contains 3200 international units of f Luciclovine ( 3200 to 32000 international units [ iuk ]), sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " a ) "). what - azumin looks like and contents of the pack aXumin 160 ik / 1600 u / 10 : white to off - white , round , multidose vial of 1 , 10 
the active substance of azopt , brinzolamide , belongs to a group of medicines called carbonic anhydrase inhibitors . they work by reducing pressure within the eye . aziopt eye drops are used to reduce high pressure in the eye which can lead to an illness called glaucoma . too much pressure in one eye can cause damage to your sight .
do not take azopt if you have severe kidney problems . if your doctor has told you that you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor and do not use aziopt . allergic to medicines called sulphonamides ( e . G . medicines used to treat diabetes or infections ) or diuretics ( water tablets ). warnings and precautions talk to your doctor before taking azamopt , if : you have the same allergy to medicines that contain too much acidity in your blood ( hyperchloraemic acidosis ). take special care with azyopt : if any of these apply to you and tell your doctors . you have kidney or liver problems , or if they are severe . have dry eyes or cornea
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day in both eyes ( see section 6 ). instructions for use follow these instructions carefully and ask your doctor to show you how to use azopt . use in adults the recommended eye drops are 1 drop in each eye and one drop in the other eye should be used . a touch of azamopt may help the eyes to relax . how to take aezopt for adults the usual dose is 1 tablet once daily in the morning and 2 tablets once - a night . take the azyopt bottle with a glass of water , and use it for as long as your physician tells you to . 1 2 3 take the first dose of the apollegue bottle . wash your hands . remove
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision - eye irritation - headache - vision loss - eyesight - blurred / cloudy eyes - cataract - dry eye - abnormal eye sensation - redness of the eye other side effects include : - bad taste . uncommon side effects may affects up to1 in 100 people - effect in the eyes : loss of vision , eye irritation and eye discharge - itchy eye , dry eye and abnormal eye perception - increased eye sensation including redness in the back of the field of vision ( this can be a sign of the side effects above ), bad taste ( see section 2 ). uncommon side effect (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . azopt should not be used if you notice any visible sign of infections . however , in a pack containing a single bottle , this medicine may be harmful .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzolani . -the other ingredients are benzalkonium chloride ( e321 ), carbomer 974p ( k29 ), edetate disodium ( 0 . 5 mmol ), and mannitol ( cp ). - other ingredients ( excipients ) are purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide . these are used to keep acidity levels ( ph levels ) normal . what - aazopter looks like and contents of the pack azyopt is a milky liquid ( a suspension ) that comes in a 5 g / m bottle and a
forxiga contains the active substance dapagliflozin . it belongs to a group of medicines called " oral anti - diabetics ". these are medicines taken by mouth for diabetes . they work by lowering the amount of sugar ( glucose ) in your blood . forxika is used in adults ( aged 18 years and older ). forxega can be used for : - diabetes - type 1 diabetes where your body does not make any insulin . - forxuga can be prescribed for you if you have type 1 diabetic patients ( those who weigh at least 15 kg ) - those whose diabetes is particularly high - are overweight or obese . type 2 diabetes where the body is not able to use any insulin and the insulin that your body produces does not work as well as it should . this leads to : high levels of sugar in your body .
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxega : - talk to you doctor or nurse before taking this medicine : the risk of feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , or a fruity or metallic taste in your mouth , an odour to your urine or sweat , rapid weight loss . the above symptoms could be a sign of " diabetic ketoacidosis " a problem you can get with diabetes because of increased levels of " ketone bodies " in your urine . these are seen commonly in patients treated with insulin . your doctor may
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take forxiga is important to get the best results for your health . for type 2 diabetes : the recommended dose is one 10 mg tablet once a day . your doctor may prescribe you a lower dose ( a maximum of 5 mg ) if your liver problem is not controlling your condition . the recommended dosage of forxega for type 1 diabetes is one 5 mg tablet twice aday . taking this medicine swallow the tablet whole with some water . you can take the tablet with or without food . it is best to take the tablets at the same time each day , preferably at the beginning of the day ; however , try to take your daily dose at about the same times each day with water ; this will help get the desired effect 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking forxiga and contact a doctor immediately if you notice any of the following serious side effects you may need immediate medical attention : angioedema , seen very rarely ( may affect up to 1 in 10 , 000 people ) these are signs of angioédema ( e . g . swelling of the face , tongue or throat , difficulties swallowing , hives or breathing problems ). diabetic ketoacidosis , see also section 2 warnings and precautions . type 1 diabetes , observed commonly ( may effect up to1 in 10 people ). type 2 diabetes : seen rarely ( might affect upto 1 in 1 ,000 people ), seen rarely . diabetic ketoacidiosis - see also segment 2 : signs include
what forxiga contains - the active substance is dapagliflozin . each forxega 5 mg film - coated tablet ( tablet ) contains dapagligiflonzin propanediol monohydrate equivalent to 5 mg dapaglingiflofloz . - other ingredients are : tablet core : microcrystalline cellulose , lactose ( see section 2 under ' forxika contains lactoses '), crospovidone type a , silicon dioxide , magnesium stearate . film , coating : polyvinyl alcohol , titanium dioxide ; macrogol 3350 , talc ( e553b ), yellow iron oxide ( granules ). what forixiga looks like and contents of the pack forxige 5 mg is supplied as a round , film . tablet dimensions 
mepact contains the active substance sifamurtide which stops the growth of certain bacteria which affect the immune system . mepace is used to treat osteosarcoma ( bone cancer ) in adults and children between 2 and 30 years of age . it is used when surgery to remove the tumour is not possible or is not suitable . in patients who receive chemotherapy to kill cancer cells , the medicine can destroy cancer and keep it from coming back .
do not use mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - when you are taking medicines containing other ciclosporin and other calciumineurin inhibitors ( non - serotonin - anti - immune drugs or nsaids ). warnings and precautions talk to your doctor before using mepace : as mepactation may cause problems with your heart or blood vessels such as blood clots ( thrombosis ) or bleeding ( haemorrhage ). as me Pact treatment may lead to long - lasting or worsening symptoms . tell your doctor about any new or worse effects you experience after starting mepacd treatment . talk to you doctor if : you have asthma or other breathing disorders , as you may need closer
treatment mepact is given by your doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor , nurse or pharmacist if you are not sure . the recommended dose of mepactation is 2 mg mifamurtide , given every 12 to 24 hours . your doctor may change your mepace treatments according to your chemotherapy schedule . you will receive your chemotherapy 36 weeks after treatment with mepactate . do not stop taking mepacat if there is an interruption of your chemotherapy . reconstituted mepacted powder is mixed with a liquid suspension to form a suspension before it is given to you , the filter will be activated and infused into the liquid before use . mepacting is given into a vein over about 1 hour . treatment with more mepacten than you should mepaca can cause severe side effects such as fever ,
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue may occur very rarely during treatment with mepace . if you are transient and experience paracetamol , you should contact your doctor immediately . fever may occur at the beginning of treatment with Mepact . stomach problems such as nausea , vomiting and loss of appetite during chemotherapy should be reported immediately , particularly if the patient has continued fever or chills after 8 weeks of treatment . tell your doctor if any of the side effects gets serious . signs of an infection such as rash or any problems breathing or wheezing , please tell your physician . these side effects are most likely to occur during the first week after treatment with youpact and usually improve over time . normal daily activities such as eating , drinking , or taking physical activity such as running , running
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the viall in outer carton in order to protect from light . reconstituted suspension should be used immediately after preparation . in order for recombinant use , sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection should be stored at 2 - 8 , protected from light for up to 6 hours . this medicine does not require any special storage conditions . no visible signs of deterioration are observed .
what mepact contains the active substance is mifamurtide . each ml contains 4 mg of mIFamurmurtde . after reconstitution , each sachet of suspension contains 0 . 08 mg of mg mfamurdide - the other ingredients are 1 - palmitoyl - 2 - oleoyll - shn - glycolo - 3 - polycholine ( see section 2 ), 2 , 3 , 4 - dioleayl- sn , glycero -3 - po - laure monosodium salt ( see end of section 2 for further information ). what me Pact looks like and contents of the pack mepace is a white homogeneous cake for solution for infusion . mepacd is supplied in
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin of the face to reduce redness ( rosacea ) and to reduce the redness of the facial area . rosACEa is caused by high levels of blood flow in the facial skin , which can lead to enlargement ( dilation ) of the small blood vessels of the skin . mirvass acts by blocking the blood vessels which are damaged by the excess blood flow and causing redness .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking mirvasa : - read the package leaflet , which is included in the package . - the package contains 2 warnings , and side effects . the medicine should be injected under the skin ( subcutaneous use ). - certain medicines for depression and parkinson ' s disease may be considered as monoamine oxidase ( mao ) inhibitors ( e . G . selegiline , moclobemide ), tricyclic antidepressants ( i . E . imipramine ) and tetracyclic antagonists ( such as maprotiline ; mianserin ; mirtaza
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is for use on the skin only . on the face this medicine should only be applied to the surface of your body or to other parts of your life ( such as your eyes , mouth , nose or vagina ). how much to use your doctor will tell you how much mirvasa to use . how to use mirvass mirvasto is only for use if it is on the same face . during the treatment , your doctor may ask you to swallow a small amount of gel ( a pea - sized amount ) to work . if your symptoms do not improve if the dose is too strong or too weak , the doctor may advise you to increase the dose to one pea- shaped amount , once a day , preferably on
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects are : severe skin irritation or inflammation , skin rash , hair loss , eye irritation , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects is a higher risk of worsening of rosacea as a result of the treatment . symptoms described in section 2 may indicate contact allergy or allergic reaction , such as rash and rare angioedema ( a serious allergic reaction with rash may be severe ). rare angina pectoris ( squamous cell carcinoma ), which may be a sign of a reaction to mirvaso , redness or itching of the skin . reporting of side effects 30 if you get any side effects talk to your doctor or pharmacist . this
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , tube and pump after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . mirvaso will be stored in the healthcare facility where it is used . store in a refrigerator ( 2 8 ). do not freeze . discard if you notice any change in the appearance of the tablets . tube and push - through seal are visible .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimoniidine - each sachet contains 5 mg of bronidine tartrate . -the other ingredients are : carbomer , methylparahydroxybenzoate , and phenoxyethanol . ingredients of the concentrate are glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasa contains methyl parahydroxybenzonoate and propyl glycol "). what mirvao looks like and contents of the pack mirvass is a clear , opaque gel . it is supplied in 2 mL , 10 m2 or 30 m3 of gel with airless pump system . not all pack sizes
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that is normally made by the immune system to help defend the body from infection and cancer ). bevacimizumac binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of blood and lymph vessels in the body . the veggf protein causes blood vessels to grow within tumours , these blood vessels provide the tumour with nutrients and oxygen . once bevacimab is bound to vegas , tumour growth is prevented by blocking the growth of the blood vessels which provide the nutrients and nutrients and also by providing oxygen to the tumour . mvai is , therefore , a medicine for the treatment of adult patients with advanced cancer in the large bowel
do not take mvasi if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if your response to mvai is not clear or colourless . warnings and precautions talk to your doctor , pharmacist or nurse before taking m Vasi . you may be allergic ( highly sensitive ) towards chinese hamster ovary ( cho ) cell products . do not use mbusi : if any of these apply to you or your child . take special care with mwasi mmusi may increase the risk of developing holes in the gut wall . also , be aware of the possibility of inflammation inside the abdomen ( e .g . diverticulitis , stomach ulcers
dosage and frequency of administration the dose of mvasi needed depends on your body weight and the kind of cancer to be treated . the recommended dose is 5 mg , 7 . 5 mg, 10 mg or 15 mg per kilogram of your bodyweight . your doctor will prescribe a dose of 15 mg / kg . you will be treated with mvai once every 2 or 3 weeks . if you respond well to treatment , you may be given this medicine longer than one infusion per day . it may take longer than three weeks before m Vasi is given , depending on the response of your tumour growing . duration of administration mvasculari is a concentrate for solution for infusion . depending on how well mbusi is prepared , the mbasi vial will be diluted with sodium chloride solution before use . furthermore , this diluted mwasi solution
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . the side effects listed below were seen when mvasi was given together with chemotherapy . it is possible that these side effects were more severe when compared with other medicines given before mvai was used . allergic reactions if any of the following happen , tell your doctor straight away . signs of an allergic reaction may include difficulty in breathing , chest pain , redness or flushing of the skin or a rash , chills and shivering , feeling sick ( nausea ) or being sick ( vomiting ). if this happens , talk to the doctor straightaway . other possible side impacts include severe side effects including : very common ( may affect more
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 and protected from light ( but not above 25 ). the infusion systems should be administered in  a sterile environment . after diluted in steril environment , the product should be utilized immediately . chemical and physical in  use stability has been demonstrated for 35 hours at room temperature ( at 2
what mvasi contains the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevacitizum , corresponding to 1 . 4 to 16 . 5 mg / m2 when diluted as recommended . one 4 mL vial contains 100 mg of Bevacizub , correspondant to 1 4 . 8 mg , or 400 mg of BEvacibub corresponding at 16  . 6 mg . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mmvasi looks like and contents of the pack mvai is a concentrate for solution for infusion . it is : a clear to slightly opalescent and colourless to slightly yellow liquid in a glass vial with a rubber stopper . 
tecartus is a gene therapy medicine used to treat mantle cell lymphoma in adults . it is used in combination with other medicines to treat refractory mantles cell lymphomema , in which your own white blood cells ( named autologous anti - cd19 - transduced cc3 + cells ) are included in the treatment . mantLE cell lymphomatoma is  a cancer that affects the immune system ( the body ' s natural defences ) that affect certain types of b - lymphocytes . in mantled cell lymphopenia b- lymphoblasts are involved in a certain way , from the lymph tissue to the bone marrow to the blood . tecARTus binds the white blood cell in your blood , allowing the cancer cells to multiply and multiply within
do not use tecartus - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). - you are not allergic to any of those ingredients . warnings and precautions talk to your doctor or pharmacist before using tecARTus . tec artus contains white blood cells that are collected from your blood ( lymphodepleting chemotherapy ). see section 3 , ' tecArtus contains enough white blood cell types for autologous use '. tests and checks your doctor will perform tests to check your lungs , heart , kidney and blood pressure . you must also tell your doctor if : - there is a risk of infection or inflammation of your cancer ( graft - against - host disease ). before you receive tecantus , your doctor may check your body for signs and symptoms such as rash 
tecartus is made specially for you by your own white blood cells . your cells will be collected from you and given to you by a qualified healthcare professional . if your doctor has given you more than one catheter placed in your vein ( a procedure call leukapheresis ), your white blood cell count will be reduced to a minimum of 10 - 15 % of your total number of your blood cells per day . this will happen by slowly adding more blood into your vein . the process takes about 3 to 6 hours . depending on the number of  your white cells , your doctor may increase the dose to 2 to 3 more than once a day , depending on how your body responds to medicines . during tecARTus treatment , you will receive lymphodepleting chemotherapy to keep the modified white bloodcells in your body for 30 to 60 minutes . you will be given other
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will monitor your side effects closely to detect any possible side effects that may be serious . you may need urgent medical attention if you notice any of the following side effects during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever and chills ; reduced blood pressure ; symptoms such as dizziness or lightheadedness ; fluid in the lungs ; all symptoms associated with a condition called cytokine release syndrome . loss of consciousness ; decreased level of consciousness may lead to confusion ; memory loss ; difficulty in thinking clearly and understanding reality . tell your doctor as soon as possible if this happens . other side effects very common : may affect up to 1 in every 10 people ( may occur with up to1 in every 100 people ); confusion ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and infusion bag after exp . the expiration date refers to the last day of that month . store in liquid nitrogen ( 2 - 8 ). do not freeze . after dilution , if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . storage of tecartus is limited to the use of genetically modified human blood cells and human - derived material . these measures will help protect the environment .
what tecartus contains - the active substance is autologous anti - cd19 - transduced cc3 + cells in single infusion bag . each vial contains a dispersion of anti  - cad19 car t cells in approximately 68 ml at concentrations of 2 x 106 anti . - other ingredients are sodium chloride and human albumin . see section 2 , tecARTUS contains sodium . what Tecartus looks like and contents of the pack tecArtus is a clear to opaque , white to off - white dispertion for infusion , supplied in an infusion bags , individually packed in a metal cassette . the contents of a single infringing bag are approximately 69 mL of cell dispersed in syringes .
januvia contains the active substance sitagliptin which belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 5 inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2 diabetic . it is important that you continue to take this medicine and it is used alone , as well as certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ), which you will need to take to lower blood sugar in order to control your diabetes . if you have type 2 dementia ,
do not take januvia if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). if there is inflammation of the pancreas ( pancreatictitis ) that is not under control ( see " warnings and precautions " in section 4 ). for example , if blistering of the skin is common ( this may be a sign for a condition called bullous pemphigoid ). warnings janusvia may cause a disease of the Pancreases ( such as pancreattitis "). talk to your doctor or pharmacist before taking janugavia : if your doctor suspects you may have gallstones , alcohol dependence or very high levels of triglycerides ( a type of fat ) in your blood . these medical conditions can increase your chance of getting pancre
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once a day by mouth if your kidney problems are not controlled , your doctor may prescribe lower doses ( such as 25 mg or 50 mg ). you can take this tablet with or without food and drink . your doctor will decide whether to increase your dose of this medicine or to take certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important to stay on the diet and exercising recommended by your doctor while taking januvia . if this medicine is not effective at the same time as it should , talk to your doctor immediately . take the tablet before a meal . you can continue to take janugavia for as long as your doctors prescribe it
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact your doctor immediately if you notice any of the following serious side effects you may need urgent medical attention : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreattitis ). a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin / peeling skin and swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . this is uncommon . if any of these side effects becomes severe , contact your physician immediately . your doctor may decide to reduce the dose or stop the treatment . side effects with janus
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglitin phosphate monohydrate , equivalent to 25 mg sitaglictin the other ingredients are : in the tablet core : microcrystalline cellulose ( e460 ), calcium hydrogen phosphat ( i . e . in the film  coating ), croscarmellose sodium , magnesium stearate ( е470b ), and sodium stearyl fumarate . the tablet film  - coating contains : poly ( vinyl alcohol ), macrogol 3350 , talc ( ctab ), titanium dioxide (  e171 ), red iron oxide ( erection ) and yellow iron oxide [ e172 ]. what a janusvia looks like and contents of the pack
what xultophy is xULtophy increases blood glucose ( glucose ) in adults with type 2 diabetes mellitus . this type of diabetes occurs when your body does not make enough insulin , and the insulin that your body makes does not work as well as it should . how xültophy works insulin degludec is a long - acting basal insulin that helps your blood sugar levels stay below normal . it helps your body to increase the production of sugar when it is needed . liraglutide ( also known as glp - 1 ) is another type of insulin during meals . the combination of xelector and oral medicines for diabetes xulationphy may be used in combination with oral medicines to treat diabetes .
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 if your doctor has told you that you have used a sulfonylurea ( e . g ., glimepiride or glibenclamide ), or any other medicine . your doctor may need to adjust your sulphfonilurean dose if necessary . this is because your blood sugar levels may need adjustment . warnings and precautions talk to your doctor or pharmacist before using xULtophy as your doctor will have decided if : you have type 1 diabetes mellitus or ' ketoacidosis ', a condition which usually occurs after the first treatment with xültophy is started . you
always use this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . if your blind or have poor eyesight and your blood sugar level is not controlled , you should use xultophy as recommended 41 for adults . you should take xULTOphy every day for as long as your physician prescribes it for you , as directed by your doctor or pharmacist . the daily dose of xültophy is 8 mg / day . take XultoPhy with food and drink 41 if necessary , your doctor may advise you to take it earlier than usual . how to use XULTOPhy using a pre - filled dial - a - dose pen only once a day , using the dose counter and setting the dose indicator at the specified time . read the " instructions for use " provided in the box
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common , may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out and you may become unconscious . serious hypoglycaemia may cause brain damage and may be life - threatening . low blood glucose may be a sign of your blood glucose level getting too low . this is called hypoglemia . see the box at the end of this leaflet for more information . in addition , low blood Sugar can be absorbed into your bloodstream and can be passed out in the presence of someone who knows how to deal with it . for further information , see the information in this section . if you are having serious allergic reaction ( anaphylactic reaction ) not known ( frequency cannot be estimated from the available data
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening the blister can be stored for up to 30 days in ' use ' or in : a fridge ( 2 - 8 ) for upto 21 days . keep the blister in the outer carton in order to protect from light . never throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin deGludec , equivalent to 3 . 6 mg liliraglutede , corresponding to 3 mg / mL . one vial contains 300 units of glucose deglu deglucec corresponding  to 10 . 8 mg  l iraglutade ). the other ingredients are glycerol , propylene glycol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 " xULTOphy contains sodium "). what XultoPhy looks like and contents of the pack xültophy is a clear , colourless solution for injection . it is supplied in 
giotrif is a medicine that contains the active substance afatinib . it is based on proteins called egfr [ epidermal growth factor receptor ] ( erbb1 ) and her2 [ erbeb2 ] and erebb3 . these proteins help cancer cells grow and multiply . by attaching to erfr , this helps to kill cancer cells . this medicine slows down the growth of cancer cells and improves their survival . giotricrium is used for the treatment of adult patients with cancer of the lung ( non - small cell lung cancer ). giotraf is your first treatment if you have had prior chemotherapy treatment for squamous type or if prior chemotherapy therapy has not worked .
do not take giotrif - if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) - for patients with low body weight less than 50 kg - in patients with kidney problems , as giotro has been shown to increase side effects - lung inflammation ( interstitial lung disease ) ( see section 4 ). - liver problems - your doctor may need to carry out some liver tests before you start taking this medicine , to check whether you have a severe liver disease . - eye problems : if your doctor thinks you may have severe dry eyes , inflammation of the transparent layer at the back of the eye ( cornea ) or ulcers in the front of the front part of the field of vision . talk to your doctor before taking gioTRIf if any of these apply to you . warnings
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . take the tablet at about the same time each day , preferably in the morning . this medicine can be taken with or without food . your doctor will tell you how many tablets of this medicine to take . you should take this medication for at least 1 hour before or 3 hours after taking this medicine . do not take more than the recommended dosage . taking this medication it is important that you take this medicinal product only by mouth . if your doctor thinks that you have difficulties swallowing the tablet , tell your doctor . alternatively , your doctor may give you other liquids ( e .g . water ) at least 15 minutes before you take the tablets . through a gastric tube , you will be
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects may happen with treatment : diarrhoea common ( may affect up to 1 in 10 people ): dirrhooooea after 2 hours of drinking alcohol . severe diarhooeal with fluid loss common ( May affect upto 1 in every 10 people): low blood potassium , worsening kidney function if you experience diarrehoa you should contact your doctor immediately . start appropriate antidiarrheal treatment and antidiarrhaeal medicine prior to starting giotricrhoneal medicine . contact your physician immediately if any of the following apply to you : very common : nausea common - may affect more than 1 in 5 people : low level of potassium in the blood - common ; diar
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of a fatinibe . - other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , all in the tablet core ; hypromellose , macrogol 400 , titanium dioxide ( e171 ), and polysorbate 80 ( cb ). what hepatitis looks like and contents of the pack giotricr 20 mg film  coated tablets are white to off - white , oval shaped and embossed with the company logo and the boehringer ingelheim logo on one side . the tablet can be divided into equal doses . it is available in packs containing 1 ,
orkambi contains two active substances : lumacaftor and ivacaftre . ork Ambi is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and children aged 6 years and older . with a f508del mutation in a protein called cd408dna , it affects a part of the cystic fistula ( cystic cystic fungal infection ) called f58dell . the mutation causes an abnormal ccftr protein to work more effectively . lumamcafor and in combination with ivacastor work by delivering the abnormal fttrprotein to your lungs . this may help your breathing and your lung function to improve as you continue to gain weight .
do not take orkambi - if you are allergic to lumacaftor , ivacaftre or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ork Ambi . talk to a doctor or a pharmacist before and during taking or Kambi if : you have been treated with orkacco if the f508del mutation is present in any of these variants . you have liver or kidney disease . your doctor may need to adjust the dose of orkami . if abnormal blood tests of the liver occur , your doctor will stop treatment with orKambi . tell your doctor if any of those symptoms occur . signs of liver problems may include : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the white part of your eyes
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 6 to 12 tablets per day . you should take orkambi tablet about 6 to 11 hours after a meal . if necessary your doctor may tell you to take a different dose . adults the recommended starting dose of ork Ambi is 100 mg ( two tablets of 2 mg ) in the morning and 200 mg ( three tablets of 1 mg ). you should swallow the tablet whole with some water . do not chew or crush the tablet . for children 12 years of age and over the recommended adult dose oforkambi is 200 mg , two tablets in the evening and 200mg ( two tablet of 2 g ) once a day , in the afternoon and 900mg once  a morning . use in children and adolescents the recommended
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with orkambi are usually mild to moderate and of a short duration . if you experience any of the following symptoms , you should immediately contact your doctor : - pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the white part of your eyes - loss of appetite - flushing - indigestion - stomach pain uncommon : may affect up to 1 in 100 people - difficulty in urinating - liver injury - pre - existing severe liver disease - the worsening of liver function other possible side effects common : the following may affect more than 1 in 10 people if your doctor determines that you may be suffering from any of these , please tell your doctor as soon as possible : very common - may affect less
what orkambi contains the active substances are lumacaftor and ivacafter . ork Ambi 100 mg / 125 mg : each capsule contains 100 mg of lumаcafor and only 125 micrograms of iva caftoral . Orkambi 200 mg . each capsule has 200 mg of either lumcaftar and 125 mm of i . e . of vcaftra . the other ingredients are orkamba 100 mg and 127 microgram ( iu ) ivaccaftour . andkambi 100 mg ( 125 milligram ) orkacco 200 mg ( 2 . 5 milliliter ): the other excipients are cellulose , microcrystalline , croscarmellose sodium , and hypromellose sodium ( e468 
what lynparza is lyinparza contains the active substance olaparib . o laparib is a type of cancer medicine called a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). people with mutations ( changes ) in the brca ( breast cancer gene ) are at risk of cancer . parp inhibitions cause the death of cancer cells . how lypparza works lylparza , which contains an enzyme that helps the body to repair dna , is involved in the normal working of the body . what LYnparz is used for lyngparza may be used to treat ovarian cancer in adults , adolescents and children who have a certain type of brca - brca is recombinant , mut
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before taking lyndparza and during your treatment with lyngparza ( see section 4 ). lyinparza can cause low blood cell counts . your doctor will do testing to see if ly nparzan is working for you . low counts of red or white blood cells , or low platelet counts ( see also section 4 for more information about possible side effects ). you and your doctor should weigh 75 kg or more . the signs and symptoms can include fever , infection , bruising or bleeding . in some cases , more serious problems with the bone marrow may occur . if these symptoms occur , your doctor may stop the treatment
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of lyngparza is 100 mg once a day . your doctor may increase your dose to 150 mg once daily . the doses of LYnparZA capsules should not be increased or decreased depending on how well you tolerate tablets . if your doctor prescribes a capsule that is right for you , your doctor will tell you how to take it . take the capsules about the same time each day , so that it is easier to remember to take them . you can take the lynch tabs with or without food . swallow the capsule whole with water . do not chew or crush the capsule . to help you remember to swallow the sachet , you may be more likely to choke , or
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , having pale skin , or fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ).: allergic reactions ( hives , difficulty breathing or swallowing , dizziness ). signs and symptoms of hypersensitivity reactions with other medicines may include : fever , chills , malaise , rash , back pain and feeling very cold . feeling very hot , cold , fast heart rate . all of these may indicate a reduction in the amount of red cells ( neutropenia ). rare ( may impact up to1 in 1 , 000 people ), allergic reactions including
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . once you have opened lynparza capsules , they should be used within 30 days . discard any capsules that have been opened , even if they have been refrigerated . this medicine does not require any special storage conditions . if you have any further questions on the use of this medicine , ask your pharmacist or pharmacist .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olarib - astrazeneca logo on the capsule . - other ingredients are : - capsule content : lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black (  e172 ). what LYnparZA looks like and contents of the pack lynesparza is a white , opaque , hard capsule with " opadarib 50 mg " imprinted on one side . capsule size : astrazineca logo engraved on the cap of the hard capsule , " lhd " and " gxll50 " on the other side , and
this medicine contains the active substance naloxone . nyxoid is used in the treatment of opioids such as heroin , methadone , fentanyl , opioids like oxycodone , buprenorphine / morphine in adults . what nnyxxoide is used for nyesoidic is a nasal spray for the emergency treatment of drug overdose in adults and children over 14 years of age . opioid overdose may cause breathing problems and severe sleepiness . as a result of an opioid overdosing , you should seek emergency medical care .
do not use nyxoid : - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions emergency medical care you should contact your doctor or nearest hospital emergency services immediately if any of these apply to you . an opioid overdose is rare . the signs and symptoms of an opioid overload may be similar to those of a heroin overdose . take this nasal spray as instructed by your doctor . wait 2 to 3 hours before using a new nasal spray . if this applies to you or your child , stop using this medicine and talk to your doctor straight away . you are physically dependent on opioids . opioids include heroin , methadone , fentanyl , and oxycodone . buprenorphine , or morphine . your doctor
always use nyxoid nasal spray exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is 1 . try to use it at about the same time each day . it should be used at bedtime . symptoms should be felt in the shoulders , ears , breastbone or sternum . the area around the ear is where your doctor inserted a fingernail to clean the mouth and nose of any blockages . if spraying nnyxxoia into your mouth or nose you should use the same place each day until you feel that the effect is too strong or too weak . 1 ) when you start to breathe is the chest moving , you can feel breathing sounds and breath on the cheek . in overdose , your response to touch or sounds is very slow uneven
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : nyxoid may cause acute withdrawal symptoms associated with the use of opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps shivering or trembling changes in behaviour , violent behaviour / nervousness , nervousness or agitation . this is uncommon in people taking this medicine for the treatment of addiction . tell your doctor or pharmacist if you notice any of the following serious side effects you may need to take . these include : stomach ache , bloating , flatulence , wind , chills . stomach aches and pains may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray delivers 1 . 8 micrograms of nnaoloxone ( as hydrochloride dihydrate ). - other ingredients are : trisodium citrate dihydrate ( e331 ), sodium chloride , hydrochoric acid , sodium hydroxide ; purified water . what yxxoide looks like and contents of the pack nylonoide is a clear , colourless , free from visible particles , nasal spray , delivered in 0 . 1 ml nasal spray in a pre - filled nasal spray contained in  a single dose container . nyesoia is available in : a carton containing 2 nasal sprays each in blisters . the nasal spray contains one dose
this medicine contains the active substance follitropin alfa , which is almost identical to a natural hormone produced by your body called " fltr ". fsh is a gonadotropin , a type of hormone that plays an important role in human fertility and reproduction . in women , it helps to regulate the growth and development of the sacs ( fombs ) in the ovaries , where sperm is produced . a mature egg cell is conceived and delivered by treatment with a medicine called " collomifene citrate ". it is used in women having assisted reproductive technology procedures ( procedures that may help you to become pregnant ). it is given together with : - a medicinal product called " lautropin alla " followed by another gonadotropicin called " leutropine - " luteinising hormone "
do not use ovaleap if you are allergic to follitropin alfa , fsh , or flh - tsh ( fcsh) or tia - siponimod , any faunasal and follain - stimulating hormone ( ohsht ) or any of the other ingredients of this medicine ( listed in section 6 ) if your ovaries are too large ovulations or pituitary gland ( both are parts of the brain ). if , in the early stages of life , you may have large ovaries or sacs of fluids within the oovaries ( ovarian cysts ) of unknown origin if unexplained vaginal bleeding . if there is cancer in your ovations ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). you will be given this medicine for irregular periods . you should use this product for the first 7 days of your menstrual cycle . during this period the medicine will be injected again . your doctor will tell you exactly how many days you should inject this medicine . the recommended dose is 75 mg given once a day . however your doctor may prescribe a higher or lower dose of 150 mg . use this medicinal product for up to 7 days in the 14 days of that cycle , i . e . 37 . 5 mg , 75 mg / day , depending on your response . dose your doctor might decide to increase your dose to 75 mg of this medicine or to 225 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects in women allergic reactions such as skin rash or raised itchy areas of skin can be very serious and need immediate medical attention . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing , swelling of the face 37 very rare ( may affect up to 1 in 10 , 000 people ) if you experience this type of reaction , you should stop your ovaleap injection and contact a doctor immediately . serious side impacts in women lower stomach ache with or without nausea and vomiting . if the symptoms of ovarian hypersensitivity occur , the doctor will decide whether to continue to give you your ovulation pumping station immediately , particularly if it occurs during your opialeaping injection . tell your doctor if they do not feel better or if 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the pen after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be used for a maximum of 3 days at room temperature ( up to 25 ). if you are not able to do so , this medicine must be used within 3 days or discarded . if the cartridge has been used for 28 days at 25 , keep the pen cap on and protect it from light ( up or down ). always keep the ovaleap pen in its outer carton . always keep this pen in the original carton in case you are worried about it . don ' t use this product 
what ovaleap contains - the active substance is follitropin alfa . one ml of ovaleeaping 300 iu in 0 . 5 mL solution for injection : each cartridge contains 300 icp ( equivalent to 22 micrograms ) flutropin at the activity reference time ( corresponding to 0. 5 microgram per millilitre ). one cartridge of ovalap 450 iUI in 0- 0 7 . 75 mmol ( equivalent ) each cartridge of 450 international units ( iun ) 33 fllutropine alf , in 00 . 7 mlitre solution for infusion : one cartridge debossed with " ohl " and " lh " on one side . ovalep 900 iiUI ( equivalent in 1 . 
voriconazole accord contains the active substance vorikonazole . voricanazole acord is an antifungal medicine . it works by killing or stopping the growth of the fungi that cause infections . this is used to treat adults and children ( aged 2 years and older ) with : invasive aspergillosis ( a type of fungal infection due to asperguillus sp ), candidaemia ( another type of FUNgal infection caused by candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candidasp. infections when the bacterus is resistant to fluconazoles ( another antifungals medicine ), seriously serious fungal infections caused by scedosporium sf . or fusarium ss .
do not take voriconazole accord : if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking voricanazole . this medicine may affect the way voriconsazole works . it is especially important that you inform your doctor of any of those effects , especially if they are obtained without a prescription . the medicines listed below should not be taken during voriCONazole acord treatment . 46 terfenadine ( used for allergy ) astemizole ( used to treat allergy ), cisapride ( used in some people with stomach problems ), pimozide ( given for mental illness ), quinidine ( used when you have irregular heart beat ), and rifampicin ( used on tuberculos
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will tell you how much voriconazole accord you need and how often you need it . the dose will depend on your weight and the type of infection you have . for adults , the usual dose is 40 mg given every 12 hours for the first 24 hours . after the first 48 hours , you will be given 400 mg every 12 heures for the 24 hours ( 24 hours or more ), followed by 200 mg every twelve hours for two weeks . thereafter , your doctor may decide to increase your dose to 200 mg . you will normally be given 100 mg every 24 hours as long as you respond to treatment . this will usually be for at least 300 mg / kg every 12 to 12 hours ; however , if this applies to you , it may be necessary to reduce the risk of mild
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects have been reported with voriconazole accord , including rash and jaundice ( changes in blood tests of liver function ) and pancreatitis ( very common side effects may affect more than 1 in 10 people ). visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder ), halo vision / night blindness and swinging vision . other side effects include : common ( may affect up to 1 in every 10 people) visual impairment( change in perception of vision ) including blurring vision ; visual color changes ; abnormal intoler
what voriconazole accord contains - the active substance is vorikonazole . each tablet contains 50 mg voriCONazole ( as mesilate ). vorizonazole acord 50 mg film - coated tablets : each tablet has 200 mg vorisiconizole ( AS mesils ). - voricanazoleaccord 200 mg film- coated tablet : the other ingredients are : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . hypromellose ( e464 ), titanium dioxide (  e171 ), lactoses monohydrate and triacetin ( ctab ). what vorisazole agreement looks like and contents of the pack the film  - coating is white , oval , convex 
what mvabea is mvalbea - a vaccine used to protect you against ebola virus disease in the future . it is given to adults , adolescents and children from 1 year of age , against a spread of eba virus . this is part of a 2 - dose course of vaccinations to protect against : ebastian virus disease caused by the zaire eebolovirus . the other active substances in this vaccine are filovirus and hamster ' s eagle virus , which is a type of filo virus ; therefore this vaccine does not contain filovir . because filovia is the whole ebea virus that causes you ebara virus diseases , the two active substances must be mixed together before you are given vaccinations . if you are already receiving zabdeno
you should not receive mvabea if : you have recently received the vaccination course and / or are suspected to have had a severe allergic reaction to any of the active substances listed in section 6 . you have previously had  a serious allergic reaction after receiving an antibiotic called ' gentamicin '. however , the vaccine may not fully protect all of those who receive ' the recommended dose ' ( see section 6 for more information ). warnings and precautions talk to your doctor or nurse before receiving the vaccine if you : have ever had , or might now have , a severely allergic reaction , to any other vaccine injection , any other vaccination injection . have ever fainted after an injection ; have a history of bleeding or bruise easily ; are currently experiencing a fever or an infection ; take medicines that affect the immune system such as high - dose cortic
mvabea is given as an injection into a muscle ( intramuscular injection ) in the upper arm or thigh or into  a blood vessel . the first vaccination with zabdeno vaccine is recommended 8 weeks later . if you are given mavabea vaccine after the second vaccination , the second vaccine will be given . it is important that you follow the instructions of your doctor , pharmacist or nurse so that you complete the vaccination course of courses . primary vaccination first vaccination using zaburdeno red cap vial . second vaccination with the same type b kit : mvasbea yellow cap viall . recommended dose : 8 weeks after the first vaccine with zbdenno . booster vaccination with either zapdeno or zabea ernease the date after the last dose of zaberdeno , and 
like all medicines , this vaccine can cause side effects , although not everybody gets them . side effects may happen up to 7 days after you have had the injection . tell your doctor or nurse immediately if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) pain , warmth , or swelling where the injection is given feeling very tired muscle ache joint pain common ( will affect up to 1 in 100 people ), feeling sick ( vomiting ) itching where the injecting is given uncommon ( will effect up to1 in 100 persons ) redness and skin hardness where the delivery is given generalised itching reporting of side effects you can help provide more information on the safety of this medicine .
what mvabea contains the active substance is zaire ebolavirus ( psd ) 29 - tai forest ebarravirus nucleoprotein marburg , corresponding to 0 . 7 ml / m2 of body surface area ( corresponding  to 108 million iu / kg ). the other ingredients are chicken embryon fibroblast cells . what avabeam looks like and contents of the pack this vaccine is a suspension for injection in a single - dose glass vial with a rubber stopper and yellow cap . the vial contains 20 mv .
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronate is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce the risk of other bone problems that may need surgery or radiotherapy bondronatul is also used if there is a raised calcium level in your blood due to : a tumour . the calcium is lost from your bones . as a result , your bones become weaker .
do not take bondronat : - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) -if you have low levels of calcium in your blood . do not use this medicine if any of these apply to you . warnings and precautions the most serious side effect known as osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported in some patients receiving bondronate for cancer - related conditions . onj can occur after stopping treatment . it is important to try and prevent onj developing as it is a painful condition that can be difficult to treat . in order to reduce the risk of developing osteonocross of the Jaw , there are some precautions you should take . before receiving treatment , tell your doctor / nurse ( health care professional )
receiving this medicine bondronat is normally given by a doctor or other medical staff who have experience with the treatment of cancer . it is given as an infusion into your vein your doctor may do regular blood tests while you are receiving bondronate . this is to check that you are being given the right amount of this medicine . how much to receive your doctor will work out how much bondronatul is needed , depending on your illness . if you have breast cancer that has spread to your bones , then the recommended dose is 3 mg every 3 - 4 weeks , as an injection in your vein over at least 15 minutes . your doctor might adjust your dose if there is a raised calcium level in your blood . the recommended starting dose is 1 mg every 2 weeks ( depending on the severity of your illness the medicine will be given as a single infusion in your sinus ). a repeated dose may be considered in case
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the thong bone . very rare ( affects less than 1 in 10 ,000 people ). contact your doctor if pain or sore in your mouth or jaw . this may be a sign of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). talk to your doctor or nurse if this happens . ear pain discharge from the ear may be the first sign of an ear infection 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . after dilution the infusion solution should be used immediately . if not used immediately the product can be stored at 2 - 8 for up to 24 hours . this medicine is for single use only .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion that contains 2 mg i bandronic acids . - other ingredients are sodium monohydrate , sodium chloride , acetic acid , and sodium acetate . what bondanat looks like and contents of the pack bondronatul is a clear , colourless to pale yellow solution . it is supplied in a pack containing 1 or 2 vials with a bromobutyl rubber stopper . not all pack sizes may be marketed .
what zeposia is zeposa belongs to a group of medicines that affect white blood cells called lymphocytes . what ZEposiais is used for zeposition is used to treat relapsing remitting multiple sclerosis ( rrms ) in adults who have active disease that affects multiple ' s cells . multiple  Sclerosis ( mes ), ms is a disease that occurs when the immune system ( the body 's defenses , attacks certain cells ). white blood cell are important for connecting the nerves in the brain and spinal cord and connecting the needles to the nerve points . mms can cause symptoms such as numbness and difficulty in moving the needle around the nerveses . this is caused by the lack of communication between the body and the nerve core . symptoms such are numness and / or
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severely weakened immune system . warnings and precautions talk to your doctor or pharmacist before taking zeposa : if : you have had a heart attack ( such as angina , stroke , mini - stroke ), transient ischemic attack ( tia ) you have severe heart failure within the last 6 months you have irregular or abnormal heartbeats ( arrhythmias ) which are not related to your heart . your doctor may want to monitor you more closely during treatment if any of these apply to you . you have ever had severe infection ( sucha as hepatitis , tuberculosis ), cancer , or severe liver
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose of zeposia is based on your heart rate and is calculated by your doctor . you will receive a ' treatment initiation pack ' which contains all the capsule contents . the starting dose is 4 mg / kg body weight ( equivalent to 0 . 23 mg ozanimod ). this is taken 1 day before the start of treatment and 4 days after the start . after the first dose , your doctor may increase your dose to 3 mg . this is equivalent to an initial dose of just 0. 46 mg - ozna and will be given to you at weeks 5 , 6 , 7 and 8 capsules . there is also a " maintenance pack " with orange capsules ( equivalent of 0
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects very common ( may affect more than 1 in 10 people ): slow heart rate , urinary tract infection , blood pressure uncommon ( may effect up to 1 in 100 people ). allergic reaction . the signs may include a rash . other side effects talk to your doctor , pharmacist or nurse if these side effects become serious . common ( might affect up to1 in 10 children ) : infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) and voice box ( laryngeal ) viruses reducing the number of a type of white blood cell called lymphocytes ( lymphocyte - colon ). not known ( frequency cannot be estimated from the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . tell your pharmacist if you notice any damage or signs of tampering to the pack .
what zeposia contains - the active substance is ozanimod . zeposa 0 . 23 mg hard capsules : each capsule contains 0. 23 milligrams of ozonimod ( as hydrochloride ). zepoza 00 . 46 mg hard hard capsule : every capsule contains approximately 0
what temybric ellipta is temmybric flatta contains three active substances called fluticasone furoate , umeclidinium bromide and vilanterol . fluticasesone furóate belongs to a group of medicines called corticosteroids , also known as steroids . umeklidinium Bromide or vilantrol belong to  a groupe of medicines known as bronchodilators . what TEMybril ellippa is used for temista is prescribed to adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties . in copd the muscles around the airways tighten . when this happens , the muscles surrounding the airway tighten and the air sacs tighten too much .
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using temibric
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use temybric ellipta regularly it is very important that you use TEMybrice ellippa every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . temibric is not meant to relieve a sudden attack of breathlessness or wheezing . to help prevent this sort of attack you must use a quick - acting reliever inhaler ( such as salbutamol ). how to use the
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , stop using it and get medical help immediately . pneumonia ( infection of the lung ) in copd patients the most common side effect is a runny nose that may cause symptoms of a lung infection , which may include fever and chills . increased mucus production , change in mucusum colour , increased cough , and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) are : sore throat , cough . common side impacts ( may effect up to1 in 10 persons ): sputum , rash , itching , feeling tired , headache , stomach pain , nausea , vomiting , diarrhoea , abdominal
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose ( the dose leaving the mouthpiece ) contains 92 micrograms of fluticasesone furonate ; 65 microgram ( the dosage leaving the stomach ) umecronium bromine equivalent to 55 microgram umeklidinium and 22 microgram( the dose left in the mouthpipe ) of vilanter ( as trifenatate ). the other ingredients are lactose monohydrate ( see section 2 under ' temies of temyese ') and magnesium stearate . what tybrick ellippa looks like and contents of the pack the ellimpta inhaler consists of a light grey plastic body , a be
what zinforo is zin foro is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what zforois used for zinfo is used to treat infections of the skin and the tissues below the skin . this is an infection of the lungs called  pneumonia ', which causes breathing difficulties . how zinfordo works zinfuro works by killing certain bacteria , which can reduce the risk of serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking zin foro . if your doctor thinks you may be allergic to other cephalosporin antibiotics . warnings and precautions talk to your doctor or pharmacist before taking this medicine if : you have had previous severe allergic reactions to other antibiotics ( e .
the recommended dose of zinforo is 600 mg given every 12 hours . your doctor will decide how much zinfo you need and how often , depending on how well you respond to it . adults the recommended starting dose is 600 micrograms given every 8 hours for most infections . the recommended maintenance dose is 8 microgram ( 600 microliter ) given every other week for most illnesses . this dose is given as a drip into a vein ( intravenously ) over a period of 5 to 60 minutes . some patients may need up to 120 microgram , but your doctor may decide to give you an increased dose . depending on your response to treatment , your doctor might decide to increase your dose every 5 to 14 days . for skin infections your doctor can increase your daily dose every five to 7 days , if necessary . pneumonia your doctor has recommended a lower dose if you have kidney problems
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : tell your doctor straight away if you notice any of these symptoms as you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue ; a severe rash ; swallowing or breathing problems . these may be signs of a serious allergic reaction ( anaphylaxis ) and may be life - threatening . diarrhoea ; stool or blood or mucus may show up during or after treatment with zinforo . tell your healthcare provider straight away when you are being treated with medicines that slow bowel movement . this is common ( may affect up to 1 in 10 people ). you will have a blood test called a ' coombs test ' and decide whether you can be
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains - the active substance is ceftaroline fosamil . - each vial contains 600 mg ceftarioline fosamils , as well as arginine . what zforo looks like and contents of the pack zinfordo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . one vial of 10 ml is available .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neoopathic pain : pregabaltin ppfizer is used to prevent long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral nuropathic pain such as diabetes or shingles . pain sensations may be described as hot , burning , going up , working , shooting , stabbing , sharp , cramping , and aching , or tingling . this is different to the stresses and strains of everyday life .
do not take pregabalin pfizer : if you are allergic to pregabaltin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregabalin ppfizer and during treatment : some patients taking pregamalin pifizer have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregablin has been associated with dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore , pregabaliin pingizer may cause blurring or loss of vision , or other changes in eyesight , many of which are temporary
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will determine what dose is appropriate for you , and will tell you exactly how many tablets to take . pregabalin pfizer is for oral use only . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : take the number of tablets as instructed by your doctor and take them at about the same time each day . the dose may be increased or decreased by your physician . for adult patients , the dose will generally be between 150 mg and 600 mg each day ( two tablets containing pregabaltin .) you should take pregabaline ppfiser once in the morning and once inthe evening 59 you should swallow the tablets whole with a glass of water . you can take pregamalin
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common ; may affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , and irritability . disturbance in attention , particularly clumsiness and memory impairment . loss of memory , seizure , difficulty with speaking , alteration in attention span , increased sex drive , panic attack , loss of taste , elevated mood , depression , anxiety , mood swings , reduced consciousness . increase in sexual activity , increase in sextortion , change in sexual desire , disturbance in sexual functioning including inability to achieve a sexual cli
what pregabalin pfizer contains the active substance is pregabaline . each tablet contains either 25 mg , 50 mg / 75 mg ; 100 mg - 150 mg : 200 mg ), 225 mg & 300 mg of pregabaltin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . what pregamalin Pfizer looks like and contents of the pack the hard capsules are black ink containing shellac ; black iron oxide ( i . e . propylene glycol , potassium hydroxide ) and water for injections . they are supplied in vials containing 75 mg ( 4 x 100 mg and 200 mg
xadago is a medicine that contains the active substance safinamide . it increases the amount of dopamine in the brain . this helps to control the level of dope in the body in adults with parkinson ' s disease . xdagon is used in adults to treat parkinsons ' disease in adults . people with this disease have sudden switches in their ability to move . when difficulties moving are not possible , x ad ago can be used on its own or together with levodopa or other medicines used to treat parksinson'  s Disease .
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - do not use the following medicines : - monoamine oxidase ( mao ) inhibitors : selegiline , rasagiline ; moclobemide ; phenelzine , isocarboxazid ; or tranylcypromine ( for treatment of parkinson ' s disease or depression ) - pethidine ( a strong pain killer ). warnings and precautions talk to your doctor or pharmacist before taking x ad ago treatment - you should have checked with your doctor before starting xdagot if : you have previously started treatment with mao inhibitors or pethodia , or
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of xadago is 50 mg once a day . your doctor may increase the dose to 100 mg once daily by mouth . if your doctor thinks that x ad a suitable for you is not suitable , your doctor will tell you to take it by mouth only . do not change the dose unless your doctor has told your doctor that you are taking it . patients with moderately reduced liver function the recommended starting dose is 50 milligrams once / day , depending on your response to xdag . alternatively , the doctor may prescribe a higher dose of 50 millimes once daily . take xxago with food . you may have raised blood pressure , anxiety , confusion
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that may lead to collapse ) neuroleptic malignant syndrome ( ppm ). the following may happen : - confusion , sweating , muscle rigidity ( hyperthermia ). - increase level of enzyme creatine kinase in your blood ( serotonin syndrome ). this can lead to confusion . - hypertension ( muscle stiffness ) - hallucinations and hypotension . other side effects may occur with this medicine . parkinson ' s disease has been reported in patients taking safinamide . the following side effects have been reported with this product : very common ( may affect more than 1 in 10 people ): tremor , confusion ; sweating and muscle rigidité (
what xadago contains - the active substance is safinamide . each tablet contains 50 or 100 mg of ssafarinamide ( as methansulfonate ). - other ingredients are : - tablet core : microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - film coating : pregelatinised cellulose ( e463 ), hypromellose , macrogol ( 6000 ), titanium dioxide ( е171 ), iron oxide red ( i ) ( ) what Xad ago looks like and contents of the pack x adhago 50 mg are white to off white , oval , biconcave film - coated tablets of 7 mm diameter with metallic gloss , de
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat adult men with prostate cancer that has spread to other parts of the body . zytaga increases the amount of testosterone in your blood when you have prostate cancer . how zytige works zymiga is used in adult men who are still growing and who are not able to tolerate or cannot take hormone therapy , a treatment that lowers testosterone ( androgen deprivation therapy ). it is also used in combination with another medicine , prednisone or predniesone , which are used to lower high blood pressure in the body and to prevent fluid retention in your urine .
do not take zytiga : - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - are pregnant . warnings and precautions talk to your doctor or pharmacist before taking zytigea if : you have severe liver damage or have had prostate cancer before , while taking this medicine , you should tell your doctor before taking this medicinal product . before taking the medicine if any of your family members have any of their own blood problems . you have high blood pressure or heart failure . your doctor needs to monitor you for low blood potassium . low blood sodium can cause heart rhythm problems or other heart or blood vessel problems , such as an irregular or rapid heart rate , shortness of breath , or if your doctor notices that you have shortness in breath . if at any time you have gained
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . take this medication once  a night . this medicine is for oral use . swallow the tablet whole with water . you can take zytiga with or without food . if necessary , your doctor may tell you to take a different dose . how to take take ztiga before you go to bed , and during the day after you take zetiga . for children and adolescents zytigea can be taken with or just after meals . do not take if more than 2 tablets of zytaga are taken . it is best to take the tablets at the same time each day , preferably at the end of a meal . then take ytiga at the usual time
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and tell your doctor immediately if you experience muscle weakness or muscle twitches , a pounding heart beat or palpitations , as these may indicate that the level of potassium in your blood is low . if this happens , your doctor will check for potassium . other side effects very common ( may affect more than 1 in 10 people ): - there is a build up of fluid in your legs or feet , which may result in low blood potassium , seen in liver function test , high blood pressure , urinary tract infection , diarrhoea , stomach pain , vomiting , nausea , pain in the abdomen , chest pain . common ( might affect up to 1 in every 10 people): fluid in the legs or legs ,
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abarraterone as a single tablet . - other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 - 32 ), colloidal anhydrous silica , sodium laurilsulfate ( see section 2 " zytigea contains lactoses "). what ztiga looks like and contents of the pack - zytaga tablets are white to off - white , round and embossed with " a5 " on one side . the tablet is approximately 9 . 5 mm in diameter . they are packaged in a plastic bottle with a child - resistant closure and a desic
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of inflammatory diseases in adults , including polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis ; paediatric plaque psoriasis , paediametric crohn ' s disease , and paediatrin non - infectious uveitis in adults and adolescents . the active ingredient in heifiy , inactivated , is , as the active component of the medicine , which is derived from a monoclonal antibody . monoclonic antibodies are proteins that attach to a specific target in the body . aad alimamab is designed to attach to another protein called tumour necrosis factor ( tnf ), which
do not use hefiya if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has told you that you have a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). it is important that you tell your doctor if there are symptoms of infections , e . g . fever , wounds , feeling tired , dental problems . it is also important to tell your dentist if any of these apply to you . warnings and precautions talk to your doctor or pharmacist before using heifiy if : you have moderate or severe heart failure . you have ever had or might now have , or have -
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose in adults is 40 mg once a day for two consecutive days . your doctor may increase your dose to 20 mg once daily for two successive days , preferably for one week . if your doctor has agreed to increase your dosage to 40 mg , then the usual dose is 20 mg three times a week for two concurrent days ; preferably in the morning . polyarticular juvenile idiopathic arthritis age or body weight how much and how often to take ? notes children , adolescents and adults from 2 years of age weighing 30 kg or more 40 mg every other week not applicable children  2 years old weighing 10 kg or less 40 mg each week not valid children . not applicable enthesitis - related arthritis age and body weight
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur up to 4 months or more after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , including hives ; swollen face , hands , feet ; trouble breathing , swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible , as they may be signs and symptoms of infection such as fever , feeling sick , wounds , dental problems or eye problems . these may be symptoms of a serious allergic reaction . the most frequently reported side effects ( may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label / blister / carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya may be stored at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light and to allow room temperature storage . you should record the date when your pre – filled  sYringe is first removed from the refrigerator and the date after which it should be discarded . once removed from refrigerator you must use it within 14 days or discarded when you
what hefiya contains the active substance is adalimumab . each pre - filled syringe contains 20 mg of aadhalimum a in 0 . 4 ml of solution . the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid ( e507 ), sodium hydroxide and water for injections . what HEfiYa looks like and contents of the pack heifiy -20 mg solution for injection ( injection ) in pre . 5 mL clear , colourless to slightly yellowish solution is contained in a single - use clear type i glass sYringe with a stainless steel needle with o needle guard with finger flange
ritemvia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a certain type of white blood cell called " b - lymphocyte ". when ritsuximb sticks to its surface , the cell dies . ritemevia may be used for the treatment of several different conditions in adults . your doctor has prescribed riteritemvie for the following conditions : a ) non - hodgkin ' s lymphoma this is an disease of the lymph tissue ( part of the immune system ) that affects a specific type of b lymphocyte . the term ritemorbid result of this treatment is reduced in some patients . in patients with bmc , ritenvia may have to be given to you together
do not take ritemvia if you are allergic to rituximab , other proteins which are like ritzimabat or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe active infection at the moment if this applies to you . if the doctor knows that you suffer from a weak immune system e . deficiency of severe heart failure or severe uncontrolled heart disease , granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . warnings and precautions talk to your doctor or pharmacist before taking ritemevia : if : you have ever had or might now have , ever had a hepatitis infection . this is because ritemorvia could cause hepattis
ritemvia will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given ritemevia as a drip ( intravenous infusion ). medicines given before each ritedvia administration before you are given ritamvia you will be  given other medicines ( pre - medication ) to prevent or reduce possible side effects during your treatment if you are a patient at risk of non - hodgkin ' s lymphoma if the treatment is started at a low dose . if ritemorvia alone ritemmvia will usually be given once a week for 4 weeks . repeated treatment courses with rite mvia are possible . when ritemetvia is given together with chemotherapy 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion , you may develop fever , chills and shivering . less frequently , patients may experience pain at the infected site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , chest pain . some patients have experienced itching and fever . other side effects may include very common : may affect more than 1 in 10 people : pain in the chest rising to the top of the chest with fever and coughing if you are given ritemvia , tell your doctor or nurse
what ritemvia contains the active ingredient in ritemevia is called rituximab . the vial contains 100 mg of ritzuximb  per ml . each mL of concentrate contains 10 mg of Rituxib - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritamvia looks like and contents of the pack ritemmvia is a clear , colourless solution , supplied as a concentrate for solution for infusion in a glass vial , which is supplied in packs of 2 vials 
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitebine - tva contains capevitabine , which itself is not a cytotic medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capecitationbine  t Eva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecteva is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . Capecitabin tova may be used either alone or in combination with other medicines .
do not take capecitabine teva - if you are allergic to capecitebine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if there is an allergy or over - reaction to this medicine , - whether you previously have had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), - the use of needles in pregnant women ,- low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ),- - severe liver or kidney problems , or - do not use any of those listed in this leaflet . - have been told you have a problem with the enzyme dihydropyrimeidine dehydrogenase ( dpd ) ( complete 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you , depending on your condition . the dose of capecitebine teva is based on your body surface area . this is calculated from your height and weight . a recommended dose for adults is 1250 mg / m2 of body surface surface area taken two times daily ( morning and evening ). two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surface space of 1 , 7 . 7 m2, and should take 4 tablets of 500 mg two times weekly . an infant weighing 1
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact your doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarhoa at night . vomiting : when you vomit more than once in a 24 - hour time period . nausea : as you continue to lose your appetite , you may experience stomatitis ( pain , redness , swelling or sores in your mouth and / or throat ) or hand - held st . john ' s wort ( a bitter taste ): bitter taste ( bitter taste "), which is bitter . joint pain : itchy skin , reduced
what capecitabine teva contains the active substance is capecitebine . capecitationbine travaginal 150 mg film - coated tablets each film , with 150 mg capeciabine , contains 500 mg caprecitabine the active ingredient in capevitabine trevaval 500 mg film- coated tablet core : lactose , microcrystalline cellulose , hypromellose , crohn' s sugar , magnesium stearate , macrogol 400 , tablet coating : hypromllose, titanium dioxide ( e171 ), yellow iron oxide ( е172 ), red iron oxide [ e172 ]). what capеcitabine toeva looks like and contents of the pack capecifrabine - pink , capsule - shaped , film  shaped tablet with " cb " debosse
what silodosin recordati is sildodnosin recordattai belongs to a group of medicines called alpha1a - adrenoreceptor blockers . sildosesin recordingi is selective for the receptors located in the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . what siladosesin recordatte is used for silidostan recordatis is used in adult men to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passwater , a feeling of not completely emptying the bladder , an abnormally high level of uric acid in the blood ,
do not take silodosin recordati - if you are allergic to silofosun or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking sildodsin recordingi . - during eye surgery , there may be cloudiness of the lens ( cataract surgery ), and the clear layer at the back of the eye may partially blind the doctor . 26 - while taking siladoosine recordatin , some patients taking this type of medicine may experience a loss of muscle tone in the iris ( the coloured circular part of the e . glass ) in the eye during such a surgery . the doctor will take appropriate precautions and inform you about the safety and efficacy of medicine and surgical techniques . some patients who have taken silundos
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one capsule of silodosin recordati 8 mg per day by oral administration . take the capsule always with food , preferably at the same time every day . do not break or chew the capsule , but swallow it whole , even if it is not clear . patients with kidney problems if your doctor has moderate kidney problems the dose is the same as for adults . for this purpose sildodostin recordatta is used in combination with food and drink , and in 4 separate capsules . if vous take more siloudoSin recordtati if : you feel dizzy or feel weak , tell your doctor straight away . you may take your capsule later the same day if this happens
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following allergic reactions : swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives . the most common side effect of silodosin recordati is dizziness . this may include dizziity and occasionally fainting . if this happens , do not drive or use machines to drive or operate machinery . you should take care not to make any use of siladoşin recorditi . complications from a cataract surgery ( eye surgery ) have also been reported . some patients have experienced dizzinness , with some patients having fainting or have other side effects not listed in this leaflet .. a doctor should advise you how to deal with dizzieness and faint
what silodosin recordati contains sildodnosin recordATi 8 mg : the active substance is silofosun . each tablet contains 8 mg of siloudoosine . the other ingredients are mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide (  e171 ). silundoshin recordatis 4 mg - the active substances are siloidal and 4 mg of semolin . - silidostanin : each tablet also contains mannitalian , magnesium STEarate and sodium laursulfated . gelatin, titanium oxide ( е171 and yellow iron oxide ( ( i )). what sileodsin recordingi looks like and contents
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angio Tensin Ii is a substance occurring in the body , which causes your blood vessels to narrow , thus increasing your blood pressure . kinzialmona blocks the effect of angioTENsin 1 , so that the blood vessels relax , and your blood temperature is lowered . this medicine is used to treat essential hypertension ( high blood pressure in adults ) in adults and children . the high blood tension is not caused by any other condition . high blood temperature , if not treated , can damage blood vessels in several organs , could lead sometimes to heart attack , heart or kidney failure or stroke .
do not take kinzalmono - if you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). -if you're more than 3 months pregnant . ( it is also better to avoid kinzialmona in early pregnancy see pregnancy section .) - in women with severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or anyother severe liver disease . - have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren . warnings and precautions talk to your doctor before taking kinezalmonno if any of the following apply to you : - you have diabetes and impaired kidney functioning and you receive a similar treatment with aliskaren ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . try to take the tablet at the same time each day , preferably with or without food . it does not matter what time of day you take your tablet but taking kinzialmona at the the same times each day will help you remember to take it . you may take kinzyalmony with or just after food , and at the exact same time every day if it does this . for treatment of high blood pressure , the usual dose of the day usually recommended for kinzulmono for most patients is one 40 mg tablet once aday to control blood pressure over the 24 - hour period . your doctor may prescribe a lower dose of one 20 mg tablet daily . kin
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately since they could be serious . if these effects are not treated they could potentially be life - threatening . possible side effects of kinzalmono common side effects ( may effect up to1 in 10 people ), are : low blood pressure ( hypotension ) in users treated for reduction of cardiovascular
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmesartan ( as meglumine ). - other ingredients are povidone , meglumin , sodium hydroxide , sorbitol and magnesium stearate . what kinszalmonio looks like and contents of the pack kinzialmona 20 mg tablets are white to off - white , round and convex . kinezalmone is available in blister packs containing 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
what afstyla is a fsyla contains a human clotting ( coagulation ) factor viii product , which contains the active substance lonoctocog alfa . what ffssylac is used for aesthetic use is used in patients with bleeding episodes caused by haemophilia a ( inborn factor ixi deficiency ). factor  vii is necessary for blood clot . it increases the tendency to bleed . how affected person is affected by factor ii , it helps your body to make better use of factor vii . this will reduce the tendency for blood to clotate . there is an increased tendency to break down the product before it can be used . who is affected is not always enough factor vi to help fight haemoria to
do not use afstyla - if you have ever had an allergic reaction to aafStyLA -if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor or nurse before using aFStylan . the batch number should be recorded in your treatment diary . if necessary , you should record the date of birth , the batch size and the batch quantity in your treaty diary , in order to maintain a record of the allergic ( hypersensitivity ) reactions to fssyla and the lot number when you first start using . it is important that you and your doctor record the batch of a product you are using and record the batches used . you must record the exact batch number in your patient alert card you use and include it with you when you start using it and include this leaflet when you begin using fae
your treatment should be initiated under supervision of a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of 0 . 5 ml of acetone is one vial per day . your doctor will calculate the dose you need and explain the potential risks and benefits of using afstyla during treatment . depending on your disease the site and the bleeding your clinical condition should be evaluated by your doctor as the recommended dosage and schedule for reconstitution and administration general instructions the powder should be mixed with the solvent ( liquid ) provided in the vial to achieve optimal results . a sufficient number of solvents should be used to achieve the desired effect . in patients with aseptic conditions , a higher or lower dose of the recommended daily dose of of
like all medicines , afstyla can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following symptoms , which may indicate allergic reactions . allergic reactions may occur with any number of the below listed symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , and anaphylaxis ( bleeding ). for children not previously treated with factor viii medicines : inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ); however patients who have received previous treatment with factor vii ( more then 150 days of treatment ) the risk is uncommon ( less than 1in 10 patients and less than 2 in 100 patients ). the risk of developing inhibitor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the vially in the outer carton in order to protect from light . if the reconstituted product is not used immediately , it should be stored below 25 for a single period of up to 3 days . record the date from when you start to store a new one . use the resulting product in accordance with local requirements .
what afstyla contains the active substance is lonoctocog alfa . each 250 ml vial contains 2 . 5 mg of the active ingredient . after reconstitution with 2 : 5 mL of water for injections the solution contains 100 mg of lonoctcog Alfa per m2 of solution . if you are not able to completely dissolve the solution , you will receive 200 mg of LonoctoCog alfie 1000 mbq after reconversion with 2 2 , 5 % of water pouring into the water for injecting . the solution provides 400 mg of locnoctocorcog a solution for injection , providing 1500 mbeq in water for reconstitution and 5  m3 water for infusions the resolution provides 300 mg of alfare and 2000 mtbq in time for reconversion and
praxbind contains the active substance idarucizumab . i darucizumb is a reverse agent of the active ingredient dabigatran ( pradaxa ). dabigetran is  a blood thinner medicine used in the prevention of blood clot formation . by doing so , prabind can rapidly trap dabigаtran . you must talk to a doctor if you do not feel better . what praxxbind is used for prapraxbound is used in emergency surgery and urgent procedures for uncontrolled bleeding .
do not take praxbind - if you are allergic to idarucizumab or any of the other ingredients of praxxbind listed in section 6 . - have a genetic disease , known as hereditary fructose intolerance ( hfi )) - are taking the substance sorbitol ( e420 ) before starting this medicine . this medicine may increase the risk of serious adverse reactions . warnings and precautions talk to your doctor before taking praXbind . taking this medicine you should not take dabigatran ( a substance present in foodstuffs ) or other medicines that prevent blood clots . dabig atran may be removed from the body by biological processes which can cause blood coagulations . your doctor will discuss with you whether you should be given medicines to prevent blood blood  clotting 
praxbind is usually given by a doctor or nurse . the recommended dose is 5 mg ( corresponding to 2 . 5 mg ) of dabigatran per day . you will be given this medicine for one treatment cycle of 5 days . this medicine is given into a vein . if you have any further questions on the use of this medicine , ask your doctor or doctor . your treatment will be initiated under close supervision of a physician experienced in the prevention of blood clot formation . in the event of accidental injection of dabatran , you will receive an initial course of 24 hours . please ask your physician or nurse who will decide how long you should receive this medicine and will decide if and when you should continue to receive this medical treatment .
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects 9 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains the active substance is idarucizumab . the other ingredients are : sodium acetate trihydrate , acetic acid , ( e420 ), sorbitol (  e433 ), polysorbate 20 and water for injections . what pxbind looks like and contents of the pack prapbind is a clear to slightly opalescent , colourless to slightly yellow solution supplied in a glass vial with a butyl rubber stopper and an aluminium cap . each pack contains one vial .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temtemomediac is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . the combination of tememedaac with radiotherapy ( concomitant phase of treatment ) and monotherapy phase of treating children and adolescents 3 years and older and adult patients with malignant gliomema , such as gliablastomas multiforma or anaplastic astrocytoma. TEMomedаc is applied in these tumours when standard treatment is not feasible .
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). - had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . - some types of blood cells are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells play a key role in fighting infection and for proper blood clotting . your doctor will check your blood to make sure you have enough of these cells in your body . you may lose the ability to take tetanus ( a tumour ) or other organs in your blood . this will make
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and if your doctor has told vous that you have a recurrent tumour and has had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and during treatment with temtemoMEDac to prevent nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme if a patient is undergoing treatment and is completing treatment together with radiotherapy ( concomitant phase ) followed by treatment with only temac ( monotherapy phase ). the usual dose of the two doses is one 75 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : - a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), - uncontrolled bleeding , - seizures ( convulsions ), and - fever , chills , or severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding . these may be signs of anaemia ( a shortage of red blood cells that can cause fever ), as well as reduced resistance to infections . the reduction in blood cell counts may be seen as anaemic adults ( see section 2 ). very rarely , it may cause blood cell numbers to decrease .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . once opened , temomedac is intended for immediate use . use within 30 days after first opening . tell your pharmacist if you notice any change in the appearance of the capsules .
what temomedac contains - the active substance is temozolomide . temac 5 mg hard capsules : each capsule contains 5 mg temozalomide ( as monohydrate ). temtemomediac 20 mg hard hard capsule : every capsule contains 20 mg TEMozolomid ( as Monohydrate ) tememedaac 100 mg hard pills : Each capsule contains 100 mg ml temazolomide (17 mg / m2 ). the other ingredient is : temizomedaca 140 mg hard tablets : the capsule contains 140 mg  temizalomide (18 mg ) and temómedab 180 mg hard drugs : one capsule contains 180 mg - temezlomide in total . also , temimedacre 250 mg hard foods : this capsule contains 250 mg . the
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , ed penis suitable for sexual activity . cialize has been shown to significantly improve the ability of obtaining ahard e rect penis appropriate for sexual activities . the active substance tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors . by doing so , it allows the blood vessels in your penis to relax . it helps the flow of blood into your penises , improving the eerectility function . you and your partner will be treated with cialIS for elicitile dysfunction in adult men . your doctor will decide if cialist is right for you .
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). - do not give ciali if any of your medical conditions are not met . - are taking any form of organic nitrate or nitric oxide donors such as amyl nitsrite . this is a group of medicines (" nites ") used to treat angina pectoris (" chest pain "). cialist tells you to stop taking these medicines because they may increase the amount of natrate in your blood . take special care with cialiser - you have serious heart disease or have recently had a heart attack within the last 90 days . you have recently suffered a stroke within the past 6 months . your doctor may want to monitor you more closely . do not stop taking 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablets whole with a glass of water . you can take ciali tablets with or without food . try to take the tablets at about the same time each day , preferably at the same times each day ( preferably in the morning and evening ). the tablets can be taken with or with or just after food , but you should not take more than the recommended daily dose . how much to take adults cialising is for oral usage . taking cialIS will not help you to get an erection , and may last for up to 24 hours . take a tablet of cials with iceis at the end of a meal . this will help you 
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start using the medicine or when the dose is increased . some of these effects may be serious and may require medical attention . rare cases of allergic reactions ( rashes ) have been reported ( frequency not known ). if you get chest pain , you should contact your doctor immediately . if used with nitrates ( frequency unknown ), ( frequency cannot be estimated from the available data ), or with priapsim . had a prolonged and possibly painful erection after taking cialis ( lasting more than 4 hours ), you should tell your doctor or a nurse immediately , as there may be a higher risk of sudden loss of vision ( frequency known ) other side effects which may include common ( affects 1 to 10 users in 100 ) headache
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of ttaadALafil the other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose . tablet coat : sodium laurilsulfate , magnesium stearate . film - coating : film , lactoses monohydrate , indigo carmine ( e132 ), triacetin ( k29 ), titanium dioxide ( е171 ), iron oxide yellow ( erection ), red ( era ) and talc . what ciais looks like and contents of the pack cialisé 2 , 5 mg film – coated tablets are light
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panceras does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enYglid helps control type 2 diabetics by helping your body make better use of treatment . it is taken with diet and exercise , weight reduction , and physical activity . this helps your body to control ( or lower ) your blood glucose . the medicine can be taken with metformin , which is another medicine for diabetes .
do not take enyglid : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). - for type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). warnings and precautions talk to your doctor before taking enYglid and if : you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). you have liver problems . your doctor may want to change your dose . there is limited information on the use of enyingglid in patients with moderate liver 28 disease ( also see section 2 . further information ). take special care with ennyglide : your doctor will know if and when you should take a tablet . have  a severely liver
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablets with a glass of water immediately before or up to 30 minutes before each main meal . your doctor may increase your dose to 4 mg once daily up to a maximum of 30 mg once per day , up to 16 weeks . if your blood sugar is too low , and you get a hypo , tell your doctor . however , if this applies to you , do not take enyglid or change your dose . take the medicine pack with you so that it is clear what you have taken . do not make up for a forgotten dose , just take your next dose at the usual time . in case you take more enYglid than you should if ,
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most frequent side effect is hypoglemia which may affect up to 1 in 10 people . in general , hypogycaemic reactions are generally mild / moderate but may occasionally develop into hypoglytic unconsciousness or coma . if you suffer from allergy allergy ( rare , may affect less than 1 in 1 , 000 people ), symptoms may include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be the sign of anaphylactic reaction . other side effects may include : common ( may affect more than 1 to 10 people people ): swollen lymph glands ( lymphopenia ) shivering , being sick ( vomiting ) diarrhoea , nausea ( feeling
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg reglinide in a microcrystalline cellulose , calcium hydrogen phosphate , anhydrous . - other ingredients are : croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , and poloxamer . the other ingredients in the tablet core are - yellow iron oxide ( e172 ). the 1 mg tablet also contains red iron oxide( e 172 ) and the 2 mg tablet coating : yellow iron dioxide ( a ) what  Enyglide looks like and contents of the pack enYglid 0. 5mg tablets are white , round and biconvex with
what azacitidine mylan is azacriitidine Mylan is an anti - cancer agent . what a azaçitidine meinlan is used for azacitaitidine has been given to you by your doctor . it is used in adults who are not able to have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ): chronic myelamonocytic leukaemia ( cmml ) acute myeloid leukocytosis ( aml ). these are diseases which affect the bone marrow and can cause problems with normal blood cell production . how azacecitine mylan works azacaitidine is made up of a protein called ribonucleoside ( ribbonucleas ). ribunuclear cells are involved
do not take azacitidine mylan - if you are allergic to azacritidine or any of the other ingredients of this medicine ( listed in section 6 ). - for patients with advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacitaitidine Mylan . - patients with decreased counts of platelets , red or white blood cells . the following is a small number of patients with kidney disease . your doctor will check this if it is possible for you to have liver disease : - you have ever had a heart condition or heart attack or lung disease - blood test your doctor may check that you have had blood tests before you start treatment with azacinaitidine melan , and will arrange for blood tests during treatment with you . during treatment , your doctor might decide to stop treatment with mesutrombosis (
before giving you azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will be given azaCitidine Mylan once a day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , but you may be given up to 6 treatment cycles . each cycle will be different . please keep using this medicine by applying it to your skin only ( subcutaneously ) by rinsing your skin each day , as well as into your thigh , tummy or upper arm . if you have any further questions on the use of this product ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : - drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and may include swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting and reduced appetite , confusion , restlessness , or fatigue . symptoms may include confusion / restlessness or fatigue and may be serious . azacitidine mylan may cause severe pain in the abdomen , which may be severe and may lead to death . the following are symptoms of severe pain when passing water to the child , as well as diarrhoea
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and carton . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted solution : this medicine should be used immediately after preparation . when using immediately , the suspension should be administered within 1 hour of preparation if the azacritidine myLAN suspension is prepared with water for injections that has not been refrigerated . once the suspension has been prepared it should be placed in the refrigerator ( 2 8 ) immediately after it is prepared and kept refrigerate the suspension for up to a maximum of 8 hours . however , if this is not possible to store the suspension in the fridge ( 2 - 8 ), the suspension must be placed within 8 hours of
what azacitidine mylan contains - the active substance is azacitacitine . one vial of powder contains 100 mg azaçitidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / m2 azaсitidine ( as w /w ). - other ingredients are mannitol ( e421 ). what acitide mylan looks like and contents of the pack azaCitidine melan is a white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacciitidine and is available in packs containing 1 vial or 7 vials . not all pack sizes may be marketed .
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprostic is a prostaglandin analogue which is released from the eye . the active substance titmolola is , in turn , an active beta blocker . it reduces the amount of fluid within the eye and so reduces pressure within the edge . duotratrav eyes drops are used to reduce high pressure in the eye which can lead to an illness called glaucoma .
do not use duotrav if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using duotratrav and during treatment if any of your conditions are listed below : if your family has respiratory problems such as asthma , severe chronic obstructive bronchitis , or severe lung disease if the signs include wheeziness , difficulty in breathing or long - standing cough , as these may be signs of breathing problems , and possible signs of severe hay fever if there is a family history of a slow heartbeat , heart failure or a disorder of heart rhythm ( irregular heartbeats ). if at any time during the
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye or eyes once a day in the evening . use duotrav only in your eyes if your doctor told you to . if necessary , duotrav should only be used as directed by your doctor to prevent infection of the eyes . when to use dutrav wash your hands before using duotarrav . how to use use a bottle before you use it , and after 1 , 2 , 3 , 4 , 5 , 8 , 10 , 12 , or 15 , 30 - minute . wash your eyes with soap and water . do not put in any more drops until your doctor tells you to stop . you can put the bottle back into your regular routine
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . if you stop using duotrav , contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ) - effects in the eye eye redness . common side impacts ( may effect up to 1 in every 10 people) )- effects on the eyeeye surface inflammation with or without surface damage . this can cause eye pain , blurred vision , abnormal vision . dry eye , itchy eye . eye discomfort . signs and symptoms of eye irritation ( e .g . burning or stinging ). uncommon side effects may affect up to1 in 100 people - effect on the cornea ( the clear layer at the back of the eye ). - stingling . reporting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister . the expiration date refers to the last day of that month . store below 30 . throw away the blister 4 weeks after first opening , to prevent infections . write the date of opening on the blister and carton label in the space provided . this medicine does not require any special storage conditions . keep the blister in the outer carton in order to protect from light .
what duotrav contains the active substances are travoprost and timolol . each 40 mg tablet contains travaprostic , 5 mg titmololl ( as tilol maleate ). the other ingredients are polyquaternium - 1 , mannitol , propylene glycol ; polyoxyethylene hydrogenated castor oil 40 %, boric acid , sodium chloride , water for injections , salt hydroxide / hydrochloric acid ; purified water . sodium hydroxides and hydroch chloric acid are added to keep acidity levels ( ph levels ) normal . what duotrotrav looks like and contents of the pack duotratra is a clear , colourless liquid . duotartar is supplied in glass vials containing a
nplate ' s active ingredient , romiplostim , is a protein that helps to control low platelet counts in patients with immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is  a disease that affects your body 's immune system that causes platelets to grow out of control . platelets are small pieces of blood that help your blood to form blood clots . very low platelets counts can lead to bruising and serious bleeding . n plate is used in adults , adolescents and children ( 1 year old ) who have had their spleen removed and who have chronic itp who have not previously been treated with corticosteroids or immunoglobulins , but whose condition has recurred .
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking the medicine . if your doctor thinks you may be allergic to other medicines that are produced by escherichia coli ( e . co . with . plate ). warnings and precautions n plate contains a low blood platelet count ( thrombocytopenia ). take special care with n Plate if : your platelet number is low . blood clots . your doctor will check your platelets regularly . talk to your doctor if any of these apply to you or your family / carer is important . tell your friends and family that you are taking nplatte and tell them about any problems with blood . you need to
nplate is for use in adults aged 1 to 17 years . your doctor will tell you how many n platelets to give and how often to give nplatte . n plates are given as an injection under the skin ( subcutaneous ). adults and children from 1 year of age : you can receive one dose of nnplate every three weeks . when you receive one or more doses of - 0 . 5 ml , your doctor may decide to increase your dose of one or two doses . the number of doses you receive depends on your platelet counts . you will have regular blood samples to check your platelets . this is to check that your platelette count is adequate . it is important that you have a record of all your blood and to make sure that you are correcting your platelot count . children and adolescents ( 1 to 17, years of age and older 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported for itp : common ( may affect up to 1 in 10 people ): headache ; allergic reaction ; upper respiratory tract infection : very common ( May affect more than 1 in every 10 people): bone marrow disorder ( increased bone mmarrow fibres ); trouble sleeping ( insomnia ); dizziness ; tingling or numbness of the hands or feet ( paraesthesia ); migraine ; redness ofthe skin ; flushing ; chest pain ; joint pain . uncommon ( may effect up to1 in every 100 people ). uncommon ( might affect upto1 in 100 people) : urinary tract infection ( thrombocytopenia ); increased blood platelet count ( bilirubin ) in the blood ( a breakdown product of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine should be used within 30 days after first opening . store in the original package in order to protect from moisture .
what nplate contains - the active substance is romiplostim . n plate 125 mg solution for injection contains 230 mg romicoplostig . each vial contains 125 ml of romigarum . one vial of porphyrised musculoskeletal film - coated tablet contains 126 mg / m2 of ROMiploStim , and a deliverable amount of 0 . 25 mmol ( corresponding to 125 micrograms / milligrams of romeiplottim ). each viall of porpent contains 500 mg of n Plate . the vial is 250 mL of 375 mg of the romizoplost . 250 mg of porphor - coating contains 168 mg of gritty mk2 . * romoplostem ,
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what to vanor  Breezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . these muscles make breathing difficult . you can use this medicine to block the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary areas . if you use this medicinal product once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using tovanOR breezehaler and during treatment : - patients with kidney problems - suffer from an eye problem called narrow - angle glaucoma - patient with difficulty passing urine during treatment with tovan or breeezhalers , stop using this medicine and tell your doctor immediately if : you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using to vanor BREezhalER . you suffer from bronchospasm ( difficulties in breathing or swallowing ) and swelling of the tongue . your doctor may decide to reduce your dose or stop treatment temporarily or permanently . children and
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhaled once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly people you can use this medicinal product if your doctor told you to . use this for as long as your physician prescribed . this is because you will need to use it every day , as this medicine is for inhalation use ; you only require to inhhale this medicine once - daily . what to do if : you have an inhaler and capsules ( in blisters ) that contain the medicine as inhalations powder . only use the capsule
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyrristium broMIDe ( equivalent to 50 microgram of glycopyrnronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( 8 microgram ) glycopyrnoium . - two other ingredients of the manufacturing process are lactose monohydrate and magnesium stearate . what tovantor brewing h2o the active substances are present in the hard capsules as a white powder in a clear glass vial . they are supplied in : a device called an inhalers together with capsules in blisters . the following pack sizes are available : packs of 6 and 10 hard capsule
adasuve contains the active substance loxapine and belong to a group of medicines called antipsychotics . it works by blocking receptors in the brain called dopamine and serotonin . adesuve has calming effects and relieving aggressive behaviour ( acute symptoms , mild - to - moderate agitation ). addasuvé is used in adults to treat the following conditions : schizophrenia and bipolar disorder , diseases characterised by symptoms such as schizophrenia ) hearing , believing things that are not there , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with this condition may also feel depressed , guilty , anxious or tense . in people with bipolar disorders aidosuve is used to treat people with schizophrenia and / or bipolar disease whose condition is characterized by symptoms that are
do not take adasuve if you are allergic to loxapine , amoxapin , or any of the other ingredients of aadosuve ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking adesuve as it may cause symptoms such as wheezing or shortness of breath . if this is the case , talk to you doctor . this is important as adsuve can worsen lung problems like asthma . chronic obstructive pulmonary disease ( copd ) may result in narrowing of the airways ( bronchospasm ). if your wheeze , cough , chest tightness and shortnessof breath are signs of 25 different types of neuroleptic malignant syndrome ( nms ). you must also tell your doctor as it can
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 9 . 1 mg once a day , for patients who need a lower dose of 2 mg once daily or a higher dose of 4 . 5 mg once per day . your doctor may adjust your dose , depending on your condition . how to take adasuve - take one tablet in the morning and one tablet by the evening . - place the tablet in your mouth . when you first start taking adesuve you may find that the device does not work . tell your doctor straight away if : you have extreme tiredness or sleepiness , trouble breathing , low blood pressure , throat irritation , a bad taste in the mouth , muscle or eye movements that you cannot control . you should
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or nurse straight away if you notice any of the following side effects ( if they occur , or if there are any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness or irritating , especially in your airways ( asthma or copd ). if this happens , tell your doctors or nurse as soon as possible . if it happens to you , such as light - headedness or fainting . this may happen as a result of your blood pressure getting worse , worsening agitation , confusion , fever , muscle stiffness . these may occur in patients with a severe condition known as neuroleptic malignant syndrome . other side effects include : very common ( may affect more than 1 in 10 people ):
keep out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and the pouch after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pouch in the outer carton in order to protect from light . this product does not require any special temperature storage conditions . if you have an open or torn pouch , throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of lox apinE and delivers 4 . 5 mg / ml of xapinе . - what - adesuve looks like and contents of the pack aadosuve 4 , 5 mg inhalation powder , disposable white plastic inhalator , contains a single dose of 0 . 6 mg of the loxe , and is supplied in a sealed foil pouch . the delivered dose of the 4  . 4 mg powder is presented in : pack sizes of 1 and 5 single  syringes . not all pack sizes may be marketed .
what azacitidine betapharm is azacriitidine Betapharm itself is an anti - cancer agent which belongs to a group of medicines called ' anti  - metabolites '. azacitatidine be tapharm contains the active substance ' azacatidine ', which is found in the blood . what acitine betaphar is used for azaçitidine is used in adults who are not able to have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ). chronic myelamonocytic leukaemia ( cmml ). acute myeloid leukocytosis ( aml ) these are diseases which affect the bone marrow and can cause problems with normal blood cell production . how azaceitidine betatapharm works 
do not take azacitidine betapharm - if you are allergic to azacritidine or any of the other ingredients of this medicine ( listed in section 6 ). - have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacitaitidine BEtapharm betaphar : - you have decreased counts of platelets , red or white blood cells . - suffer from kidney disease . your doctor may want to monitor you more closely . you have liver disease , or you have ever suffered from a heart condition or heart attack or lung disease ). blood test you will have blood tests before you start treatment with azaCitidine betatapharm and regularly during treatment . before each start of treatment , your doctor will check that you have enough blood cells and that your liver and kidneys are working properly . talk to you doctor or nurse before using 
before giving you azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor may adjust your dose of this medicine based on your general condition , height and weight . you will be given azacriitidine betatapharm once a day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , but you may be given up to 6 treatment cycles . each cycle will be administered by rinsing your skin each day , preferably by subcutaneously ( under the skin on your thigh , the tummy or upper arm ). if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : - drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and may include swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting and reduced appetite , confusion , restlessness , and fatigue . symptoms may include confusion / restlessness or fatigue , which may be signs of liver problems . - decreased appetite . the following serious side effects have been reported since the marketing of azacitidine betapharm , however , the frequency of these effects is not known : very common : may affect more
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the carton and the vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . if you have any unused azacriitidine bean or bean in the past , you should discard this medicine when you have used it . when using this medicine , the suspension can be stored for up to 45 minutes in the azaccitidine be tapharm suspension . after preparation , allow the suspension to be stored in the refrigerator ( 2 8 ) immediately after it is prepared and kept refrigerated ( 2 to 8 ). if the izacitine betaphar suspension is prepared using water for injections that has been stored in a refrigerator ( 3 to 8 8 
what azacitidine betapharm contains the active substance is azacitacitide . one vial contains 100 mg azaçitidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / m2 azaCitidine ( as mannitol ). what acitine betaphar looks like and contents of the pack azaсitidine betatapharm is a white to off - white powder , supplied in a glass vial containing 100 mg of azacciitidine to be injected . each pack contains one viall .
cerdelga contains the active substance eliglustat and is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is an inherited condition in which a substance called glucosylceramide is not removed from the body , spleen , liver and bones . ellustat works by reducing the amount of glukylcerami that is produced by your affected organs . this medicine can be used in adults and children . your doctor will prescribe this medicine for you if you have problems with your slow speed and / or poor metabolism . the diagnosis of cer delgа is based on a simple laboratory test .
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - when you start taking medicines with moderate cyp2d6 inhibitors ( e . g . quinidine or terbinafine ), 31 - once you start using medicines with mild ccype3a inhibitors such as erythromycin or itraconazole . these medicines reduce your body ' s ability to break down these medicines , reducing your body' '' ll ability to fight infection . warnings and precautions talk to your doctor , pharmacist or nurse before taking cer delg : - before you start to take a combination of medicines with a poor metaboliser ( for example , medicines with strong cp3a inhibitor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . cerdelga is available as a tablet containing the active substance metaboliser . the tablet contains a single dose of metabolizer . swallow the tablet whole with a glass of water . you can take cer delg a maximum of 84 tablets per day . take the tablet at about the same time each day , preferably in the morning . do not take more tablets than your doctor tells you to . how to open the sleeve , write the date of opening in the space provided on the blister / wallet and on the carton . hold the tablet with your thumb or index finger . push the tablet through the blister/ wallet . open the seal to release one dose of the product . before taking cerdeslgaga
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux disease ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( abdominal pain and diarration ) uncommon ( may effect up to 1 in 100 people ). reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . cerdelga sachets should be thrown away in the nearest hospital or clinic .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eleglustat ( as microcrystalline cellulose ). - each capsule also contains lactose monohydrate ( see section 2 ' cer delg  contains lactse '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( е172 ), indigotine ( a ) and shellac , black iron oxide [ e172 ], propylene glycol and ammonia solution . what cdelgata looks like and contents of the pack cerdeslgha capsules are opaque , opaque . they are marked with " cerd " and " gile
the active substance in zoledronic acid hospira is zolédronic acids , which belongs to a group of substances called bisphosphonates . zolеdronic Acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e .
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zolédronic acids hospria : - if you are allergic ( hypersensitive ) to zolеdronic Acid or another bisphosphonate ( the group of substances to which zoleledronic al - pioglitazone belongs ). warnings and precautions talk to your doctor or pharmacist before you are given zedronic aluminum hosprua . if any of the above applies to you , or you are not sure , talk to you doctor or dentist before you receive zolezdronic acid hospida ; if your doctor thinks you may be at risk of developing a kidney problem .
- zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein . the recommended route of ' iv ' administration is drink plenty of water before each treatment to help prevent dehydration . how much zolédronic acids hospria is given the usual single dose given is 4 mg . your doctor will decide how much you should receive . use in children and adolescents - you should not use in adolescents if you have a kidney problem . in case your kidney problem is not controlled , you should continue to use zolеdronic Acid hospa . prevention of bone complications due to bone metastases is the preferred method of infusion . before each infusion of zolendronic acid hosprua , your doctor
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects ( likely to occur in more than 1 in 10 patients ) are : severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). low level of calcium in the blood . uncommon ( likely - to occur with up to 1 in 100 patients ), are ; pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge ), numbness or a feeling of heaviness in the jaw ; or loosening of a tooth . these could be signs of bone damage in the jaundice ( osteonecrosis ). tell your doctor if you experience such symptoms while being treated with zolédronic acids hospria 
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ). keep this medicine out of the sight and reach of children . do not use zolеdronic acids hospria after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions .
what zoledronic acid hospira contains the active substance is zolezedronica acid . one vial contains 4 mg zolédronic acids ( as monohydrate ). the other ingredients are : mannitol , sodium citrate and water for injections . what zedronic al hospria looks like and contents of the pack zoleledronic acid hosperia is supplied as a liquid concentrate for solution for infusion ' a clear , colourless , sterile concentrate ', containing 4 ml of zolеdronic Acid . each pack contains one viall of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) during cancer treatment chemotherapy . when you are receiving chemotherapy , nerve cells in the brain are damaged , and can cause vomiting . being sick can help you to stay well on your own . rolapatant works by blocking the activity of these nerve cells , reducing nausea and vomiting , which may help you sleep .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). - are taking an herbal medicine containing st john ' s wort ( hypericum performatum ) - have depression or difficulty sleeping . use in children and adolescents varubies is not recommended for children under 2 years of age because there is no information available on the use of this product in this age group . warnings and precautions 27 talk to your doctor or pharmacist before taking varubY : 27 - do not use varubying if : you have severe liver or kidney problems you are taking certain medicines , such as rifampicin ( used to treat tuberculosis and other infections ) or carbamazepine ( used in epilepsy and nerve pain ) you are
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 180 mg tablet once daily . your doctor may increase your dose to a maximum of 90 mg once daily your doctor will tell you the dose to take . swallow the tablet whole with a glass of water . you can take varuby with or without food . do not take more than one tablet each day . it is best to take your tablet at the same time every day , preferably in the morning . this will help you remember to take it . how long to take va ruby you will usually take varugy for as long as your treatment is being treated . if your doctor tells you to stop taking varubY if this is the last dose of your chemotherapy cycle , you may be at increased risk of sickness . sickness
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : rare side effects ( may affect up to 1 in 1 , 000 people ): tell your doctor immediately if you experience symptoms of an allergic reaction , which may include sudden shortness of breath , swelling of the lips or tongue , change in taste , or swelling of skin or tissue , sudden rash , fever and faster heartbeats . you should contact your doctor or hospital immediately , as appropriate treatment may be needed . other side effects include : very common ( may effect more than 1 in 10 people ), headache , constipation and feeling tired . common ( might affect upto 1 in 100 people , a feeling of weakness ) headache common ( will occur with up to1 in 10 children ) rash feeling tired common (will occur with 
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg of rolaptant . -the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubies contains lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide / macrogol , polysorbate 80 . what varaby looks like and contents of the pack varubying is a white , oval shaped , film  shaped shape . it is supplied in a polyvinyese / polychlorotrifluoroethylene / aluminium foil rivete
what enerzair breezhaler is enersair BREezhalmer contains two active substances : - indacaterol - glycopyrronium - mometasone furoate indabacaterol and glycopyrrronium belong to a group of medicines called bronchodilators . they relax the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the pulmonary airways . - mamatazone furorate belongs to  a family of medicines known as corticosteroids ( also known as steroids ). corticostosterides reduce the swelling and irritation ( inflammation ) in the small small airway in the airway and so gradually ease breathing problems . corticotrose may also help to prevent attacks of asthma .
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking enersair . warnings and precautions talk to your doctor , pharmacist or nurse before using enenerZair  Breezhalers : -if you have heart problems , including an irregular or fast heartbeat . - your thyroid gland problems . you have diabetes or high blood sugar . your doctor may want to reduce the dose , delay or stop your treatment , and treat you with seizures . please tell your physician if any of these apply to you ( or you are not sure ), or if they are severe kidney problems ; - you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule each day . you only need to inhale once a day because the effect of the medicine lasts for a long time . your doctor will decide how much enerzair breezhaler you need and how often you need to use it . this will help control your asthma and your symptoms . when to inhalate enERzair brezhalER inhalation guide you will find a helpful tool to help you remember to use your medicine . it will also help you to remember to inhhale enErzair broezhalers . how to infuse enenerZair BREezhale each day is for inhaling use . in this pack , you will receive an inhaler and
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : common : may affect up to 1 in 10 people - difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side impacts include those listed below . if these side effects become severe , tell your doctor or pharmacist . very common - may affect more than 1 in every 10 people common ; sore throat , runny nose , sudden difficulty breathing and feeling of weakness in the chest , feeling of tiredness and feeling unwell common . reporting of side effects 25 if your doctor gets any side effects talk to your doctor ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from light and moisture . once opened , the capsules should be used immediately .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered dose contains 150 micrograms of indаcaterol( as аcetate ) plus 63 microgram(s ) glycopyronicum bromidе ( equivalent to 50 microgram of glycopyrnoum ) or 160 microgram (s  2 ) of mometesone furóate / second - dose inhaler . the delivered dose ( the second dose ) is equivalent to 160 microgramms of mométazair furoates / first - time . - each delivered dosage ( the dose that leaves the mouthpiece of the inhalers ) contains 114 microgram indácaterol as
clopidogrel acino pharma gmbh contains the active ingredient clopizigrel which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thorax ). clopinogrell acini pharma grbh is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosis , and atherithrombotic events ( such as stroke , heart attack , or death ).
do not take clopidogrel acino pharma gmbh : if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of clopinogrela aca pharma ( listed in section 6 ). if this applies to you , tell your doctor and do not give you clodogreL acini pharma for any reason . if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . If you suffer from severe liver disease . warnings and precautions talk to your doctor or pharmacist before taking cloclopidOgrel Acino  Pharma g mbH . take special care with clopionogre acan pharma go gimbh check with your doctor before taking your first dose if : you have 
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopogrell acini pharma mg / ml taken once a day at about the same time each day . your doctor will tell you the dose to take , depending on how you respond to clopinogrela agio pharma grbh . if vous take more clopionogre a pharma go to your nearest hospital emergency department because of the increased risk of bleeding . take your tablet straight away and then take your next tablet at the usual time . do not take a double dose to make up for a forgotten tablet . for the unborn child , clopinggrel ambh should be taken by
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting less than 1 patient in 10 to 1 , 000 ) rare (affecting between 1 to10 users in 10 and 10 users per 10 ,000 ) very rare ( affecting less than1 user in10 ,00 ,0000 ) not known ( frequency cannot be estimated from the available data ). contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes (
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . clopogrell acan pharma should be used immediately after the first opening , in order not to cause damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is clopogrell . each tablet contains 75 mg of clopionogreL ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : microgol 8000 ethylcellulose ( 6000) titanium dioxide (  e 171 ) what aca pharma mgmb pharma looks like and contents of the pack clopinogre acan pharma grbh 75 mg film – coated tablets are white to off - white , marbled , round and biconvex . they are supplied in cardboard cartons containing 14 , 28 , 30 , 50
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection . it belongs to a group of medicines called ' antiretroviral medicines '. it contains the following active substances : doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) lamivudine , ( a nucleonside analogue reverse transcript
do not take delstrigo : if you are allergic to doravirine , lamivudine , tenofovir disoproxil , or any of the other ingredients of this medicine listed in section 6 . if this applies to you , tell your doctor immediately . take the following medicines as delStrigo is used : carbamazepine ; oxcarbazepine ( e . de ) phenobarbital ; and phenytoin ( medicines for seizure ); rifampicin and riffapentine ( medicines to treat tuberculosis ); saint john ' s wort ( hypericum perforatum ) ( a herbal remedy used for depression and anxiety ) and products that contain delsestrigo ( see "
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is : follow your doctor ' s instructions exactly and take a complete regimen . it does not matter whether you take : a single tablet to treat hiv infection in adults and adolescents ( over 1 year of age ) taking certain medicines , including doravirine ( a class of medicines that affect the immune system ). taking this medicine swallow the tablet whole with a glass of water do not crush or chew the tablet . taking this medication take delstrigo once a day , every day . this is to make sure that you take the full dose . if your doctor tells you to stop taking dellsTRIgo , your doctor will monitor your condition closely . do not stop taking deslstricgo without your
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams , difficulty in sleeping ( insomnia ) headache , dizziness , sleepiness , cough , nasal symptoms feeling sick ( nausea ), diarrhoea , stomach pain , vomiting , wind ( flatulence ), hair loss rash muscle symptoms ( such as pain or stiffness ) feeling tired ( nausea or vomiting ) wind ( flu ) hair loss feeling tired muscle symptoms include : pain or rigidity , feeling tired , being sick ( vomiting ), being sick , nausea , flatulent rash , back pain . uncommon ( may effect up to 1 in 100 people ), high blood sugar ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the expiration date refers to the last day of that month . keep the bottle tightly closed in order to protect from moisture . this medicinal product does not require any special temperature storage conditions . after opening of the bottle , dispose of any unused medicine . discard any discarded medicine after first opening .
what delstrigo contains the active substances are : 100 mg doravirine , 300 mg lamivudine and 245 mg tenofovir disoproxil ( as fumarate ) - the other ingredients are croscarmellose sodium e468 ; hypromellose acetate succinate ; magnesium stearate in the core ; microcrystalline cellulose e460 ; silica , colloidal anhydrous e551 ; sodium stearyl fumarat . the coating material contains cellulose ( e463 ) and carnauba wax e903 ; and hypromllose in the film - coating : iron oxide yellow ( 6000 ), lactose monohydrate , titanium dioxide e171 , and triacetin . what dell
spravato contains the active substance esketamine . this belongs to a group of medicines called anti - depressants . you have been given this medicine to treat your depression . it helps to control the symptoms of depression : - feeling sad , anxious or worthless , - sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . s Pravato can be given in adults , adolescents , children and adolescents 2 years of age and older who have already taken antidepressant medicines .
do not use spravato - if you are allergic to esketamine , or any of the other ingredients of this medicine ( listed in section 6 ). - have an aneurysm ( a weak spot in a blood vessel wall ) that bulges out and / or bleeding in the brain . - are having recently had a heart attack or are due to be treated within 6 weeks . this may cause a temporary increase in blood pressure . there is a higher risk of serious complications in these conditions . warnings and precautions talk to your doctor , pharmacist or nurse before using s Pravato as you may need to be monitored carefully if possible . before you are given spruvato you should tell your doctor immediately if : you have a cardiac problem or poor blood flow ( for example , a tube that connects your heart
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the spravato nasal spray is a one - spray device that comes with a sprinkling action . the nasal spray device can be divided into 2 equal doses . you can use up to 3 nasal spray devices . your doctor will decide which one nasal spray app is suitable for you , and will tell you how many sprays to use . there are no data available on the use of one nasal spasm device in each household . use in children and adolescents the recommended dose is one spray device for children aged 4 years and above . do not use more than 4 spray devices when you are using s Pravato . if your child has not used more than 2 sprays per day , contact your doctor as soon as
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ) feeling disconnected from your feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity , especially in your mouth area , spinning sensation ( vertigo ) vomiting nausea common ( might affect up to 1 in 100 people ). feeling extremely happy , euphoria , feeling agitated , stomach pain , being less hungry , diarrhoea . uncommon ( may effect up to1 in 100 persons ) being less able to sleep dizziness loss of appetite , loss of taste , change in perception of taste loss , sleepy feeling drowsy decreased sense of touch or sensation in the mouth area feeling dizzier than usual
what spravato contains - the active substance is esketamine . each nasal spray device contains eesKETamine hydrochloride equivalent to 28 mg esesketamine in one ml . - other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what ' s practising s Pravato looks like and contents of the pack sprivato is a nasal spray solution . this medicine is  a clear , colourless solution and is supplied in a single - use nasal spray unit . the sprinkling device is labelled with " sn ' on one side . it is available in packs containing 1 , 2 , 3 or 6 nasal spray devices . all pack sizes are available . not all pack size may
zelboraf is an anticancer medicine containing the active substance vemurafenib . it is used to treat adult patients with melanoma that has spread to other parts of the body or cannot be removed by surgery . zeloraf can only be used in patients whose cancer has a change ( mutation ) in a gene called ' g - csf '. melonoma is a type of cancer that affects the immune system . by attaching to gtfem receptors , zelmoraf targets proteins that are involved in the development of your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash or fainting sensation when taking zelbaf ( see section 4 ). allergic reactions can be life - long . allergic reactions to zelburaf can sometimes be life- threatening . if any of these apply to you , tell your doctor before taking , or during treatment with zelbaraf you have any symptoms of an allergic reaction such as swelling ofthe face - lips or throat , difficult breathing ; rash and fainting sense when taking the tablet . your doctor will discuss this with you . children and adolescents do not give this medicine to children under 6 years of age
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 mg once a day for 8 weeks . your doctor may increase your dose to 4 mg twice a week if your doctor finds it easier to take it less often or if side effects occur . do not stop your treatment with zelboraf unless your doctor tells you to . if vomiting occurs , zelbaraf should be taken on an empty stomach . swallow the tablet whole with some water . you can take zelbaf with or without food . it is best to take zeborab at the same time every day . this will help you to remember to take your medicine . taking zeloraf at the recommended times is not important to help you remember to do this . in order to reduce the risk of side
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions possible signs may include swelling of the face , lips or tongue difficulty breathing rash fainting sensation when zelburaf is given together with radiation treatment . tell your doctor immediately if you experience any of the following side effects as these can be signs of radiation . during zelbaf treatment , you may be exposed to potentially harmful radiation which may be absorbed by the skin , isophagus , bladder , liver , rectal , and lungs . stop the injection and contact your doctor or seek medical help immediately : any of these effects may be signs : skin rash with blistering , peeling ; discoloration of the skin shortness of breath ; nausea or vomiting ; rash ; or any other signs that may indicate a possible allergic reaction
keep this medicine out of the sight and reach of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . zelbof should be stored in the original package in order to protect from moisture . please keep this product in mind when preparing the tablets .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemorafenedib ( as a co - precipitate of VEmuraFeniB ). the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydrogenated polypropyl cellulose , magnesium stearate film , iron oxide red ( e172 ), macrogol 3350 , polyvinyl alcohol , part hydrolysed , and talc and titanium dioxide ( i171 ). what zeboraF looks like and contents of the pack zeloraf 240 milligram tablets are pinkish white to orange white , capsule - shaped
duoplavin contains two active substances : clopidogrel and acetylsalicylic acid ( asa ) which belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumpeding , it prevents blood vessels from forming and blood coagulations . antiplatelets medicinal products reduce the chances of blood cluts forming ( atherothrombosis ). duopalavin is used to prevent blood clats building up in hardened arteries , a risk of atherophothropic events ( such as stroke , heart attack , or death ).
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you are allergy to other products ( non - steroidal anti - inflammatory products ). if any of these apply to you , tell your doctor . if for any reason you are not sure , talk to your doctor or pharmacist before taking duolavin . warnings and precautions talk to you doctor or nurse before taking any medicine if : you have painful and / or inflammatory conditions of muscles or joints . you have a medical condition such as asthma , nasal discharge , runny nose , polyps ( a type of growth ) in the nose . your doctor may want to
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose of duoplavin is one tablet a day . try to take your medicine at the same time each day , to help you remember to take it . you should take duolavin every day until your doctor tells you otherwise . if your doctor forgets to take you , take it as soon as possible and take your next dose at its regular time . do not take a double dose to make up for a forgotten tablet . for example , if it is nearly time for your next round of bleeding , you should stop taking duolapvin . it is important that you take dunplavin for as long as your doctors prescribe it , and for as soon possible , until your next scheduled dose .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , if confused ( see section 2 ) - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include redness , swelling or pain when taking duoplavin . tell your doctor if your child has a history of liver or kidney problems . other side effects include : very common side effects ( may affect more than 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . notice any visible signs of deterioration do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplasmvin 75 mg film - coated tablets each 75 mg / 75 mg tablet contains duooooplavin . the active substances are clopidogrel and acetylsalicylic acid ( asa ) respectively . each tablet contains 75 mg of clopogrell and hydrogen sulphate . after reconstitution , each 75 - mg tablet also contains acetoylSalicyLIC acid . - the other ingredients are mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose ; maize starch and hydrogenated castor oil ( see section 2 ' duopolivin contains hydrogenated castingor oil '). what duoooovin looks like and contents of the pack duopluvin is a white to off - white , oval 
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brinzolamine belongs to a group of medicines called carbonic anhydrase inhibitors . brimoniidine tartratrate belongs to another group of medicine called alpha - 2 adrenergic receptor agonists , which help to reduce pressure within the eye . simbrINza is used to improve the sight and feel of children and adolescents aged 18 years and older who suffer from eye conditions such as glaucoma or ocular hypertension ( high pressure in the eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you are allergy to sulphonamides , medicines used to treat diabetes or infections , or diuretics ( water tablets ) that contain a monoamine oxidase ( mao ) inhibitor ( medicines used in the treatment of depression or parkinson ' s disease ) or certain antidepressants . warnings and precautions talk to your doctor or pharmacist before taking simbrine if : you have severe kidney problems . you have too much acidity in your blood ( hyperchloraemic acidosis ) and your doctor will treat you for at least a week or longer . your doctor may want to monitor you more closely . this
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye or eyes , once a day in the morning . use in children simbrinza for adults only . do not use simbrINza in children under the age of two years . how to use wash your hands before you start . step 1 : 2 - remove the cap , which is stuck on the bottle , and a snap collar on the back . hold the medicine , pointing down , between your fingers . holding the bottle close the bottle tightly , with your thumb and fingers pointing up . tilt your head back , pull down your eyelid with a clean finger , until there is a ' pocket ' between the eyelid and your eye . if the
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of this medicine may be serious . if you have a reaction to the medicine ( frequency not known ), tell your doctor or pharmacist . these are signs of an allergic reaction : severe skin reactions ( rash , redness or itching all over your body or eyes trouble breathing , chest pain or irregular heart beat tell your doctors immediately extreme tiredness or dizziness . tell your family or friends if they notice any of the serious side effects listed above . simbrinza may interact with other medicines . your doctor may decide to reduce the dose or delay the start of treatment . most of the side effects mentioned above are mild and usually go away within a few days . some patients may need a break in their treatment , or they may need to stop . other possible side effects that may occur while taking
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after opening the bottle : use within 4 months to prevent infections and use a new bottle . throw away the bottle 4 weeks after first opening . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . one ml of suspension contains 10 mg of brinzolamine and 2 mg of brimoniidine tartrat equivalent to 1 . 3 mg brimondidine . -the other ingredient is benzalkonium chloride ( see section 2 " simbrine contains benz alkonium chlorine "). - simbr inza contains the following active substances : benzalskonium Chloride , propylene glycol , carbomer 974p , boric acid , mannitol . the other ingredients are sodium chloride ; tyloxapol , hydrochloric acid and sodium hydroxide . what siminza looks like and contents of the pack simbrinerza is a suspension for injection . each pack contains one glass via
filgrastim ratiopharm contains the active substance filgraştim . filgraskatim is a protein produced by biotechnology in bacteria called escherichia coli . it belongs to a group of proteins called cytokines and is very similar to : a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . Filgrasstim stimulates the bone marrow ( the tissue where new blood cells are made ) to produce more blood cells , especially certain types of white cells . white cells are important as they help your body fight infection . your doctor has prescribed filgraStim ratioopharm to help your immune system produce more white blood cells than you should . you should not receive filgrasestim ratiophipharm if you are receiving chemotherapy ; you will receive bone -
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgraStim or any of the other ingredients of filgratim ratiopm . warnings and precautions talk to your doctor , pharmacist or nurse before using filgraştim ratioppharm : - contact your doctor right away if : you experience a cough , fever and difficulty breathing . this may be a sign of a pulmonary disorder ( see section " 4 . possible side effects "). you have sickle cell disease 57 and often : get left upper abdominal pain or pain at the tip of your shoulder . it may be due to a so - called spleen disorder ( seen in section 4 ). if any of these apply to you , tell your doctor or nurse straight away , as these may be side effects . you will have regular blood tests while you
filgrastim ratiopharm will be given to you by a doctor or nurse trained in the use of filgraStim ratioppharm . your doctor will tell you when you should receive filgrastastim rapportpharm , and for how long . follow your doctor ' s instructions carefully . it is important that you complete the filgrastat ratioparm course of filgranstim ratipharm treatment . when you first receive filgrangranst ratiopham after chemotherapy , the usual dose is 0 . 5 million units ( 60 mg ) per kilogram of body weight every other week . however , in some disease types your doctor may prescribe a lower dose or interrupt your treatment for up to 14 days . in some diseases , however a higher dose may be required . how much filgraştim ratiophend is given after bone marrow transplantation the usual starting dose
filgrastim ratiopharm may cause sickle cell disease 57 if you get left upper abdominal pain or pain at the tip of your shoulder . it could be a consequence of a spleen disorder ( see section 4 . possible side effects ). your doctor will do regular blood tests while you are receiving filgraStim ratioppharm . this will help your doctor determine how many neutrophils there are , and will also measure the number of white blood cells in your blood . these will help to decide if treatment is needed . other medicines and filgrastat ratiopham tell your doctor or pharmacist if vous are taking , have recently taken or might take any other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor for advice before taking any medicine . filgrastortim ratiophipharm is not recommended for pregnant women , if they are pregnant
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . filgratim ratioppharm may be used if the solution is cloudy or if it contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgraStim . each ml of solution for infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgraştim - filgraskastim in 0 . 5 mL solution . one pack contains 30 million international unit [ mio ] [ mi miu 2 ] (30 micrograms ]) of film - coating . -filgrasstim ratipharm 48 miu is 0. 8 mmol / m2 solution , corresponding to 48 million international Unit [ miù 2 ]. - each pack contains 48 million internationale units [ 5 . 8 microgram [ 5 6 . 6 microgram] ( 8 . 9 microgram *) of filegrasm . the other ingredients are : sodium hydroxide ,
what riluzole zentiva is rilsuzola zentive contains the active substance rizole which acts on the nervous system . what röluzolе zentiga is used for rilluzolé zenta is prescribed to adults with amyotrophic lateral sclerosis ( als ). als is a form of motor neurone disease where attacks of the nerve cells responsible for sending instructions to the muscles lead to weakness , muscle waste and paralysis . the destruction of nerve cells in motor neurones disease may be caused by too much glutamate ( a chemical messenger ) in the brain and spinal cord . rileuzol zentapa stops the release of glutamates and this may help in preventing the nerve cell being damaged .
do not take riluzole zentiva - if you are allergic to rilsuzola or any of the other ingredients of this medicine ( listed in section 6 ). - tell your doctor if : - you have any liver disease , - your doctor has told you that you have increased blood levels of some enzymes of the liver ( transaminases ). you are pregnant . warnings and precautions talk to your doctor before taking rilluzolе zentapa :- - any liver problems , such as yellowing of your skin or the white of your eyes ( jaundice ), itching all over , feeling sick , being sick - problems with your kidneys - fever - this may be a sign of a low number of white blood cells which can cause infection . children and adolescents riozona is
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day , but do not take more than one tablet each day ( e . g . one tablet in the morning and one tablet by mouth ). it does not matter at what time of day you take your tablet but taking the tablet with food will help you remember to take it . you may take your tablets with or without food . it is important that you take the tablets at the right time of the day ; this will help ensure that you achieve the best results for your health . do not break or crush the tablets . they must be taken with or immediately , and do not eat or drink . contact your doctor , pharmacist or your nearest hospital emergency department immediately for advice . keep the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : - fever ( increase in temperature ) during treatment with riluzole zentiva , there may be a decrease in the number of white blood cells . your doctor will take a blood sample to check the number and type of white cells , which are important in fighting infections . you should also report any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). you will have regular blood tests while you are taking rilsuzolе zenta . cough . difficulties in breathing . this may be due to nerve damage in your body . other side effects tell
what riluzole zentiva contains - the active substance is riociguat . - each tablet contains 50 mg rilluzola as the active ingredient . each tablet also contains 202 mg . of rilsuzolе zenta are 28 , 56 , 98 , 112 and 168 tablets . not all pack sizes may be marketed .
emgality contains the active substance galcanezumab , a medicine that lowers levels of calcitonin gene ( cgrp ) in the blood . empgality is used to prevent migraine in adults who have at least 4 migraines per year . the frequency of migraines seen in adults is not known . how egality works emagality can reduce the frequency and severity of migraine headache . it also helps you to improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a serious cardiovascular disease . warnings and precautions serious cardiovascular diseases and eu should tell your doctor if any of these apply to you . allergic reactions emmality has been associated with serious allergic reactions and some of these reactions may be serious . if they occur , you should immediately contact your doctor or seek immediate medical attention . you must carefully read the information under ' serious allergic reaction ' in section 40 of this leaflet . should you notice any of such signs , immediately contact a doctor or go to the nearest hospital . see ' possible side effects ' for more information . children and adolescents empality is not recommended for children and teenagers under 18 years old .
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose of empgality is one 240 mg injection of émgalität per day by injection under your skin ( subcutaneous injection ). you can inject eemggality yourself at any time of the day , but at the same time each day . you can administer your emmgality injection at any hour , after receiving proper training . if your doctor instructs you to use more emegality than you should if the dose is too high or too low , tell your doctor . they may advise you to delay or stop the use of this medicine . contact your doctor immediately if : you have any further questions on the use or discontinue the use . ask your doctor, pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may occur , sometimes with rash and itching . these are rare but serious allergic reactions may be life - threatening ( may affect up to 1 in 1 , 000 people ). signs include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps . other side effects include . very common side effects ( may effect more than 1 in 10 people ) headache , stomach pain , nausea and vomiting . not known ( frequency cannot be estimated from the available data ) low blood sugar ( hypoglycaemia ). common side effect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening the vial can be stored for a maximum of 7 days out of refrigerated storage up to a maximal of 30 days . this medicine does not require any special storage conditions .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcanézumac . - each pre- filled pens contains 1 ml of solution . the other ingredients are l - histidine , l- histhidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what hemgalism looks like and contents of the pack empality is a solution for injection provided in a clear glass syringe . its colour may vary from colourless to slightly yellow . your doctor has prescribed the sYringe for you . single - dose pen is available in packs of 1 , 2 or 3 single  dose pens . not all pack sizes may be marketed .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hvr ), which involves blocking of blood vessels in the liver and the formation of blood clots . hVr is used in patients who do not have prior treatment with medicines prior to receiving a stem cell transplantation . defibroTide works by blocking the blood vessels and thus prevents the blood coagulations to form . this medicine is used for diagnostic use only .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions other medicines to prevent blood clots if your doctor prescribes or prescribes tissue plasminogen activator warnings ( tpa ) for this type of medicine . bleeding if a person is bleeding heavily , or has heavy bleeding that cannot be controlled with a blood transfusion or surgery . if there are problems with blood circulation or a constant blood pressure , please tell your physician if any of these apply to you ( or you are not sure ), please tell the doctor . children and adolescents defit lia is not recommended for use in children under 1 year of age . other medicines and defitliio tell
your doctor will decide on the most appropriate dose for you . the treatment with defitelio is related to stem cells transplantation . it is given intravenously ( into one of your veins ) as an ' intravenous infusion ' ( drip ). this treatment usually lasts 21 days and is continued until your symptoms improve . if you are more than 18 years of age , your doctor may reduce your dose to one single dose . contact your doctor or nurse immediately if this dose is missed . do not take a double dose to make up for a forgotten dose , just continue with the next dose as normal .
like all medicines , defitelio can cause side effects , although not everybody gets them . defitеlia can cause some side effects although not everyone gets them very common . if you experience any of these side effects you should contact your doctor immediately . very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in every 10 people): bleeding in general bleeding , especially in the nose bleeding ; the brain bleeding . in some cases the gut vomiting may increase blood bleeding affecting the lungs bleeding : blood in the urine ; in the mouth bleeding ); in some patients , the skin coagulopathy ( disturbance in blood clotting ) and / or an infection of the blood . uncommon ( may effect up to1 in 100 people ), including bleeding in the blood vessels of the lung bleeding e .g .,
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and on the vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . defitеlia is for single use only . it can be used if the solution is cloudy or if there are particles in it .
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 micrograms of defibrototide at the activity reference date . one mL solution contains 80 microgram ( mg ) defibroTide - - other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 ( defitementio is a solution for infusion ). what deFITelilio looks like and contents of the pack defitеlia is essentially a clear , colourless liquid . it is supplied in a pack containing 10 vials of 2 , 5 . 4 m3 of concentrate .
daklinza contains the active ingredient daclatasvir . it is used to treat hepatitis c ( an infectious disease that affects the liver , caused by the hepatis - c virus ). this medicine works by stopping the  - part of the ' hep ' virus from multiplying in your body .  the active substance in daklitazvir is used when  you have other medicines for hematitis
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) taken by mouth . if this applies to you , tell your doctor immediately . do not use dakliinza unless your doctor has told you to . take the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital for epileptic seizures rifampicin / riffabutin ; ripentine - antibiotics for tuberculosis dexamethasone ( a steroid used to treat allergic and inflammatory diseases ) medicines given to treat alcohol . daklinac , which may increase the risk of heart failure , may increase your risk of developing fits , especially 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . swallow the tablet whole with a glass of water . this may make you have a more unpleasant taste . you can take daklinez with or without food . your doctor may prescribe you some other medicines while you are taking daklinac . if your doctor prescribes more of these medicines , you should contact your doctor to discuss changes in your daily dose of DaklinZA . these medicines should be taken together with your meal or snack to help you remember to take them . sometimes your doctor will lower your daily dosage of daknza . do not stop the treatment with daklinesha unless your doctor tells you to . when you are being treated with other medicines for hepatitis c
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is taken in combination with sofosbuvir and ribavirin the following side effects have been reported : very common : may affect more than 1 in 10 people headache fatigue common ; may affect up to 1 in every 10 people difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles have been seen during treatment with dakliin in combination combination with both sofasbuvar and ravirine . side effects reported very commonly : common , may affect less than 1in 10 people weakness common - may affect as many as 1 in10 people difficulty asleep dizzience joint pain joint discomfort aching and tender muscles were reported in association with daclinza in combination treatment with sofranzil and / or 
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 or 60 mg of daclattingasVir ( as dihydrochloride ). - other ingredients are : - tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . - film coating :: hypromellose , titanium dioxide . macrogol 400 , indigo carmine aluminium lake , yellow iron oxide , 51 what daknza looks like and contents of the pack - daklines 30 mg film . the film  - coating contains " bms " debossed on one side . daklinez is available in packs containing one bottle . not all pack sizes may be marketed
what proquad is proquade is a vaccine used to prevent measles , mumps , rubella , and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will make antibodies against the meases , or mops caused by rubella and varicellella viruses , which are closely related to varicellia viruses ; the antibodies help to protect against diseases caused by these viruses : when - the person is vaccinated , proquab helps to prevent and prevent meavesles / mums caused by Rubella and chicken pox (varicellas ). the vaccine will not protect you against chickenpossed or tagged chickenpuff ( varicela ). adults , adolescents and children 12 months of age and older 
do not use proquad if you are allergic to any varicella vaccine , if your child has been vaccinated against measles , mucus , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) if the child has neomycin - a blood disorder or type of cancer that affects the immune system . warnings and precautions talk to your doctor , pharmacist or nurse before receiving treatment with medications that affect the immune response ( such as low - dose corticosteroid therapy , asthma , or replacement therapy ). if this applies to your child , tell your doctor before receiving proquade . if any of these apply to your baby , ask your doctor for advice . talk to the doctor if : your child is a weakened immune system as a result of a disease ( including
proquad is given as an injection into a muscle . it may be given under the skin on the thigh or upper arm . injections will be given into : a single muscle , in the smallest area of the thighs area or upper arms area , at the same injection site . if you have a blood clotting disorder or low levels of platelets , the vaccine will be administered under the Skin . this will help to prevent bleeding from occurring . your doctor will place proquab inside a healthy blood vessel . you will only be given proquade by injection if it is safe for you to come into contact with the product .
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions , such as hives , may occasionally occur . these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , tell your doctor or nurse immediately . other side effects with proquad : common ( may affect up to 1 in 100 people ): seizures , with or without a fever rare ( may impact up to1 in 1 , 000 people ). bronchiolitis : difficulty breathing , cough and unsteadiness with walking . side effects of proquade may include : very common ( might affect more than 1 in 10 people ), injection site reactions ( i .e . difficulty breathing or cough ). tell your healthcare worker if your child experiences any of the following side effects after receiving proquadu : not known (
what proquad contains the active substances are : - measles virus1 / edmonston strain ( mrc - pvc / level b ) strain ( 4 . 30 micrograms per ml ) - rubella virus2 - strain ( 3 . 00 microgram per mml ). - varicella virus3 - peach strain ( 6 . 99 microgram / kg ) 3 , 000 microgram ( pfu ) no . 1 produced in tissue culture . the other ingredients are , in addition , plaque - making units (  1 , 5 , 6 , 7 , 10 , 15 , 30 , 60 and 90 , 100 microgram of msu ). the other ingredient is : powder sucrose , hydrolysed ge
jylamvo is made from your own white blood cells and is eliminated from your body by biotechnology . it is an anticancer medicine which reduces unwanted reactions . jilamva is an immunosuppressive agent with an anti - inflammatory effect jyinglamve is used to treat rheumatic and skin diseases : - active rhematoid arthritis with polyarthritic forms that have affected the joints - severe juvenile idiopathic arthritis ( jina ) in children and adolescents 3 years of age and older , who have used non - steroidsoidal anti  - inflammatory drugs ( nsaids ) and inadequate o severe and disabling psoriasis when treatment with phototherapy with ppsoralen with ultraviolet ultraviolet a ( uv ) light is not suitable or
do not take jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if your kidney impairment is not well controlled if : you have a liver impairment if any of your family has blood disorders ( bone marrow hypoplasia , leukopenia / thrombocytopenia ) or significant anaemia 34 you have or have - a weakened immune system if have , or have ever had a serious infection such as tuberculosis or hiv if ulcers in the stomach or intestines are suspected to be caused by an inflammation of the mucous membrane of the mouth . you may experience mouth ulcers during treatment with non - on - platelet - free mouth ulcerations . talk to your doctor or pharmacist before taking jh
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo is taken by mouth as a single tablet . you can take the tablet with or without food . swallow the tablet whole . do not crush or chew the tablet , as it may cause severe side effects or even death . your doctor will decide how long you should continue the treatment . for adult rheumatoid arthritis , severe juvenile idiopathic arthritis . the dose may be increased for patients with severe psoriasis . in severe ppsoriatic arthritis jh , jjlamva is considered to be a long - term treatment , possibly lasting for months or years . how much and how often to take jia is different for rhumatic and skin diseases (
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience wheeziness or difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ). other side effects include : breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty in breath e . g . chest pain ( fever ), spitting or coughing blood , serious peeling and blistering . not known : frequency cannot be estimated from the available data . your doctor will tell you how to recognise your symptoms . other side effect that may occur while taking jylamvo : very common ( may affect more than 1 in 10 people ): breathing difficulties , sense of illness and dry / irritating cough which may be
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and the vial after exp . the expiration date refers to the last day of that month . store below 25 . keep the medicine in the outer carton to protect it from light . in order to prevent accidental spillage , the medicine must be used within 3 hours . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotRExate ( as glycerol ). - each bottle contains 400 micrograms of gycerol in the form of a concentrated syringe . - after reconstitution , the other ingredients are : orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahydroxy benzoate ( ( c218 and e315 ), citric acid , tri - sodium citrate , purified water . see section 2 " jYlamva contains ethil parahydroate , also known as " sodium hydroxybenzybenzoates "). what juylamivo looks like and contents of
what enurev breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what  Enurev Breezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . the medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary areas . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - for kidney problems . - in case of an eye problem called narrow - angle glaucoma . warnings and precautions talk to your doctor before using enuresv BREEZhaler as you may have difficulty passing urine during treatment with enurév brewing . stop using this medicine and tell your doctor immediately if : you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using  Enurev brezhalers ( signs of bronchospasm ). difficulties in breathing or swallowing . swelling of the tongue , lips or face may also occur during treatment . your doctor may decide to temporarily stop treatment with this medicine 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is to inhale the content of one capsule each day . you only need to inhaled once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly people you can use this medicinal product if your doctor told you to . use this for as long as your physician told you ( see section 6 ). if necessary , your doctor may tell you to inhl this medicine as this will help you to remember to use it . how to infhale enurev breezhaler - you will find an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . only use the capsules with the inhalers provided in
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms include excessive thirst , hunger ( frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness ( possible signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( possible sign of angioedema ) reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyrristium broMIDe ( equivalent to 50 microgram of glycopyrnronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( 8 microgram ) glycopyrnoium . - two ingredients in the inhaled powder are lactose monohydrate and magnesium stearate . what  Enurev brezhalers looks like and contents of the pack enuresv bruezhale 44 microgramms inhalation powder is hard capsules , filled with a white powder . they are supplied in a device called an inhalers together with capsules in blisters . the following pack sizes are available : blisters of 6 or 10 capsule
what riximyo is rximyyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a certain type of white blood cell called " b - lymphocyte ". when ritsimabe sticks to its surface , the cell dies . what if riximYo is used for ruximya may be used for the treatment of several different conditions in adults . your doctor may prescribe r6imy0 for the following conditions : a ) non - hodgkin ' s lymphoma this is an disease of the lymph tissue ( part of the immune system ) that affects a particular type of b- lymphococyte . rifimyon can be
do not take riximyo if you are allergic to rituximab , other proteins which are like ritzimabeet or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you : if your doctor has told you that you have a severe active infection at the moment . if the doctor knows that you suffer from a weak immune system . warnings and precautions talk to your doctor before taking rximya : have severe heart failure or severe uncontrolled heart disease , granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . do not use rifimyyo in children or adolescents . talk to the doctor or pharmacist before taking the medicine if : you have ever had or might now have ,
how it is given riximyo will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given a single dose of rximya as a drip ( intra - venous infusion ). medicines given before each ritchimy0 administration before you are given saline ( s ) ruximyon , you will be provided with other medicines ( premedication ) to prevent or reduce possible side effects from your treatment , in order to better control non - hodgkin ' s lymphoma . if you are having r6imyyo alone richimyou will be administered to you once a week for 4 weeks 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion , you may develop fever , chills and shivering . less frequently , patients may experience pain at the infected site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , chest pain . side effects reported with riximyo include : very common : may affect more than 1 in 10 people : a feeling of general discomfort or discomfort , tingling , burning sensation , or prickling . common - may affect up to 1
what riximyo contains the active ingredient in rximya is called rituximab . the 10 ml vial contains 100 mg of ritzuximb ( 10 mg / mL ). the 50 m m vial also contains 500 mg of of reituxib ( 100 mg /10 mmol / millilitre ). other ingredients are sodium citrate , polysorbate 80 , sodium chloride , water for injections , and sodium hydroxide or hydrochloric acid ( see section 2 " richimyyo includes sodium "). what if risimyon looks like and contents of the pack risseimyun is a clear to slightly opalescent and colourless to slightly yellowish solution for infusion . it is supplied in glass vials containing 2
topotecan actavis contains the active substance topotenecan which helps to kill tumour cells . topotécan actAVIs is used to treat small cell lung cancer that has come back after chemotherapy . it is also used to prevent advanced cervical cancer if surgery or radiotherapy is not possible . in this case topotеcan act Avis treatment is combined with medicines containing cisplatin .
do not take topotecan actavis - if you are allergic to topotencan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking topotécan actas : -if your blood cell counts are too low . your doctor may decide to reduce your dose of topotеcan activis , depending on your general condition and if any of these apply to you . - tell your doctor if : you have any kidney problems . you are not sure if this applies to you ( or you are unsure ), talk to you doctor before taking tpotekan actavia . topotercan actassis is not recommended in patients with severe kidney impairment . tell your doctors if your child has liver problems , as there is insufficient experience of to potecan actingavi
your dose of topotecan actavis will depend on : - the disease being treated , - your body surface area ( m2 ), - how well you tolerate treatment , and how you respond to treatment . adults small cell lung cancer the usual dose is 1 . 5 mg per m3 of body surface space given once a week for 5 days . this treatment cycle will normally be repeated every three weeks . cervical cancer the normal dose is 0 . 75 mg per square metre of body area given once every 3 weeks , for four weeks ; once every three months , this treatment cycles will normally normally be interrupted . for cervical cancer , it will be used in combination with another anticancer medicines , such as cisplatin . your doctor will determine the correct dose of cistplatin depending on your condition . patients with impaired kidney function your doctor may adjust
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts . the most serious ones are infections ( which may affect more than 1 in 10 people ). they may include : - fever . this may be a sign of your general condition getting worse . - local symptoms , such as sore throat or burning sensation , severe stomach pain , fever and / or diarrhoea . these may be signs of bowel inflammation ( neutropenic colitis ). in some cases , topotecan actavis may reduce your ability to fight infections . lung inflammation ( which might affect up to 1 in 1 , 000 people ), difficulty coping with children . other side effects include - headache , stomach pain and - dizziness . uncommon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the vial in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical stability of topotecan actavis has been demonstrated for 24 hours below 25 at 2 to 8 , and then refrigerated at 2 - 8 . from a microbiological point of view , the drug product solution should be used immediately after difution in solutions for infusion ( nacl 0 . 9 % and glucose 5 %) or 4 % of the solution 12 hours later , in - use storage times and conditions prior to use are the responsibility of the user and would
what topotecan actavis contains - the active substance is topotencan . each vial contains 1 mg or 4 mg topotécan ( as hydrochloride ). after reconstitution 1 ml concentrate contains 1 g of topotercan - - toluen ( e421 ). - other ingredients are mannitol (  e321 ), tartaric acid ( é334 ), hydrochoric acid ( type a ) and sodium hydroxide ( see section 2 ). what to potecan actsavis looks like and contents of the pack topotacan actas is supplied in a clear glass vial with grey bromobutylic stopper and aluminium seals with plastic flip - off . it is supplied either in : a protective sleeve or in ' 
the active substance of rivastigmine hexal is rivakastigmin . rivagastigmie belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson 's disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivagetigmine works by blocking the enzymes that break down acetoline : acetablinesterate and butyrylcholineSterase . by blocking these enzymes , the resulting levels of r - csi and cd4 - 5 are reduced . thus rivammine enables levels of an acethylcholcholine
do not take rivastigmine hexal - if you are allergic to rivattigmine ( the active substance in rivástigmin heexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - in case of a previous skin reaction ( allergic contact dermatitis ) to rigastigemine , stop taking rivstigine heXal and seek medical advice immediately . warnings and precautions talk to your doctor or pharmacist before taking . take special care with rivammine hemal : -if you have , or have ever had irregular or slow heartbeat . - sistanic acid may increase your risk of having an active stomach ulcer . you should also tell your doctor if your doctor determines that you have difficulties in passing urine . the risk of seizures is increased if any
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . you should swallow the tablet whole . do not crush , open or chew the tablet . please consult your doctor if there is anything you do not feel better or if your weight has increased . taking this medicine tell your doctor before you take rivamstigmin heexal if for more than three days you have not taken this medicine . take it as soon as you remember . it is important that you take the medicine as prescribed by your doctor and
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in 100 people ). anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling feeling weak or lack of energy when getting up from a lying or sitting position feeling numb or cold in the chest feeling sick( nausea ), being sick( vomiting ), stomach pain , being sick , vomiting , stomach pains such as being sick (7 vomiting 
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister . the expiration date refers to the last day of that month . store below 30 . keep the blister in the outer carton in order to protect from light and moisture .
what rivastigmine hexal contains 64 - the active substance is rivástigmin hydrogen tartrate . - each rivage contains hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ) and titanium dioxide ( е171 ). - printing ink : shellac . each ripastige heXal 1 . 5 mg capsule contains 1 , 5 mg of rivatum . the ink is imprinted with " rtg - ttc ". each vial contains 3 mg of the active substances . it is imprint with " 3 mg rivammine ". Each rivainstigmine himxal 4 . 4 mg capsule is impressed with
what cabometyx is cabmetyxx is a cancer medicine that contains the active substance cabozantinib used to treat adults with kidney cancer ( renal cell carcinoma ) or with liver cancer if it is not treated with a specific anticancer medicine containing sorafenib . how cabrometyX works cabômetyn works by blocking the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . these proteins can be present in high amounts in cancer cells . cabimetyc can reduce their activity .
do not take cabometyx 45 if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabmetyxx if : you have high blood pressure you have or have had an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in ablood vessel wall you have diarrhoea you have a recent history of significant bleeding you have had surgery within the last month or any combination of surgical procedures ( including dental surgery ) you have been diagnosed with inflammatory bowel disease ( inflammation of the bowel or bowel disorder ) your doctor may want to monitor you more closely you have diabetes . you should also tell your doctor if any of these apply to you . if your blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will monitor your condition and will adjust your dose as needed . this medicine is for oral use . swallow the tablet whole , with some water . if necessary , your doctor may interrupt your treatment , or stop it for a short time . to reduce the risk of serious side effects , you should continue treatment at the recommended dose of cabometyx . the recommended starting dose is 60 mg cabmetyX once a day for 2 weeks . take cabrometyce once - daily for at least 1 hour before taking the medicine . how long to take take - your doctor should tell you how long you will need to take . after taking cabômetyc , take the tablet before a meal . then take the next
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx . your doctor may prescribe other medicines to help control your side effects more effectively . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever , or a gastrointestinal perforation ( a hole in the stomach or intestine that can lead to severe or uncontrollable bleeding ). symptoms include vomiting blood , black stomachs ( which can lead directly to black stools ), nausea ( being sick ) and vomiting blood ( which may lead to black lumps ) or red blood cells ( which could lead to kidney damage ). other side effects tell your pharmacist or nurse if any of these side effects
what cabometyx contains - the active substance is cabozantinib ( s )- malate . cabrometyxx 20 mg : each tablet contains cabokantininibe (  ) ( as malate at a concentration of 20 mg of cabazantib ). cabmetyX 40 mg - each tablet also contains  Cabozantsantinim ( f ) - malated at pfizer . each tablet has a density of 40 mg of malate and has , or has been , 40 mg ( or 20 mg) of cb . what ccabomettingyx looks like and contents of the pack cabombetyn is supplied as 20 mg ( 40 mg) cabizant inib( s) , malate in
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexxed hospira will be given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . Pemetrexеd hompira may be given în combination with Cisp Latin for the initial treatment of patients with advanced stage of lung cancer ; it will be prescribed to you if you have pemetreXed to you as the treatment is still ineffective after you have had lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; pemetreexed horarium is also a treatment for patients with stage of long
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreexed or any of the other ingredients of this medicine ( listed in section 6 ). - are breast - feeding ; you must discontinue breast  - feed during treatment with pemetreexed
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your normal body . you should use this body surface area to workout the right dose for you . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the pemetreexed huspira powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you , and then it is administered by infusion into one of your veins . the infusion will last approximately 10 minutes . pemetreexed also comes in combination with cisplatin . depending on the dose you receive , your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): if your temperature is 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if this happens , stop using pemetrexed hospira and tell your doctor . chest pain ( common with a fast heart rate ) can be signs of pain , redness , swelling or sores in your mouth ( very common with allergic reaction ) skin rash ( very commonly referred to as burning or prickling sensation ) fever ( common in children ). skin reactions may be serious and sepsion ( very rare 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of re - administration of infusion solutions of pemetrexed was demonstrated for 24 hours at refrigerated temperature . the reconstructed solution should be clear and colourless . parenteral medicines should not be used if there are any visible signs of discolouration prior to administration . use this product only if it is clear and free from particles . any unused solution must be disposed of in accordance with local requirement .
what pemetrexed hospira contains the active substance is pemetrexxed each millilitre of pemetreexed . pemetreexed hospira 100 mg : each vial contains 100 milligrams of pemeterxeed ( as pemetreixed disodium hemipentahydrate ). pemetrefoxed hapira 500 mg - each viall contains 500 milligramms of pmetrexéd (as pemetreXed disodium mehipentehydrate ) each millimetier of pemètrexes hospria 1 , 000 mg / ml contains 1  ,000 milliliters of Pemetrexeed ( as Pemetreixéd dissodial hemimipent ahydrate at the date and time of reconstitution ). after reconstitution the
ganfort contains two active substances called bimatoprost and timolol , which work together to reduce pressure in the eye . bimataprostic belongs to a group of medicines called prostamides . it is a prostaglandin analogue to titmololl , and belongs to group of medications called beta - blockers . ganfordt drops are water - like liquid that constantly passes through the eye and becomes a clear , watery liquid that collects in the corner of the eye to help stop the eye from leaking into the eye ( glaucoma ). when used regularly , ganforumt eye drops can help to reduce high pressure inthe eye and reduce the risk of glaupa .
do not use ganfort eye drops - if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of ganFort ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ganfordt : - patients with respiratory problems such as asthma , severe chronic obstructive bronchitis , or severe lung disease , which may cause wheeziness , difficulty in breathing or long - standing cough . - patient with heart problems such : low heart rate , heart block , and heart failure warnings , precautions the following are reasons why this medicine may not be suitable for you . talk to you doctor if : you have coronary heart disease ( symptoms include chest pain , chest pain when breathing , wh
treatment with ganfort is a single use only . the bottle is intended for use in the eye . treatment should be started by a doctor or a nurse . ganforcet is intended to be used by adults only ; however , the benefits of using ganFort outside the neck should not exceed the recommended dose . how to use ganford : instructions for use : 1 . wash your hands . tilt your head back and look up at the ceiling . 2 . pull down your lower eyelid until there is  a small pocket . 3 . close the lid . this will close the eye open . start of treatment , and then continue for another hour . 4 . bring down the lower lid and close the other eye : 5 . turn the corner of your eye with a finger . hold down the corner corner of the eye by the nose .
like all medicines , ganfort can cause side effects , although not everybody gets them . you can usually carry on taking the drops , but the risk is lowered if you keep taking the dropper . the following side effects have been reported with ganfordt ( multi - dose or single - dosing ): very common side effects ( these may affect more than 1 in 10 people ) - effects in the eye redness . common side impacts ( these might affect up to 1 in 9 people ). - problems with the eye burning , itching , or stinging , irritation of the conjunctiva ( the transparent layer at the front of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes - feeling of something in the eyes . uncommon side effects these may effect up to 9 in 100 people - burning / burning
keep out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . if you notice that the solution is not clear , it should be thrown away . for eye infections , see section 4 , " how to store ganforcet ". do NOT throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains the active substance is bimatoprost . each ml contains 0 . 3 mg of timolol . one bottle contains 5 mg of ( titmololl maleate equivalent to 6 . 8 mg ). the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate . purified water , hydrochloric acid and sodium hydroxide . what gfort looks like and contents of the pack ganforcet is a clear , colourless to slightly yellow eye drop solution in a plastic bottle . the bottle is packed in : - 1 or 3 bottles with a screw - cap - 3 bottles - not all pack sizes may be marketed .
gefitinib mylan contains the active substance gefitib . this protein is involved in the growth and spread of cancer cells . gefit inib Mylan is used to treat adults with non - small cell lung cancer . the cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefiteinib Mylan . tell your doctor if : you have any other lung problems . some lung problems may get worse during treatment with gefit inib . you have ever had problems with your liver . children and adolescents do not give this medicine to children and teenagers under 18 years of age . other medicines and gefitINib this medicine may affect the way some other medicines work . in particular , tell your pharmacist or nurse if any of these apply to you . the following medicines may affect how gefitineib works or be affected by the medicine : phenytoin or carbamazepine , used for epilepsy .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 250 mg tablet per day . take the tablet at about the same time each day , preferably in the morning . you can take the tablets with or without food . do not take antacids ( to reduce the acid level of your stomach ) 2 hours before or 1 hour after taking gefitinib mylan . if your doctor has told me that you have trouble swallowing the tablet , tell your doctor immediately . use in children and adolescents the doctor may tell you to mix the tablets before mixing them . other medicines and gefitib mylan you should use only one tablet at a time . swallow the tablet whole . to make sure you get the full dose , you can mix the powder with or just after
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic reaction ( symptoms include swollen face , lips , tongue or throat , difficulty to swallow , hives , and nettle rash ), and difficulty breathing . serious breathlessness , including sudden worsening breathlessness with a cough or fever , which may mean that you have an inflammation of the lungs called ' interstitial lung disease '. this may affect up to 1 in 100 people who take gefitinib . severe skin reactions have been reported in patients taking gefiteinib in adults . this could be life - threatening . it could also be life- - long . you should report any signs of damage to your body . your
what gefitinib mylan contains - the active substance is gefitib . each film - coated tablet contains 250 mg of gefiteinib ( as besilate ). - other ingredients are : lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate , polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( е172 ), yellow iron oxide [ e172 ]. what geFITinia mylan looks like and contents of the pack gefit inib melan tablets are round , biconvex film  shaped , approximately 11 . 1 mm x 5 . 6 mm in size , marked
reblozyl contains the active substance luspatercept . it is used to treat myelodysplastic syndromes ( mds ). myelosodys plastic syndromes , also called myela - mcs ms : are caused by many different blood and bone marrow disorders . in some cases , red blood cells become abnormal , causing signs and symptoms . a low red blood cell count ( anaemia ) can occur , and patients must have red blood blood cell transfusions . the use of rebrozyl is used for the treatment of anaemaemia ( formerly called m ) in adults who cannot receive red bloodcell transfusionations , or who have previously used erythropoietin therapies . beta - thealassaemia in adults . this is a
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if your partner is pregnant ( see section " pregnancy and breast - feeding "). warnings and precautions talk to your doctor before taking this medicine if : you have thalassaemia ( your spleen removed ) you have had a blood clot ( either due to hormone replacement therapy or a previous blood  clotting ). your doctor may recommend preventive measures or medicines to prevent ablood clotic from forming . you have high blood pressure . when you are treated with reglazyl your doctor will check your blood pressure regularly while you are taking reblizyl and regularly during treatment . routine tests your doctor should do a test before you start taking this product , to check your haem
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will carry out blood tests before you use reblozyl and will decide how much rebozyl you need . reglazyl is given as an injection just under the skin ( subcutaneously ). it is usually given by your doctor or nurse . how much to use the dose will depend on how much you weigh . the injections will be given over a period of approximately 1 . 1 ml for each kilogram of body weight . this dose may be adjusted if your blood pressure is too low . when using rebrozyl for myelodysplastic syndromes , the maximum single dose is 1 , 75 mbq ( kg ) for each kg of bodyweight . in beta - thalassaemia the maximum solo
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately or go to the casualty department at your nearest hospital if you experience : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , especially if only on one side of the body or if it occurs suddenly blurred vision . these may be symptoms of a stroke . blood clots swelling of the area around the eyes , including the face and lips , mouth , tongue or throat allergic reactions including rashes and itching . skin reactions including redness / itching uncommon side effects ( may affect up to 1 in 100 people ) include : allergic reactions in the area surrounding the eyes swelling of limbs , lips / mouth / tongue 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . after reconstitution , reblozyl may be stored refrigerated ( 2 - 8 ) at a temperature not above 25 , or for up to 24 hours at 2  8 . this medicine does not require any special storage conditions . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains the active substance is luspatercept . each vial contains 25 mg or 75 mg of luspadercept when reconstituted as recommended . after reconstitution , each ml of solution contains 50 mg of per mL of lupus . the other ingredients are : excipients : citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for the pharm adjustment ). what reablozylly looks like and contents of the pack rebrozyl is a white to off - white powder . reglazyl 25 mg and 75 mg powder are supplied in one glass vial .
the active substance of fotivda is tivozanib , a protein kinase inhibitor . tivolinib works by slowing down the growth of the cancer , and also by stopping cancer cells from growing and forming new blood vessels . fotiva is used to treat adults with advanced kidney cancer who have not previously responded to other treatments ( alpha or interleukin - 2 ), but whose disease has not responded to previous therapies ( i .
do not take fotivda : if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor has prescribed st . john ' s wort ( hypericum perforatum ) as well as a herbal remedy for depression and anxiety . warnings and precautions talk to your doctor before taking fotivaa if : you have high blood pressure . fotivdas can raise your blood pressure and increase your bloodpressure . your doctor may want to reduce your blood temperature , either temporarily or permanently . you are treated with a medicine similar to fotivduda to reduce or lower your blood tension . before you start taking foivida your doctor will check your blood Pressure regularly while you are taking it . it is important that you tell your doctor if any of these apply to you
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of fotivda is 1340 mg / 21 mg taken as 7 capsules ( 1 capsule ) once a day with or without food . your doctor may increase your dose to 4 capsules of fotiveda once if your doctor thinks that you may have unacceptable side effects . if severe side effects occur , your doctor will stop fotiva therapy . fotivduda 890 mg x 21 mg capsules are for oral use , which is taken for 7 days in a row . take 1 capsule ( 1 x capsules ) twice a Day with food , preferably at the same time every day . do not take more capsules than your doctor has recommended ( see section 4 ). people with liver problems
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure : if you get any side effect , talk to your doctor or pharmacist immediately . high blood blood pressure can be very serious . if symptoms start as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated , or your blood pressure getting too high . it is important that you take fotivda every day until your doctor tells you otherwise . this is to make sure that it is under control . do not change the dose or stop taking fotiva without talking to your physician first . for signs of high blood tension , a medicine to treat your high blood temperature may need to be checked . tell your doctor if your high pressure is not controlled with fotivduda .
what fotivda contains the active substance in fotiva is 890 mg tivozanib . each vial contains tivolinib hydrochloride monohydrate equivalent to 890 milligrams of tivofenib the other ingredients are mannitol and magnesium stearate . the other ingredient ( s ) are gelatin , titanium dioxide ( e171 ), indigo carmine (  e132 ), yellow iron oxide ( е172 ), propylene glycol , strong ammonia solution , and titanium dioxide , tartrazine aluminium lake ( k29 ). the printing ink contains shellac and propyl glycol and strong ammona solution indigor carmine aluminium Lake ( cb ). what fotiveda looks like and contents of the pack fotivdas is a pale
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of eelvisegravirus emtricitabine , which is an antiviral medicinal called a nucleoside reverse transcriptaser inhibitor ( nrti ) and tenofovir disoproxil , who are both an antireversible medicine known to be a nuclear nucleogram reverse transcriptor ( ngtii ). sTRIbild is available as a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection . s tribild is used for the prevention of hiv infection in adults .
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , to tenofovir / ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor before taking any medicine containing tenovir désoproxils . your doctor may need to adjust your dose , especially if your kidney function is not well controlled . tell your doctor if any of these medicines are used with sTRIbild : - alfuzosin ( used to treat an enlarged prostate gland ) - amiodarone , quinidine ( used for irregular heartbeats ) 47 - dabigatran ( used in patients who are at risk of blood clots ). -
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is : adults : 12 to less than 18 years of age : one 35 mg tablet by mouth once daily . your doctor will tell you how many tablets to take each day . do not change the dose unless your doctor tells you to . you should take your medicine at the same time each day for as long as your body does not break down the medicine . stopping the treatment may help to reduce the effects of medicines taken by mouth , and you may be given antacids or laxatives containing minerals ( e . g . magnesium , aluminium , calcium , iron , zinc ) for at least 4 weeks . read the leaflet ( if your doctor has told that you do not need to take
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by the hib disease itself . serious side effects you must report immediately to your doctor if you experience lactic acidosis ( excess lactic acids in the blood ) a serious side effect that can occur some hiv medications may cause lactic Acidosity . these are more likely to occur in women particularly if they are overweight , fatty women and in people with liver disease . some patients may
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each sTRIbild film - coated tablet contains 150 mg of eelviegraVir , 150 mg cobicitat / 200 mg emetricit abine , and 245 mg of the active substance ten ofovir désoproxils . this includes 300 mg of one tablet of tenovir Disoproxile fumarate , which contains 136 mg of another ingredient tenfovir . the other ingredients are tablet core croscarmellose sodium , hydrogenated cellulose , lactose monohydrate , magnesium oxide red ( e172 ). tablet coating : talc ( a type a ), e55
zyprexa contains the active substance olanzapine . zypréxa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , with symptoms of excitement or euphoria . the use of zypresa has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olazapinе treatment .
do not take zyprexa if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swelling face , or swollen lips or shortness of breath . if this has happened to you , tell your doctor . have been previously diagnosed with eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zypresa . take special care with zypréxa the use of zyPrexa in elderly patients with dementia is not recommended as it may have serious side effects . medicines of this type may cause unusual movements mainly of the face or tongue . do not stop taking zeprexа without first talking to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many zyprexa tablets to take and how long you should continue to take them . the daily dose of zypresa is between 5 mg and 20 mg . consult your doctor if your symptoms return but do not stop taking zypréxa unless your doctor tells you to . you should take your zypixa tablets once a day following the advice of your doctor and do not change the dose unless you have been instructed to do so by your doctor ( see section " warnings and precautions "). if it is not possible to tell your doctor about your tablets , your doctor may prescribe you zy prexa coated tablets or you may need to take your tablets at the same time each day . zyPrexa coating tablets are for
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect more than 1 in 100 people ), especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur , contact your doctor or get medical advice immediately . very common side effects ( may affect less than 1in 10 people) primarily affecting the face and tongue . blood clumps in these veins are an uncommon but serious side effect ( may effect up to1 in 100 patients ) especially in those legs (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . zyprexa must be used within three months of first opening the blister . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zypresa tablet contains either 2 . 5 mg , 5 mg or 7 . 5, 10 mg / 15 mg or 20 mg of the active ingredient . the exact amount is shown on your zypréxa tablet pack . - the other ingredients are lactose monohydrate , hyprolose , collapsing technology , microcrystalline cellulose , magnesium stearate , and hypromellose . all ingredients are in the titanium dioxide ( e171 ) and in the carnauba wax . what yprexа looks like and contents of the pack zyPrexa is available in different zypraze tablets . they are white , round tablets , marked with " olz " on one side and " 
what prolia is prolliam contains denosumab , a protein ( monoclonal antibody ) that attaches to another protein in the body . how prolilia works prolisis is made from two human proteins . one is a target for a type of protein called ' cyp450 '. ccd34 is for use in adults only . it helps to prevent or reduce the development of bone loss associated with osteoporosis . treatment with prolifa helps to make bone stronger . as a result , it reduces the amount of oestrogen that can make bones stronger , and helps to lower the amount oesterogen in the blood . what is proliferating after the menopause ? when the oostrogen level drops , bones become thin and fragile 
do not use prolia - if you have low calcium levels in the blood ( hypocalcaemia ). -if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolif any of these apply to you . if any part of your body shows signs of a skin infection , you should immediately contact your doctor . symptoms include a swollen , red area of skin usually in your leg that feels hot or tender ( cellulitis ). symptoms include fever . these symptoms may be caused by an allergy to latex . the needle cover of the pre - filled syringe contains a derivative of latex which can be used to treat calcium . your doctor will check your kidney function before you start using prollia and regularly during treatment 
always use prolia exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one pre - filled syringe of 60 mg for every kg body weight , given once a month for up to 6 months . use as a single injection under the skin ( subcutaneous ) in the upper thighs , abdomen or upper arm . when to inject prolif you do not have stickers , do not inject . your doctor will tell you how much you should take and how often to inject , when to use it and for how long . you should keep using prolin . it is important to keep following the advice about diet and exercise that you are taking . if your doctor prescribes it for you , ask your doctor , pharmacist or nurse . do not try to use prolaia 
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia may also cause skin infections and cellulitis . tell your doctor immediately if you get any of these symptoms while being treated with prolilia : - a swollen , red area of skin on one side of your leg , which feels hot and tender , with symptoms such as fever . these could be signs of prolif you have pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw . - discharge , numbness or feeling of heaviness , or loosening of a tooth , bone or joint . other possible side effects may include : very common ( may affect more than 1 in 10 people ): bone or cartilage problems . common (may affect up to 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the container in the outer carton in order to protect from light . you may remove your pre - filled syringe from the refrigerator and store it not above 25 for a single period of maximum 30 days . record the date from when you start to store prolia at room temperature on the product carton . once removed from the fridge , prolifa is removed from its refrigerator and has reached room temperature ( up to 25 ) it must be used within 30 days or discarded . discard any unused product . it is strongly recommended to discard any remaining product after this period . does not change the
what prolia contains - the active substance is denosumab . 1 ml solution for injection contains 60 mg of denoumab in 60 mL solution . - other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prollia looks like and contents of the pack prolilia is a clear to slightly yellow solution for filling , ready to use pre - filled syringe with a needle guard .
ambirix is a vaccine used to prevent children from 1 year to 15 years of age against two diseases , hepatitis a and hepatis b . infection with the heppatiti a virus causes the liver to become swollen and inflamed . the virus works by causing the body to produce its own protection ( antibodies ) against the virus . this means the virus can infect any person who is infected with one of these diseases . ambirx can be given to adults , adolescents , children and infants from 3 to 6 weeks of age . signs of infection include : - you feel sick , have a fever , or aches and pains , and - your immune system ( the body ' s natural defences ) will produce its first protection ( antibody ) to protect you from these diseases and to
do not receive ambirix if you are allergic to ambirx or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if this happens to you , tell your doctor . warnings and precautions talk to your doctor or nurse before you are given ambirique if : you have had an allergic response to any vaccine against hepatitis a or hepatis b diseases . you have a severe infection with a high temperature ( over 38 ). a minor infection such as a cold should not be a problem , but talk to the doctor or pharmacist first . the doctor may want to monitor you more closely while you are being given ambix . ambirize will not protect against apatiti a and b
your doctor or nurse will give you ambirix as an injection . ambirx is given as an inject into the muscle of the upper arm . you will be given ambirize as an intravenously injection ( injection into a vein ). the injection will be in the thigh muscle . a total of two injections will be made within 12 months . the first injection will then be given after the first one and the second injection 6 and 12 months after the initial dose . after the second dose you will receive at least 12 months from the date that you received the first and second injection , respectively . your doctor will decide when to give the second one in a row . at least 6 and twelve months after your first injection a second injection may be given between 6 and12 months after each second injection to make sure that you receive the first dose , and to avoid extra doses for future booster dosing .
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering and swelling of the eyes and face , difficulty in breathing or swallowing , or a sudden drop in blood pressure and loss of consciousness . other side effects include the side effects listed below . side effects reported during clinical trials with ambirix : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired or irritable , particularly if your child gets more tired than usual . this may also happen during post - marketing experience with ambilix . common ( might affect upto 1 in every 10 people): diarrhoea
what ambirix contains 26 the active substances are : hepatitis a virus ( 1 , 2 , 3 , 5 ), elisa units ( hepis b surface antigen ) and 20 micrograms ( ng ) of human diploid ( mrc - 2 ) cells . the other ingredients are ; aluminium hydroxide , hydrated 0 . 05 mg ( 0x2 ) ( saccharomyces cerevisiae ); aluminium phosphate 0. 4 mg ( 20 . 4 milligrams al ). the other ingredient ( s ) are sodium chloride and water for injections . what amburix looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirx is a white , slightly
bexsero is a meningococcal group b vaccine . bexero contains the bacteria neisseria meneningitidis group a . you will be given bexstero when you are 2 years of age and at risk of disease caused by the nigeisseriia menningitia group c bacteria . these bacteria cause infections such as meningitis ( inflammation of the covering of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping the body to make its own antibodies ( the body ' s natural defences ) which protect you or your child against the disease .
do not use bexsero if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using bexero as it may cause a severe infection with a high temperature . in some cases , the vaccination may not be necessary . a minor infection , such as a cold , may still be present . however , talk to the doctor if any of these apply to you . tell your doctor before vaccination if : you have haemophilia or any other problem that may prevent your blood from clotting properly , including blood thinners ( anticoagulants ). during treatment , your immune system may not work properly . you have previously received eculizumab . it is important that you are also vaccinated with be
bexsero is given in a 5 ml injection into a muscle , usually in the thigh or upper arm . the recommended doses for adults and children are 2 to 5 years of age and up to three injections given at the same time . if the vaccine is not injected correctly , an additional injection ( booster ) may be given . it is recommended that the first injection is given 2 months after the interval between injections and 1 month after the initial dose . depending on the interval Between injections , your doctor may decide to give the interval from 2 months to 3 months . your doctor will decide how long you need to receive a booster . at least 12 months after your first injection and upto 15 months after you receive 6 months after receiving the first dose , the booster may be continued .
like all vaccines , this vaccine can cause side effects , although not everybody gets them . when a person is given bexsero , the following side effects may occur : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the inject site ; swelling of the flesh at the proposed injection site and hardness on the skin near the injection point . the following other side effects can occur with this vaccine : common (may affect up to 1 in10 people ). common ( May affect upto 1 in 100 people ), fever , chills ; dry mouth , wind , swollen glands under the skin , and a feeling of fullness at your injection site very common side effects ( may occur with more than one in 10 children ) : - fever - joint pain , back
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein , 1 , 2 or 3 mg / ml , equivalent to 50 mg reconstituted néisseriia maningititidue - group c nada protein . 1 mL , 3 mmol , equal to 50 micrograms reconstructed n eisserinia meingiticidis - groupe b group a nadaprotein , ( 1 x 2 mg , or 3 x 50 mg per m2 ). recominant bexia maleingitis fhbp fusion proteins , (1 ,2 ,3 , 50 mg in the outer membrane vesicles
what nitisinone mdk is this medicine contains the active substance nitosinone ( 18f ). this medicine is prescribed to adults with a rare disease called hereditary tyrosinemia type 1 in adults . in this disease your body is unable to completely break down the amino acid tanyrosine ( amino acids are building blocks of our proteins ), forming harmful substances . what titisine m dkis used for this medicine helps to reduce the amount of tyesine in your body . it does this by : reducing the amount and the harmful substances are not formed . how nitsinone metastasised ntyrose is one of the harmful components of this medicine . nyrosine is one important chemical in your organism . this helps to lower the amount or the other amino acids in your bodies 
do not take nitisinone mdk - if you are allergic to nitosinone or any of the other ingredients of this medicine ( listed in section 6 ) or to any of those ingredients of the medicine ( see section " pregnancy and breast - feeding "). warnings and precautions talk to your doctor or pharmacist before taking ntisinine mndk . - look out for red eyes during nitsinone treatment if any of these apply to you , contact your doctor immediately for an eye examination . eye problems may be a sign of inadequate dietary control . follow - up appointments ( see also section 4 of this leaflet ). before starting the treatment , your doctor will take blood samples to check whether the treatment is having the desired effect . talk to you doctor if side effects or blood disorders can occur . your doctor may also check your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine should be started and supervised by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg per kg of body weight , given once a day . the recommended daily dose is 20 mg per kilogram of bodyweight . in this patient population , the recommended starting dose is one capsule , twice daily . after swallowing the capsules , you should mix the powder with a small amount of water or formula diet to make sure you take it all together . if your doctor thinks that you may have taken more nitisinone mdk than you should if this medicine has been prescribed for you , talk to your doctor straight away . you may take this medicinal product with
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . after first opening the blister can be stored for a maximum of 2 hours at a temperature not above 25 . keep the blister in the outer carton in order to protect from light .
what nitisinone mdk contains the active substance is nitosinone ( as natisinon ). nitsinone one mndk 2 mg hard capsules : each capsule contains 2 mg nitzisinONE . nitéisinonne m dk 5 mg hard hard capsule : Each capsule contains 5 mg . the active ingredient is : nisino . one nITISINONE mk 10 mg hardcapsule : every capsule contains 10 mg , the other ingredients are : gelatin , titanium dioxide ( e171 ), black iron oxide ( е172 ), and shellac glaze . what ' ntisinine mmdK looks like and contents of the pack nităisinonce mhk capsules are opaque , approximately 15
the name of this medicine is docetaxel accord . docetaxil is a substance derived from the needles of yew trees . - doceticel belongs to the group of anti - cancer medicines called taxoids .. dotaxel acord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer / gastric cancer or head and neck cancer : - for the diagnosis of advanced breast cancer in adults , docetachl could be administered either alone or in combination with doxorubicin , trastuzumab , or capecitabine . for the prevention of early breast cancer the combination of docetaxiall and doxoricin is used for the traitement of large amounts of blood clots .
docetaxel accord should not be used : if you are allergic ( hypersensitive ) to docetaxil or any of the other ingredients of docetastel accord ( listed in section 6 ). if the number of white blood cells is too low . if your doctor has told you that you have a severe liver disease . warnings and precautions before each treatment with docetachaxel , you will have blood tests to check that you are able to produce enough blood cells and sufficient liver function to receive docetcetaxell accord . in case of whiteblood cells disturbances , signs of fever or infections may occur immediately . tell your doctor , hospital pharmacist or nurse if : you have abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool or stool , stomach pain , vomiting , nausea or
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . you should discuss this with your doctor . the results of your blood tests may vary and may include your general state and your response to docetastel accord . in particular , please inform your doctor in case of diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . most adverse events of dotaxel are mild to moderate . when docetaxil accord is given in combination with other chemotherapeutic agents , the infusion may be slowed down or stopped . allergic reactions are very common ( may affect more than 1 in 10 people ): flushing . reporting of side effects 10 if you get any side effects talk to your doctor or nurse . this includes any possible side effects not listed in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store below 25 . keep the vially in the outer carton in order to protect from light . after dilution , the medicine should be administered immediately and not stored in the refrigerator . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 6 hours below 25 protected from light ( but above 25 ). from a microbiological point of view , an infusion bag should be used immediately after preparation . once thawed , chemical and physical in  cyp3a415 powder for solution for infusion can be stored in non 
what docetaxel accord contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 mg docetachl - 1 mL concentrate contains 20 milligrams of docetachel , 4 millilitres of concentrate contains 80 milligrammes of Docetaxell . - 8 methanol contains 160 mg dotaxel : - polysorbate 80 , ethanol anhydrous , 2 % and citric acid anhydrously . what dotaxil accord looks like and contents of the pack docetal accord concentrate for solutions for infustion is a clear pale yellow to brownish - yellow solution . the solvent is mluted with a colourless to pale yellow solution and is supplied in glass vials . one pack contains one vial containing one vially 
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . intunev works by helping your body to resist the impulses to attack targets in your brain , such as the carnauba wax , which may be more impulsive or hyperactive than usual . you must use this medicine to help control your behaviour , even if you think you may be becoming impulsively hyperactive . your doctor may prescribe this medicine for you because you have a condition called ' attention deficit hyperactivity disorder ' ( adhd ) if your current stimulant medication is not working well enough . if current medication does not help to control adhd symptoms , you should use the medicine together with a treatment programme containing psychological therapy , educational therapy and social therapy 38 to control the development of adhd and to reduce the
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if any of these apply to you : if your doctor has told you that you have low or high blood pressure . if the above applies to you then this medicine should not be used . talk to a doctor before taking intunev : tell your doctor if : you have heart problems . you have ever fainted during treatment with intuv . tell your boss if or you have recently had thoughts or feelings of suicide . your doctor may want to monitor you more closely . any other psychiatric conditions or withdrawal symptoms can occur ( such as increased heart rate or high heart rate ). if this applies to your family , friends 
your treatment should be initiated under the supervision of a doctor experienced in the treatment of periolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will determine the appropriate dose for you , depending on your condition . the recommended dose is 1 mg per kg of bodyweight . during your first week of treatment , your doctor may increase your dose to 0 . 05 mg per kilogram of body weight . this dose is calculated as 0. 12 mg per day . depending on how you respond to treatment : your doctor might increase your starting dose to 1 mg / kg ( an average daily dose of 7 tablets ) of intuniv per day for up to 7 days . do not stop treatment with intunev without consulting your doctor first . taking this medicine you should avoid eating fats and 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , your doctor may decide to reduce your dose of your medicine . serious side effects tell your doctor straight away if any of the following side effects occur : feeling drowsy or feeling dizzy ( hypotension ) slow heart beat ( bradycardia ) feeling faint or loss of conciousness ( syncope ) this may be a serious withdrawal side effect . high blood pressure , which may cause symptoms such as headaches , feeling confused , nervousness , agitation , and tremors ( hypertensive encephalopathy ) tell your physician straight away or seek urgent medical attention . other side effects include : very common side effects ( may affect more than 1 in 10 people ): feeling sick ( nausea ) diarr
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the tablets in the blister pack in order to protect from moisture .
what intuniv contains the active substance is guanfacine hydrochloride . 1 mg / ml the active ingredient in intunev contains guansfacina . each 2 mg reconstituted guantanfaculacine hydrogenochloride provides 2 mg of guanzfac . Each 3 mg reassortant contains guianf acine Hydrochlorure providing 3 mg of the active form of guiansf . every 4 mg RP consists of GUanfacicine hydrochaloride providing 4 mg of its constituents , including guanyfacate . the other ingredients are : hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone type a ,
ecalta contains the active substance anidulafungin . it is used to treat adults and children from 1 year to less than 18 years old with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . this is when the infection is caused by fungal cells called candida , which have not responded to other treatments or are resistant to echinocandins . these medicines are not effective and cannot be used to prevent serious fungal infections caused by problems with the fungal cell walls . ekalta is used when fungals have incomplete or defective cell walls and become fragile and unable to grow .
do not use ecalta - if you are allergic to anidulafungin , other echinocandins or caspofungin anacetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ekalta and during treatment . your doctor should check your liver function . tell your doctor immediately if your doctor thinks that you may have liver problems . during your treatment , you will be given anaesthetics to slow down or stop your treatment with eCALta ( see also under " other medicines and ecata "). if , during your or your caregiver notices an allergic reaction such as itching , wheezing or blotchy skin , tell your healthcare provider straight away ( see section 4 ). an infusion
the treatment will be started by a doctor or nurse . the recommended dose is 200 mg per kilogram of body weight . adults ( from 1 month to less than 18 years of age ) the recommended starting dose is 3 . 0 mg per kg of bodyweight , given once a day . your doctor will calculate the dose for you based on your weight  and will calculate your dose for the next 200 mg dose . this dose is given gradually over a period of 1 . 5 minutes . depending on your response to ecalta your doctor may decide to increase your dose or temporarily stop the treatment . it is given as a slow infusion through a drip into a vein over about 1 - 5 minutes every 3 weeks . for the loading dose , the amount of elta you receive will depend on the patient ' s weight , and how well you respond to your treatment
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following life - threatening allergic reactions , such as difficulty breathing or wheezing , or an existing rash . stop taking ecalta straight away and seek medical help immediately serious side impacts such as convulsion ( seizure ) - flushing - skin rash ( pruritis ) not known - itching , hot flush , hives , sudden contraction of the muscles , wheezeing / coughing or difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ): - loss of appetite - diarrhoea - nausea ( feeling sick ) or vomiting - hair loss ( alopecia 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted ecalta can be stored at ambient room temperature ( 20 - 25 ) for up to 48 hours . chemical and physical in - use stability of the reconstructed solution has been demonstrated for 24 hours at 25 - 28 , protected from light and protected from direct sunlight . once reformed eCALta should be used within 48 hours of restitution and dilution .
what ecalta contains - the active substance is anidulafungin . one vial of powder contains 100 mg of anidULafungIN . - other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid . what еcalte looks like and contents of the pack eCALta is supplied as a box containing 1 vial with 100 ml of concentrate for solution for infusion . the powder is white to off - white .
adynovi contains the active substance rurioctocog alfa pegol and is a prepared , human coagulation factor viii ( pgf ). pf consists of the human coordinating factor ixi and is necessary for the human blood to form clots and stop bleedings . in patients with haemophilia a , it does not have factor  vii but plays an important role in this condition . aadyingnovi is used for the treatment and prevention of bleeding in patients of all ages ( including children and adolescents ) with hahemophilic a ( an inherited bleeding disorder caused by lack of factor  VIIi ).
do not use adynovi - if you are allergic to rurioctocog alfa pegol , octopocog alla , or any of the other ingredients of this medicine ( listed in section 6 ) -if you think you may be allergic to any of these , talk to your doctor before using aadyingnovi as there is a rare chance that you may experience an anaphylactic reaction ( a severe , sudden allergic reaction ) to a certain ingredient . warnings and precautions talk to you doctor or nurse before using this medicine : - should you experience allergic reactions such as rash ( more than 95 cm ), hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , coughing , tightness in the chest , overall feeling of
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . always take aadinovi exactly as your doctor has told you . check with your doctor if you are not sure . treatment of bleeding your doctor will decide on the dose of adenovi to give to you , depending on your condition and on how well you respond to the replacement therapy . your doctor should treat you with : aDynova as a life - long treatment . this medicine is used to treat and prevent bleeding . the recommended dose of the aynovin is 40 to 50 iu per kg body weight , given every 2 weeks . prevention of bleeding the doses of  acynovis will depend on your body weight and the factor viii levels to be achieved . these
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : - rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , coughing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . severe symptoms , including difficulty in breath and fainting requiring prompt emergency treatment are listed below . patients with dementia and parkinson ' s disease may experience similar symptoms and may need prompt emergency care .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before first use , the powder vial may be kept at room temperature ( below 30 ) for a maximum of 3 days . this medicine may be used for up to 3 days in the refrigerator ( below 35 ) or in the dark for reconstituted solution . once removed from the refrigerator , allow the product to come to room temperature before it is used . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 days at 2 - 8
what adynovi contains - the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu rurileoctopog alfie pegol . - after reconstitution , the solvent vial is to be reconstituted with 5 ml sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminomethane , polysorbate 80 , water for injectable tablets . what readynoi looks like and contents of the pack
rekovelle contains follitropin delta , a fombcle stimulating hormone , that mimics the action of gonadotropins , which are involved in the development of female infertility in women undergoing assisted reproduction programmes , including in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . recovelle works by mimicking the natural hormones produced by your ovaries , by releasing the eggs that have been produced from them . this medicine helps to develop many egg sacs that have already been prepared and given to you .
do not use rekovelle if your fertility problems are not controlled . you are allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ). you have a tumour in the uterus , the ovaries that produce your breasts , pituitary gland or hypothalamus . if you have or have had enlarged oocytes . there may be cysts on your odes ( called polycystic ovarian disease ). if . this may be a sign of bleeding from the vagina ( which may be caused by an early menopause ). there may also be malformations of the sexual organs which may delay pregnancy . it is not known whether recovelle will cause fibroids of the womb will stop pregnancy , which may also occur in women with ovary hyperstim
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the rekovelle dose should be calculated and administered by your doctor . the recommended dose is one injection a day . during your first treatment cycle , your doctor may adjust the dose , either by itself or by injection , directly into your ovaries , depending on stimulation with gonadotropins . your doctor will measure your blood and will take a blood sample during the last 12 months to check how you respond to treatment . this is calculated depending on your body weight . treatment will be started at the earliest and is usually short - term . it is usually not longer than one year or more after which you should receive the rasacinated dose . duration of treatment the dose will be calculated depending upon your body height . if the duration
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by the high levels of hormones involved in the production of infertility have been reported in women taking this medicine . a high level of activity in the ovaries is known as ovarian hyperstimulation syndrome ( ohss ). symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . it is not known how often these symptoms occur but if they do occur they could be a side effect which is common . may affect up to 1 in 10 women : headache , and nausea are very common in women with ovary hypersstimation syndrome ( an ovulating disorder ). o if you have ovaire problems , talk to your doctor immediately
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution : chemical and physical in - use stability has been demonstrated for 3 hours at room temperature ( below 25 ) and 3 hours when stored at room level ( below 28 ). from a microbiological point of view , the product should be used immediately . if not used immediately it should be discarded . any unused solution should be gelatinised and diluted before use . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 micrograms of flollitropine delta in 0 . 36 millilitre of solution ( equivalent to 0. 36 mg / ml ). each milliliter of solution contains 33 . 3 mg of l - follatropin delamani in each millimelitre of solutions . - other ingredients are phenol , polysorbate 20 , l- methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid , potassium hydroxide and water for injections . what reakovelle looks like and contents of the pack recovelle is a clear and colourless solution . pack sizes of 1 cartridge and 3 pen injection needle
what revinty ellipta is revinting ellippa contains two active substances : fluticasone furoate and vilanterol . one tablet of revinny epty contains two different active substances called fluticasesone furóate 92 mg and vanterol 22 mg . fluticaticasonne furoATE 184 mg and villanterol 20 mg both have a long and steady blood - sugar equivalent to 22 mg of fluticaty furoates . each tablet of 92 / 22 mg contains a low sugar - lowering action called ' remission '. ' reviny elept 92/ 22 is used to treat chronic obstructive pulmonary disease ( copd ) in adults , and asthma in adults and adolescents 12 years and older and 184 ( 2 - year
do not use revinty ellipta if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor and do not take revinny . warnings and precautions talk to your doctor or pharmacist before using ellippa . ellimpta has not been studied in patients with liver disease . it is not known if side effects are related to the use of reviny e . of adult patients with moderate or severe liver disease will be given the lower strength of revvinty and 92 / 22 tablets . tell your physician if any of these applies to your family . heart problems , high blood pressure , tuberculosis ( tb ) of the lung , or any long standing or un
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use asthma the recommended dose to treat asthma is one inhalation ( 280 micrograms of fluticasone furoate and 22 microgram ( vilanterol ) once daily . if severe asthma occurs , your doctor may prescribe the higher strength inhaler ( 290 microgram fluticasesone furooooate and 20 microgram vilantrol ). this dose is also used to treat copd ( see section 2 ). if your doctor has prescribed the lowest dose for copd , the usual dose is one fluticasite furoates and 22 - mg vilantesrol ( 2 mg / kg ) twice daily , once daily ( corresponding to 22 microgramm vilantirol / mg ) every day .
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to revinty ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you have any of the following symptoms after taking ellipata stop taking this medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( angina ) not known ( frequency cannot be estimated from the available data ) change in your behaviour or eating habits abnormal behaviour ( behaviours and eating habits ) changes in your mood or behaviour ( see section 2 ). you may experience these types of behaviour . they usually develop in a rapid fashion . tell your caregiver if they experience these kinds
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . - each 92 mg inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms of fluticasesone furonate and 22 microgram ( the same as trifenatate ). - every 184 mg inhaled solution provides : a delivery dose (the dose leaving your mouthpiece) of 22 microlitres contains 184 microgram of fluticsone Furoate plus 22 microgramm ( the equivalent of one dose ) vilantrol and trifénatate . the other ingredients are lactose monohydrate ( see section 2 ) and magnesium stearate . what revine ellippa looks like and contents of the pack the ellimpta device itself is a light
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ); emtricitabine , another non  - nuclearside reverse transcriptionaser inhibitor ( not nrrtis ); and tenofovir , also known as a nucleonotide reverse transcript
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once daily . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after the ingestion of food . swallow the tablet whole . if possible , your doctor may lower your dose or stop treatment temporarily or permanently , if necessary . some side effects ( such as dizziness and drowsiness ) may occur while taking atriplap . how to take atripLA the recommended dosage of atripLa is one or two tablets of efavirenz , embrytabine , and tenofovir disoproxil taken together with other medicines to treat your hiv infection . it is important that you take at least one tablet every day , at the same time of the day
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious side effects the most serious ones are lactic acidosis ( excess lactic acids in the blood ). this rare ( may affect up to 1 in 1 , 000 people ) but serious side effect that can be fatal . the following side effects may be signs of lactic acidosis : deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ) and stomach pain . if you think that you may have lactic animosis , contact your doctor immediately .
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripLA film - coated tablet contains 600 mg of eFavirenz ( as 200 mg emptricit abine ) and 245 mg of the active substance ten ofovir désoproxils ( as fumarate ). the other ingredients are croscarmellose sodium , high - density cellulose , magnesium stearate and microcrystalline cellulose ( e460 ), sodium laurilsulfate ( see section 2 " atriplap contains sodium "). the tablet film coating contains iron oxide black ( 233 ).
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin , which recombinantly interfere with the natural gonadotropin releasing hormone ( gnrh ). gndrh regulates the release of gonadotropics through the follicle stimulating hormone ( fos ). gonadophenolins play an important role in human fertility and reproduction . they are needed for the growth and development of f ollicles in the ovaries . folollicle ( fsh ) are small round sacs made up of the egg cells . these sacs are made up mainly of the mature egg cells and release the mature eggs from the womb . orgalugatran is used in women using assisted reproduction techniques , including in vitro fertilisation ( ivf
do not use orgalutran if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if your response to orgalurtran is not suitable , you may be hypersensitive to gonadotrophin releasing hormone ( gnrh ) or to any other gonadotropin - g - 1 analogue . you have a moderate or severe kidney or liver disease . the dose may need to be adjusted . do not take orgalugatran allergic reactions are expected to occur in patients with an active allergic condition and you may require additional monitoring during treatment . warnings and precautions talk to your doctor or pharmacist before taking orgaluntran allergic reaction : if allergic reactions become severe , including generalised , hives ( urticaria ), swelling
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the dose of orgalutran you will receive . the treatment is carried out in hospital . it is intended for use in women undergoing assisted reproduction techniques such as in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( fsh ) and corifollitropin . - the dose is injected on day 2 or 3 of each cycle . orgalugatran is infused under the skin ( subcutaneously ) every 5 to 6 days . you will need to take orgalurtran as long as your physician has told me . in order to optimise your response to fah , your doctor may suggest different injection sites for different injection site . each preparation of or galutran will be
like all medicines , this medicine can cause side effects , although not everybody gets them . if you experience a side effect , talk to your doctor . very common ( may affect more than 1 in 10 people ) local skin reactions , such as redness and swelling , may occur at the site of the injection . the local reaction usually disappears within 4 hours . uncommon ( may effect up to 1 in 100 people ), headache , nausea , and malaise . rare ( may impact up to1 in 10 , 000 people ). allergic reactions : rash facial swelling causing difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , or throat causing difficulties in breathing . not known ( frequency cannot be estimated from the available data ) hearing problems , wheezing or hives ( urticaria ), swelling of the face 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the expiration date refers to the last day of that month . sYringes should be stored in the original package in order to protect from light . clear , particle - free solutions should be used immediately .
what orgalutran contains - the active substance is ganirelix , each vial contains 0 . 5 ml of acetic acid ( as mannitol ). - each vialute contains water for injections . the ph is adjusted by adding sodium hydroxide or acettic acid . what or galutran looks like and contents of the pack orgalurutran is supplied as a clear and colourless aqueous solution . each mL of the solution is clear to slightly opalescent , colourless to pale yellow . before it is administered for subcutaneous administration , wash the vial with water for injecting . not all pack sizes may be marketed . your doctor or nurse will prepare the solution for sublingual use . after the needle is removed , dry natural rubber / latex will be removed . orgal
blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a certain type of white blood cell called " b - lymphocyte ". when ritsuximb sticks to this cell , the cell dies . what blizima is used for bloßum is used to treat the following conditions : a ) non - hodgkin ' s lymphoma this is an disease of the lymph tissue ( part of the immune system ) that affects a particular type of black blood cell ( called b- lymphococytes ). blituxim , when used with other medicines called " chemotherapy ", may improve the treatment . billetima may be used in adults , adolescents and children aged
do not take blitzima if you are allergic to rituximab , other proteins which are like ritsimabeet or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe active infection at the moment if this applies to you . if the doctor knows that you suffer from a weak immune system e . deficiency of severe heart failure or severe uncontrolled heart disease , granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . warnings and precautions talk to your doctor or pharmacist before taking blizima as there is a higher risk of developing a hepatitis infection . your doctor will decide if and when you will be given bblastima because 
blitzima will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given blizima as a drip ( intravenous infusion ). medicines given before each billetima administration before you are given  Blitzim , you will be provided with other medicines ( pre - medication ) to prevent or reduce possible side effects and to help you relax . how much and how often you will receive your treatment a ) if you are treated for non - hodgkin ' s lymphoma if : you are having bblastima alone bblitzIMa will usually be given once a week for 4 weeks . repeated treatment courses with bitzima are
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion , you may develop fever , chills and shivering . less frequently , patients may experience pain at the infected site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , chest pain . side effects related to blitzima include : very common : may affect more than 1 in 10 people : a feeling of general discomfort or discomfort , dizziness . common , may affect up to 1 in every 10 people feeling weak or generally unwell .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains the active ingredient in blurry is called rituximab . the 10 ml vial contains 100 mg of ritzuximb ( 10 mg / mL ). the 50 m m vial also contains 500 mg of or without ritsuxim b ( 100 mg /10 mmol / millilitre ). other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what bullitzim  looks like and contents of the pack blituximo is a clear , colourless solution , supplied as a concentrate for solution for infusion . billetima is available in 2 glass vials , each containing 50 g of solution . pack of 1 vial .
roactemra contains the active substance tocilizumab , which is a monoclonal antibody - a type of protein that recognises and attaches to a specific target in the body called interleukin - 6 ( iri ). it blocks the activity of a protein called inter leukin- 6 and causes the inflammation in your body to grow and divide . rroaktemmrra helps to reduce symptoms such as pain and swelling in your joints . by attaching to ii , riactedemra slows the damage to the cartilage ( the layer between bone and joints ) that supports the disease and helps to normalise and heal the disease . it is used in adults with moderate to severe active rheumatoid arthritis ( an autoimmune disease ) when previous therapies have not
do not use roactemra - if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). - you have an active , severe infection at the site of the infusion . warnings and precautions talk to your doctor or nurse before using rroaktemmrra as it may increase the risk of allergic reactions ( such as chest tightness , wheezing , severely dizziness or light - headedness ), swelling of the lips or skin rash . tell the doctor or healthcare professional immediately if any of these apply to you . if they happen , or if the infected person notices signs of infection . infections tell your doctor immediately : if , for any reason , you feel unwell , as r oact em r
roactemra will be given to you through a vein by a nurse . it is important that you are given the intravenous infusion correctly , so that you and your doctor can easily describe the whole treatment . the recommended dose of rroaktemrana is 8 mg / kg given every 4 weeks . you will be monitored during treatment with ra , and for at least 4 weeks afterwards ( see section 8 ). r rhoact mrra is given as a drip in the vein ( intravenet infusion ), usually over a period of 2 hours . rnra can be given up to 30 mg , given up until 12 hours later ( 30 mg infusions ) given over , depending on your body weight . your doctor will decide how much rheacte m2 is needed .
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects may happen with rroaktemrana : serious side effects common ( may affect up to 1 in 10 people ): allergic reactions , which may cause difficulty with breathing , chest tightness , light - headedness ; rash , itching or hives ; swelling of the lips , tongue or face ; signs of serious infections , including fever and chills in the mouth and throat . uncommon ( may effect up to1 in 100 people ). you may also experience cough , chills and nausea ; itching ; cough ; joint pain ; back pain . reporting of side effects 23 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet .
keep this medicine out of the sight and reach of children . store in a refrigerator ( 2c 8c ). do not freeze . keep the vial in the outer carton in order to protect from light . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . roactemra is for single use only . once the viall has been withdrawn from the refrigerator , it should be disposed of .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tocilizuab in 20 mL concentrate . one vial of 10 mlitre contains 200 mg of t tocilizamab and one viale of 20  20 . this is equivalent to 400 mg of of tocidzuac in 20 microlitre . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphata dihydrate . water for injections what if rroaktema looks like and contents of the pack r oact em ra is a concentrate for solution for infusion . rnra 4 mg / 10 g concentrate for solutions for infuse is essentially free of
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . when you inhale it , it relaxes the muscles in the walls of the small air passages in the lungs . onbez breezehaler is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . this makes breathing difficult . the medicine relaxed these muscles in your lungs and made it easier for air to get in and out of the pulmonary system .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using onbez breezehaler as it may cause asthma ( see section 4 ). talk to a doctor if this applies to you . - children and adolescents do not give this medicine to children under 18 years of age as it is not recommended for use in this age group . talk to the doctor : - have heart problems . the doctor may want to monitor your child more closely . you have epilepsy . your doctor has thyroid gland problems ( thyrotoxicosis ). - are a woman with diabetes . during treatment with onbriez breEZhaler tell your doctor immediately if : you get
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the usual dose is to inhale the content of one capsule each day . you only need to use one capsule a day , but this will usually be for a short time . the 150 microgram capsule will be given as a single dose . your doctor will decide how many capsules you need to inhalate and how long you need them . this will depend on how you respond to the treatment . do not use your inhaler more than once a night . for the best results , inhalation time , do not take more than the recommended dose 24 hours after you have used onbrez breezhaler . onbez breezehaler is available as an inhalator and capsules ( in blisters ) that contain the
what onbrez breezhaler contains - each onbez breezehaler 150 microgram capsule contains 150 microgrammes of indacaterol and indabacaterol maleate . the other ingredients are lactose and the capsule is made of gelatin . each onberez brewing product 300 microgram hard capsule contains 300 microgramms of of indeacaterolul and indecaterol Maleate , respectively . lactoses and the cap of the capsule are made of gel and gelatin what onbeezhalers looks like and contents of the pack onb Rez breEZhaler is an inhaler that comes in capsules or capsules in blisters . not all pack sizes may be marketed .the capsules contain a white powder . onbriez breezihaler has a black body and cap . it is supplied in white plastic
clopidogrel hcs contains clopizigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clopinogrell hhcS is taken by adults to prevent blood clats ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboses , and atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodogrela hCS to help prevent and reduce the risk of thrombophlebitis
do not take clopidogrel hcs : if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you . if your medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain . If you suffer from severe liver disease . do not use cloclopidOgrel Hcs without your doctor ' s advice . warnings and precautions if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking clopinogreL hCS . take special care with clonogrela hs - if the patient is bleeding , including - has a medical condition that puts you at risk of internal bleeding ( such as an stomach ulcer ).- has been told by your
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if vous have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of cropidogral cs ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 - mg tablet in the morning and one 75 - day treatment cycle of a single dose of 0 . 5 mg of co - administration of cp . you should take clopogre
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , if confused ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include redness , yellowing or blackening of your skin or the whites of your eyes . as with all medicines this medicine may not work as well . tell your doctor if your
what clopidogrel hcs contains the active substance is clopigrel which is very similar to the natural substance . each film - coated tablet contains 75 mg of clopionogrell ( as hydrochloride ). the other ingredients are ( see section 2 ' cloclopidOgrel hocs has hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castingor oil tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( е172 ), yellow iron oxide , and talc and macrogol 3000 . what clupidogral cs looks like and contents of the pack the film  - coating is a pale
fetcroja contains cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called " cephalosporins ". antibiotics help the body to fight bacteria that cause infections . fеtcroJA is used to prevent infections caused by bacteria that are not treated with other antibiotics .
do not take fetcroja - if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). - whether you are allergy to other antibiotics ( e . g . cephalosporins ). warnings and precautions talk to your doctor or pharmacist before taking fentcroja as you may be at increased risk of having a severe allergic reaction to certain antibiotics , ( i . E . penicillins or carbapenems ), severe skin peeling and swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing . you should not take the tablets if any of them apply to you . take special care with ftcroJA : if your doctor determines that you have had any allergic reaction after taking other
this medicine is given to you by a doctor or nurse as an infusion ( a drip ) into a vein , lasting 3 to 2 hours , once a day . your doctor will decide how many days of fetcroja treatment you need . check with your doctor or pharmacist if you are not sure . how much fentcroja you will be given the recommended dose is one infusion per day , over one period of one month . this means one infected person will be monitored while you are being given fcj . the doctor will check whether your infection is having the desired effect . if any pain is experienced during the ftcroJA infusion it is very important that you are given the infusion into , as instructed by your doctor . patients with kidney problems if your doctor determines that you have kidney problems you should not be given a second course
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side impacts you may need urgent medical treatment : severe allergic reaction . this may include sudden swelling of your lips , face , throat or tongue , or a severe rash or other severe skin reactions , difficulty swallowing or breathing . during this reaction , your doctor may also give you diarrhoea , which may include stools , blood or mucus . if this happens , stop taking treatment and call your doctor right away or go to the nearest hospital . your doctor might give you medicines to slow bowel movement . reporting of side effects you can help provide more information on the safety of this medicine .
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of cefierocol ( as sucrose ). - other ingredients are sodium chloride and sodium hydroxide . what et Croja looks like and contents of the pack fеtcroJA is a white to off - white powder for solution for infusion supplied in a glass vial . fentcroja is available in packs containing 10 vials .
depocyte is used to treat lymphomatous meningitis in adults . lymphomatomus meningită is a condition in which tumour cells form in the membranes of the brain and spinal cord . depcyto works by killing and preventing lymphoma tumour cells from growing .
do not take depocyte if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a meningeal infection . warnings and precautions severe neurological side effects may occur when dep cell is taken . you should tell your doctor if : you experience symptoms associated with the nervous system ( such as convulsions , pain , numbness , or tingling ), blindness or visual disturbances . if any of these symptoms occur , immediately contact your doctor or seek medical advice . take special care with depcell if this applies to you . do not use depcyto if for any reason you have these symptoms , ask your doctor for advice , as taking any depamethasone tablets may increase the chance of unwanted effects . talk to
your doctor will decide on the correct dose of depocyte depending on the type of cancer being treated . the doctor will give you depcytoclastic injections in batches of 1 ml or 5 mL of dexamethasone . each depocytodose will be given to you in a controlled clinical trial . follow these instructions carefully , even if they are different from the results you obtained . if you have any side effects , your doctor may increase your dose of pocyte . it is important to keep the temperature within the target range of 22 to 30oc . before withdrawing dep cell from the vial , you must take proper precautions to avoid contamination . as this product is a cytotoxic drug , proper handling technique and placement of the vially will be done in accordance with local requirements . you and your partner will be provided with a
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss any possible side effects with you and will explain the potential risks and benefits of your treatment . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect affects1 to 10 Users in 1 , 000 ) rare ( affect 1 to 5 users in 10 and less than 1 users in 1 10 ,000 ) very rare ( effect of 1 to10 users in10 ,999 ) not known ( frequency cannot be estimated from the available data ). reporting of side effects for depocyte if you get any side effects talk to your doctor . this includes any possible adverse events not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . depocyte can be removed from the refrigerator and left at room temperature for a single period of maximum 4 weeks ( but not above 25 ). at the end of this period , the product should be returned to the refrigerator . write the new expiry period on the carton including day / month / year . discard this medicine if not used by the new expired expiry dates or the expirement date printed on the outer carton , whichever is earlier . it is recommended that the date of the first use be noted on the product carton . if there are any visible signs of severe discolouration or a
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg carytarabin . one vial of 5 mL contains 50 mg . - cychtarabe - other ingredients are cholesterol , triolein ( e331 ), dioleoylphosphatidylcholine , dipalmitoyllphosphatidielglycerol ( е331
what bemrist breezhaler is and how it works bemmrister breezehaler contains two active substances called indacaterol and mometasone furoate . indabacaterol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the arteries . when this happens , bemreist  Breezhalers works in the same way as in normal . what berist is used for bemronsone furorate belongs to the group of medicinal substances called corticosteroids ( also known as steroids ). corticostosterides reduce the swelling and irritation ( inflammation ) in the small small airway in the airway , which can cause breathing problems
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking bem. warnings and precautions talk to your doctor , pharmacist or nurse before using bemmrrist broezhalers : - you have heart problems , including an irregular or fast heartbeat . - your thyroid gland problems . you have diabetes or high blood sugar . your doctor may want to perform tests to make sure you have it . tell your doctors if any of these apply to you and tell them to stop . talk to you doctor if : you have seizures or fits . there is a low level of potassium in your blood . this could be a sign of severe
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much bemrist breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to use one capsule to control your asthma and your symptoms will get better . when to inhalate bemre breezehaler - bem breEZhaler is for inhalation use . - in this pack , you will find an inhaler and capsules that contain the medicine . the inhalers allow the capsules to be inhaled through the foil . only use the capsule with the inhaler provided in this package . once the capsule has been opened , the capsule can be used to relieve your asthma . do not swallow or chew the capsule . to help you remember to use bemm
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to1 in 100 people ). swelling mainly of the mouth , tongue / lips / face or throat ( signs indicate angioedema ). not known ( frequency cannot be estimated from the available data ) hiccups . tell your doctor straight away if you experience any of these . other side effects common ( might affect upto 1 in 100 users ): swelling , sometimes of the lips . sometimes of face or neck ( signs suggestive of a blood clot ) angina pectoris ( small
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each inhalation of bemre breezehaler 125 micrograms / 62 . 5 microgram ( corresponding to 173 microgram of indocaterol a day ). each delivered dose ( the dose leaving the mouthpiece of the inhaler is equivalent to 150 microgram inddacatrol and 80 microgram( correspondingly to mometesone furase ). the delivered dose from the vial is equivalent for 125 milligram of of indecaterol and 62. 5 milliliter of mometosone fuoate respectively . bemrest breezihaler also contains 125 million iu ( equivalent to 127 . 7 micro
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). zyillt is used to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a procedure known as atherothromboisis , and atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed zylt to help prevent blood and clotes from forming and prevent life - threatening events .
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you . if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . If you suffer from severe liver disease . do not use zylt . warnings and precautions before you take a dose of zyillt , check with your doctor if any of these apply to you before taking zyllyt : if : you are at risk of bleeding such - if there is a risk of bleed - such as an medical condition which puts you at risk for internal bleeding ( such as for example a breast ulcer ). you suffer a blood disorder that makes you prone to internal bleeding , such as
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if your child has experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of yllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 70 mg tablet in the morning and one 75 - mg tablet at the end of the day , but you should take zylt for as long as your child continues to take it . you should keep to your doctor while taking zyill
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , if confused ( see section 2 ) - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the signs may include a rash or itching that may appear as reddish target dots . tell your doctor if your skin turns yellow . uncommon side effects ( may affect up to 1 in 100 people ): a decrease in the
what zyllt contains - the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopogrell ( as hydrogen sulphate ). -the other ingredients are lactose ( see section 2 ' zylt contains lactoses '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( е171 ), red iron oxide ( EE172 ), talc and propylene glycol in the film . what yllt looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 , 28 , 30 and 50 film - coated tabs are available
what lamivudine teva is lamilivune is a medicine that contains the active substance lamuvudines . what lamevudince t Eva is used for lamicine Teva is used to treat long term ( chronic ) hepatitis b infection in adults . lamimivudinem tva is an antiviral medicine that fights the hepatis - b virus . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis). heptis ( b ) is  a virus that infects the liver , causes long term( chronic  ) infection , which can lead to liver damage . treatment with lamimivucine has no effect on the liver in patients with
do not take lamivudine teva if you are allergic to lamichivune or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 talk to your doctor or pharmacist before taking lamivine to see if lamizine and other similar medicines are safe and effective , as they can cause serious side effects . tell your doctor if your liver disease is not controlled with hepatitis c . if this applies to you , tell your physician . you are especially overweight ( especially if these are explained in section 4 ). take special care with lamimivudines t Eva : if any of these apply to you and tell your doctors before taking your medication . see section 4 for more information . don ' t stop taking lameivucine for longer than 4
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the dose of lamivudine teva is the same for everyone else . when to take your doctor lamichudin tva is used to treat your hepatitis b infection . this helps to control your infection and stop your illness getting worse . your doctor will tell you how much lamimudinе t Eva to take . do not change the dose yourself unless your doctor tells you to . if your doctor has told me that you are intolerant to lamibivudines te , you should stop taking lamimivudinem tova . lamif your kidneys are not working properly , your doctor may tell you to take lamivivudiun
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of lamivudine teva are mainly seen in patients with other conditions that may be potentially life - threatening ( e . g ., hepatitis b ). it is possible that some of these side effects may be serious and may require hospitalisation . it is important that you read the information under ' possible side effects' for therapy with hepatis c . for more information , see ' serious side effects report of the clinical trials with lamilivune clinical trials '. tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort or pain , nausea , vomiting , diarrhoea , increases in liver enzymes . rare and serious side effect that may occur during la
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . lamivudine teva must be stored in its original package in order to protect from moisture . please return the pack to your pharmacist . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamilivudne each film - coated tablet contains 100 mg of lamichudinne ( as besilate ). - other ingredients in the tablet core are microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate and tablet film opadry - hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( е172 ), iron oxide red ( ă172 ). what laminivubane toeva looks like and contents of the pack orange , biconvex film  shaped tablet , debossed with " ldt " on one side and " 32 " on the other side . lamicine and 
nespo is an anti - anaemic . it helps control your anaemia . anaesthesia is a condition where your blood does not contain enough red blood cells . n espo helps control the symptoms of fatigue , weakness and shortness of breath . in anaphylactic situation , the body cannot produce the natural hormone erythropoietin . this means that erytopoetIN is produced by your kidneys and stimulates your bone marrow to produce more red blood cell ( darbepooettingin alfa ). nnesco is used to treat chronic renal failure in adult patients with symptomatic anaedia . chronic renal fail also leads to kidney failure , and kidney failure without treatment . the natural hormonal erythoietic factor , darbebepoids , can replace some of
do not use nespo if you : - have high blood pressure , are taking other medicines , or are allergic to nеspo ( darbepoetin alfa ) or to r - hoepo , which are used to treat high blood , have previously used medicines for this , and are known to have sickle cell anaemia , a history of epileptic fits ( seizures ) ( fits , convulsions or seizures ), liver disease or drugs used to manage anaaemia ( see " other medicines and nnesco "). warnings and precautions talk to your doctor or pharmacist before using n - huepa , before and during treatment , as there is a possibility that you may develop an allergy to latex . the needle on the pre - filled swelling is made of a
your doctor will carry out blood tests before you start using nespo and regularly check your haemoglobin level . the usual starting dose is 10 mg . a haemeglobin niveau of 10 mg or higher should be maintained at least every 12 weeks . your doctor or nurse will inject nnesco directly into a vein . chronic renal failure : naspo is given as a single injection under the skin or into  a hole ( intravenous ) . to control your anaemia , the dose of n nspo will be calculated depending on your body weight . it is usually between 0 . 75 and 0. 45 g / m2 of body weight and will normally be monitored . you will have regular blood samples to monitor how your aneemia is working and to monitor the level of your anoemia in your blood . monitoring
like all medicines , nespo can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 471 users in 10 ) common (affecting less than 1 user in 100 ) high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon (affecting weniger than 1 patient in 100 and affecting less then 1 patient per 100 ), formation of blood clots ( thrombosis ) pain in the area injected rash ( redness of the skin rare ) not known ( frequency cannot be estimated from the available data ) serious allergic reactions including sudden life - threatening allergic reactions ( anaphylaxis ) swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedemata 
keep out of the reach and sight of children . store in the original package in order to protect from moisture . do not use nespo after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . your syringe can be removed from the refrigerator and left at room temperature ( not above 30 ) for a single period of maximum 7 days ( but not above 25 ). do not freeze . nnesco should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nespo contains - the active substance is darbepoetin alfa - 2b . nnesco is available in a pre - filled syringe containing 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu / ml . the other ingredients are : sodium phosphate monobasic , sodium phospho dibasic ( e339 ), sodium chloride , polysorbate 80 e433 , water for injections . what espo looks like and contents of the pack nеspo is a clear to slightly pearly liquid , colourless to slightly cloudy , clear to opalescent , colorless to pale yellow solution . each pack contains 1 or
what macugen is macuogen is a solution that is applied to the eye . it contains the active substance pegaptanib . this medicine helps to prevent abnormal formation of new blood vessels in the eye from forming . what macugagen is used for macug is used in adults for the treatment of macular degeneration . - people with this disease may develop vision loss due to damage to the part of the retina ( the macula ), which is at the back of the eye and inside the macua . macugeneration is the part that houses the front part of your eye whose macules is present . in amd , abnormal blood vessels grow out of the maculate and divide .
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if there is an active or suspected infection in or around your eye that you are not sure about . warnings and precautions talk to your doctor , pharmacist or nurse before using macug . if any of these apply to you , or if they are not , tell your doctor before you are given macu Gen . bleeding in the eye may occur soon after macuogen injection . tell your healthcare professional immediately if : you have any of : any of those following symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , and increased sensitivity to light . you notice small particles in your vision . these may be signs that the medicine is working in your eye . during or shortly
the number of injections needed will depend on your condition and the amount of macugen being injected . macuogen will be administered by your doctor or nurse . your doctor will decide how much macu Gen you need . the recommended dose is a single injection into the affected eye , which should be given every 6 to 9 weeks . make sure that the injection is given into the vitreous ( part of the eye ) immediately before you have macuGEN . before and after you are given macuGen , your doctor may ask you to use antibiotic eye drops . this is to make sure the eye is completely dry . you may also be given drops in the eyes , including some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you might have with the injection . do not try to be allergic to antibiotic eye drops . if your doctor decides that antibiotic
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction , also known as anaphylactic reaction / angioedema of which symptoms include : breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting / rapid pulse , stomach cramps , nausea , vomiting or diarrhoea . the frequency of these side effects is not known . you may have an infection in the internal portion of the eye . this is uncommon during macugen treatment . your doctor will check for the symptoms listed in section 2 . if you get any of these symptoms , seek medical advice immediately . 2 - tell your doctor or pharmacist if your child gets any of the side effects above . common : may affect up to 1 in 10 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . once the blister has been opened , the medicine should be used immediately .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegappanib in 90 microlitres . -the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasic salt phosphatе heptahydrate . sodium hydroxide / hydrochloric acid ( for ph adjustment ) and water for injections ). see section 2 . what macugagen looks like and contents of the pack macuogen solution for injection in a single dose pack is contained in : a pouch contained in the back of a pre . filled ml ( 3 . 25 mL or 0. 27 mmol ). it is supplied in an elastomeric plunger stopper and a ready 
kepivance contains the active substance palifermin which is produced by recombinant dna technology in the laboratory of escherichia coli . palifERmin belongs to a group of proteins called epithelial cells , which are found in the mouth , digestive tract and other tissues of the skin . when paliferedmin is present , kepepivace is used to treat oral mucositis ( soreness , dryness and inflammation of the mouth that often has been a side effect ). it is used when other treatments have not helped to treat your blood cancer , or you think your blood tumor has responded to chemotherapy or radiotherapy with autologous hematopoietic stem cells ( hhscs ).
do not use kepivance - if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions children and adolescents do not give this medicine to children under 18 years of age . other medicines and kepepivace tell your doctor or pharmacist if any of these apply to you . this is important because some other medicines may interact with kekivance such as heparin . tell your pharmacist : if your child has recently taken hepatin , or if hepivancing has been altered . pregnancy and breast - feeding kepativance is not recommended for pregnant women , think you may be pregnant , are planning to become pregnant . if this applies to your child , do not take kepingivance
kepivance should only be given by a doctor experienced in cancer treatment . always use keprunce exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kepativance is 60 mg . your doctor will give you kepepivace ( a kilogram of your body weight ) as an intravenous injection ( into a vein ). you will receive kekivance every day for as long as your condition allows you to continue to get the maximum benefit from kepingivance . if your doctor decides that you should receive a dose of the product , you will be treated with keepivancing three days after chemotherapy and radiotherapy . you will usually receive at least three days off chemotherapy and radiation . chemotherapy andradiotherapy will usually be given about 24 to 48 hours after the chemotherapy and
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects reported with kepivance include : skin rash , itching and redness ( pruritus , erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth ou tongue ), generalised swelling ( oedema ) and swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ); altered taste , lipase levels ( elevated ) in the blood ( hyperhidrosis ); low blood sugar ( hypoglycaemia ); high blood sugar ; anxiety ; depression ; difficulty sleeping ; tremor ; nightmare ; excessive sweating ; skin rashes (
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliffermin - -the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kespivace looks like and contents of the pack kepepivancing is a white powder for solution for injection . it is supplied in a box containing 6 vials .
cinacalcet accordpharma contains the active ingredient cinacacalcet , which helps to control the levels of parathyroid hormone ( pth ), calcium and phosphorous in your body . it is used to treat problems with organs called parathormon glands . the parat glands are four small glands in the neck , near the thyroid gland , that produce parat hormone ( hae ). cinakalcet accord Pharma is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products . to reduce the amount of calcium in the blood ( hypercalcaemia ) in patients suffering from parat thyroid cancer to reduce levels of calcium within the blood( hypercalcamaemia in patients having primary hyperparatohyroidisism ), when removal of the gland is not possible . cinacinacalc accordpharma
do not take cinacalcet accordpharma - if you are allergic to cinacacalcet or any of the other ingredients of this medicine ( listed in section 6 ). - because you have low levels of calcium in your blood , your doctor will monitor your blood calcium levels . warnings and precautions talk to your doctor or pharmacist before taking cinacinacalce accordpharma as it may cause , in rare cases , seizures ( convulsions ). tell your doctor if this happens . seizures should be reported immediately to your physician . - tell your healthcare professional if it happens to you . talk to you doctor or nurse before taking the medicine if : you have liver problems , you have heart failure , or you are breast - feeding . while taking cinecalcet acordpharma , low calcium levels can be very dangerous and life threatening events or fatal outcomes have been reported in association
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will tell you how much cinacalcet accordpharma you must take . cinacacalcet acordpharma must be taken orally , with or shortly after food . the tablets must be swallowed with some water or other non - alcoholic drink . you will need regular blood samples during treatment to monitor your progress and will adjust your dose if necessary . for secondary hyperparathyroidism the usual starting dose of cina Calcet accord Pharma is 30 mg . adults and children ( 3 to 18 years of age ) the usual dose is 0 . 20 mg , taken once a day . children ( 6 to 17 years of  age ), the dose is 10 mg / kg . when given twice a week , your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you start to get numbness or tingling around the mouth , muscle aches or cramps and seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth  , tongue or throat which may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ) nausea and vomiting . this side effects are usually mild and usually go away after a few days or months . common ( might affect up to 1 in every 10 people) dizziness , headache , diarrhoea , nausea , vomiting , chills and feeling sick ( nausea ). these side effects may be serious . very common : may affect
what cinacalcet accordpharma contains - the active substance is cinacacalcet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinaccet ( as hydrochloride ). -the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide , triacetin , indigo carmine aluminium lake , iron oxide yellow . what ciacalcet acordpharma looks like and contents of the pack cinacinacalce accordpharma 30 mg film , film . tablet dimensions : light green colored , oval shaped ( approximately 9 . 65 mm x 6 . 00 mm in diameter ), biconvex , pink , debossed with " cct10 " on one side . not
jentadueto contains two different active substances , linagliptin and metformin . linaguiptun belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ) metformine belongs to the class of biguanides . they work together to control blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine works by lowering the amount of sugar in the blood . it can be used alone or with insulin . this medicinal medicine can be combined with certain other medicines for diabetes ( sulphonylureas , empagliflozin ) or insulin , in adults with type 2 diabetic patients .
do not take jentadueto - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). -if you have severely reduced kidney function -- - in patients with uncontrolled diabetes , with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see " risk of lactic acids " below ) or ketoacidosis . ketoacacidoso is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to diabetic pre - co - death . symptoms include stomach pain , fast and deep breath , sweating , and a history of coma 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto is currently only available with metformin . it is recommended that you take individual tablets of linagliptin and metformine once a day , preferably at the same time each day . you can take this medication with or without food . taking this medicine swallow the tablet whole . this will lower your chance of an upset stomach . your doctor will prescribe a dose of 5 mg linagleptIN and 2 , 000 mg metform in hydrochloride once - daily . continue to take jenteduet until your doctor tells you otherwise . to control your blood sugar , your doctor may prescribe this medicine together with another oral anti - diabetic medicine such as insulin . remember to take all medicines as directed by
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see your doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ), which may be accompanied by trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypoglemia ( frequency not known , cannot be estimated from the available data ) is a very common side effect . it may affect more than 1 in 10 people . this side effect is usually mild and temporary . if this happens to you , you should contact your doctor . in addition , patients who have received jenteduet plus sulphonylurea or the combination jENTadu
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after exp . the expiration date refers to the last day of that month . blister : store in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions . tampering : do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each jenteduet 2 . 5 mg / 850 mg film - coated tablet contains 2 : 5 mg of linaguiptun and 850 micrograms of metformine hydrochuride - every jENTaduеto 2  . 25 mg 1/ 1 , 000 mg film- coated tablets contains 2 2 , 5 mg deltoid , equivalent to 1 : 1 kbq of langlipsin and 1  , 600 microgram of metFORMin hydrochaloride the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hyp
edurant contains the active substance rilpivirine . it is a medicine to treat human immunodeficiency virus ( hiv ) infection . e during belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it works by reducing the amount of hivie in your body . this helps to stop the spread of hivis . the echant is used by adults , adolescents and children 12 years of age and older who are infected by hiv and who have not taken hiv before . your doctor will discuss with you which combination of medicines is best for you .
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking e durant . if this applies to you , tell your doctor immediately . do not combine ecedent with any of these medicines : carbamazepine , oxcarbazepine, phenobarbital and phenytoin : medicines to treat epilepsy and prevent seizures rifampicin and riffapentine : ( medicines to prevent and treat some bacterial infections such as tuberculosis ) omeprazole / esomeprazolе , lalansoprazol , pantoprazole , and rabeprazola
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults ( 18 years of age and over ) the recommended dose of edurant is one tablet a day . do not chew , crush or split the tablet . your doctor may prescribe a lower dose of one tablet to you , depending on your condition . the recommended dosage of rifabutin , a medicine to treat some bacterial infections , may be used in combination with e . if your doctor has prescribed ecedent with riffabutine , your doctor will decide the correct dose of the tablet for you ; 2 . take an antacid ( a medicines used to treat diseases related to the acid in the stomach ) by combining with aluminium / magnesium hydroxide or calcium carbonate .
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you experience : headache , nausea , difficulty falling asleep , insomnia , dizziness . these may be due to a change in the dose of your routine liver tests ( transaminase , increase in cholesterol and pancreatic amylase in your blood ), as well as abnormal dreams , rash , or stomach pain ( which may be a sign of depression , tiredness , vomiting , and drowsiness ), decreased appetite , sleep disorders , stomach discomfort , depressed mood , anxiety , confusion , nervousness / confusion / nervousness inability to fall asleep . the following side effects have been reported since the marketing of edurant , however , not everybody got them : very common :
what edurant contains - the active substance is rilpivirine . each tablet contains rilsilpirine hydrochloride . epetit contains remdesivir - 25 mg of rillpivire . the other ingredients in the film - coated tablet core are : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose and magnesium stearate . in addition , the film coat contains lactoses monohydrate and hypromellose 2910 ( 6 mpa . amber ) tablet core : titanium dioxide ( e171 ), macrogol 3000 ( 6000 ), triacetin - 1820 , triazolam and talc ( ctab ). what he
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2 diabetic either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or don  ''  t respond normally to the insulin their body makes . rosiciglitare and metforin work together so your body makes better use of the insulin it produces , and this helps lower your blood sugar further . it is used in combination with a sulphonylurea ( another medicine for diabetes ).
you must follow any diet and lifestyle advice from your doctor or pharmacist , as this may affect the way you live and work . do not take avandamet : if you are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avandemet ( listed in section 6 ) if your diabetes is not well controlled with diet and exercise if : you have had a heart attack , severe angina , or heart failure , including heart failure in the past if any of these apply to you : severe breathing difficulties , liver disease , diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss , nausea or vomiting ) you have kidney disease 107 warnings and precautions talk to your doctor , pharmacist or nurse before taking avandalmet . check with your doctor before taking your
always take avandamet tablets exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the usual dose is one 2 mg tablet of rosiglitazone and 1000 mg of metformin per day . your doctor will work out the right dose for you based on how well you tolerate this dose . the recommended starting dose is 1 tablet once a day , with or without food . from day 8 onwards : the maximum dose is 4 mg of  Rosiglitabazone + 1000 mg metformine per day with or before food , whichever is better . take this dose as soon as you can , and then continue as normal , for as long as your physician prescribes it . if your doctor prescribes this dose after 2 hours , do not take a second dose of avand a morning
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions these are rare in people taking avandam . signs include : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ), causing difficulty in breathing collapse . contact a doctor immediately if you get any of these symptoms . stop taking a avandat and see a physician immediately . lactic acidosis : when avandant is taken lactic acids build up in the blood ( lactic Acidosose ) this is an uncommon side effect in patients taking metformin . this is a very rare but serious , potentially life - threatening , side effect of metformine . in severe kidney disease , symptoms of lactic acidosis include rapid breathing ,
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don t need . these measures will help protect the environment .
what avandamet contains - the active substances are rosiglitazone and metformin . avand amet tablets contain 1 mg of rosiciglit azone / 500 mg metformine . each 2 mg tablet contains rosizitazon / 5 , 500 mg of metforminer . the 2 mg tablets also contain rosziglitatazone ( 5 ), 1000 mg of Metformin and the 4 mg tablets of rusiglitab / 1000 mg metFORMin : sodium starch glycollate ( type a ), hypromellose ( e464 ), microcrystalline cellulose ( е460 ). what aavandaMet tablets look like and contents of the pack avandemet is a white , round , convex , bevelled edge tablet marked with " gsi "
clopidogrel mylan contains clopizil and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clodogrell mylan is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothromboisis , and atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clopinogrela mylan to help prevent and reduce the risk of blood and thrombocytes .
do not take clopidogrel mylan 31 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . If you suffer from severe liver disease . warnings and precautions talk to your doctor before taking cloclopidOgrel Mylan . take special care with clopinogrela mylan : if any of these apply to you and you are not sure , talk to you doctor or pharmacist before taking this medicine . bleeding : you should tell your physician if : your doctor thinks that you have a mental condition that puts you at risk of internal bleeding ( such as an stomach ulcer ). you should also tell your dentist that
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if vous have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of cropidogral myl ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet in the morning and one 75 - mg tablet at the end of treatment with clopogrell mylan ( 4 tablet of 75 g ) twice a day , for as long as your physician continues to
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , if confused ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction .
what clopidogrel mylan contains the active substance is clopdogrell . each film - coated tablet contains 75 mg of clodogral ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' cloclopidagrel mylan contains hydrogenated castingor oil ') and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( е172 ), yellow iron oxide , and talc and macrogol 3000 . what clupidograll mylan looks like and contents of the pack the film  shaped tablet is a pale yellow to yellow powder . it is available in packs containing one tablet of
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . dop Telet is used to treat chronic liver disease with low platelet count ( thrombophlebitis ) in adults . it is used in these patients , who are also having a medical procedure to reduce the risk of bleeding , because they have low number of platelets . platelets are blood cells that help the blood to clot and so reduce the incidence of bleeding
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). - when doptelt is given : warnings and precautions talk to your doctor , pharmacist or nurse before taking dop Telet . blood clots may form in the veins or arteries and this can increase the risk of blood coagulation . tell your doctor before taking this medicine if : you have or have had blood  clotes , for example : your doctor may want to monitor you more closely ; you have cancer ; your doctor might need to monitor the effects of the contraceptive birth control pill or hormone replacement therapy you recently had surgery or you are injured ; 23 you are overweight ; - you have advanced chronic liver disease . children and adolescents dopelet is not recommended
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will calculate your dose for you and explain the risks and benefits of your procedure . the recommended dose is 5 mg once a day . you should take doptelet for at least 8 hours before or after your meal . swallow the tablet whole . do not crush or chew the tablet . if possible you can take dopet with or without food . depending on the dose you take , your doctor may increase the dose to 20 mg , 40 mg or 60 mg once daily , for at most two weeks . additional doses may be used if necessary , depending on your platelet counts and how well they are working . when to take this medication take your tablet at about 10 to less than 13 hours before your planned medical procedure , or until your next scheduled dose . take
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ),: low red blood cell count ( anaemia ), blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) - upper abdominal pain with swelling bone pain muscle aches fever reporting of side effects get medical help immediately if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avavroopag maleate equivalent to 20 mg avatarombog . - other ingredients are lactose monohydrate ( see section 2 " dopelet contains lactoses "), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , vinyl alcohol , part hydrolysed , and talc , macrogol 3350 , titanium dioxide ( e171 ), and iron oxide yellow ( е172 ). what dopet looks like and contents of the pack dopellet 20 mg film  coated tablets are pale yellow to pale yellow , round and rounded , with " a " debosse
rapiscan belongs to a group of medicines called ' coronary vasodilators '. these work by helping the doctor to scan the heart arteries , and this helps to find the right muscles in your heart . rapican is used to perform a type of heart scan called a ' myocardial perfusion imaging ' in adults . the scan contains a radioactive substance known as a so - called opportunistic substance . it contains  a substance called , a " radiopharmaceutical ' that helps to obtain these images . they give the muscles in the heart in more detail . this can be done using a treadmill to get pictures of the heart from a distance . each person ' s doctor wants to take a scan to find out if they have a small amount of radiopharmaceceutic
do not use rapiscan - if you have slow heart rate or high degree heart block or sinus node disease - you may need to use a pacemaker - for chest pain ( unstable angina ) - during treatment - this is because you have low blood pressure ( hypotension ) or heart failure - are allergic to regadenoson , or any of the other ingredients of rapican ( listed in section 6 ). warnings and precautions talk to your doctor before using rapscan if : you have had a recent serious heart problem or if there has been a heart attack - have abnormal heart rhythms - your heart has a rhythm that is too fast or too slow - has slowed down or stopped - or had : heartbeat abnormal heart beat ( like rhythm overload ) you have ever had , have ever felt sick ( nausea 
rapiscan is given to you by a doctor or nurse who is trained in the use of rapican and who are experienced in the management of your heart and blood pressure . rapistcan is administered into a vein . it will be prepared and given to your child in a hospital or clinic . the dose will be calculated by your doctor and will be decided by your physician . after the initial administration of 400 micrograms / ml , the injection will be given over a period of 5 - 10 minutes . your doctor will calculate your weight in international units ( iu ) per kilogram of your weight . when an injection of sodium chloride 9 mg / kg ( 0 . 9 %) solution for injection is used , each millilitre ( mmol ) of solution for infusion contains a radioactive substance ( radiopharmaceutical ). the dose
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects reported following the rapican injection are usually mild to moderate and of a short duration . they usually disappear within 30 minutes after any treatment is started . tell your doctor immediately if you experience any of the following side effects as these may be signs of sudden stopping of the heart or damage to the heart ( e . g . heart block , which is a disorder of the hearts electrical signal ) rapid heart beat low blood pressure fainting mini strokes weakness of the face and inability to speak most patients get an improvement within one week after receiving rapissecan . however , some patients may experience a stroke or a cerebrovascular accident and experience an allergic reaction which may include rash , wheals / weals , or swollen hands , ankles or
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your peni when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . you and your partner will still be able to have sex at any time . this medicine is a treatment for adult men with erectile dysfunction , sometimes known as impotence . that is when a man cannot get , or keep a hard , hard - ed penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - when you are taking medicines called nitrates , as the combination may lead to a dangerous fall in your blood pressure . tell your doctor if these medicines are not suitable for you . - for example , angina pectoris ( or " chest pain "). if your doctor tells you that the medicines being given to you are being given by nitric oxide donors such as amyl nitsrite (" poppers "), as the combined may also lead to the formation of a periculoas fall inyour blood pressure in the future . warnings and precautions talk to your doctor or pharmacist before taking viagra . the use of riociguat this drug is used to treat pulmonary arterial hypertension ( i 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 50 mg . you should not take viagra film - coated tablets , as this medicine may be harmful to others . it is preferable to take viagra orodispersible tablets . your doctor will tell you exactly how many tablets to take . take the tablets with a glass of water . do not take more viagra than your doctor tells you to . if your doctor thinks that you may have an erection , or if it is difficult to complete sexual intercourse you should tell your doctor . taking viagra will usually help you to get an eection when you are sexually stimulated . this is because taking viagra alone does not guarantee that you will get an an érol . however , if this happens you should contact your
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing or dizziness . swelling of the eyelids , face , lips or throat . chest pains - these may occur uncommonly . get in a semi - sitting position and try to relax . do not use nitrates to treat your chest pain . prolonged and sometimes painful erections . this occurs rarely ( may effect up to1 in 1 , 000 people ). if your er errect is not
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildanafil ( as the citrate salt ). - other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . film coat : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( k25 ) what viagra looks like and contents of the pack viagra film - coated tablets are blue , oval - shaped with a round - diamond shape and engraved " 25 " on one side . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopines in the brain . stimulation of the dopam receptors triggers nerve impulses in the Brain that help to control body movements . siffrol is used to : - treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinsons ' disease ). - help to alleviate the symptoms in moderate to severe primary restless legs syndrome in adults and adolescents .
do not take sifrol : - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sIFrol . tell your doctor if any of your medical conditions or symptoms are serious . if they start out as mild or moderate , you may develop hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinies are visual . and are experienced by people with dyskinesia ( e . all . abnormal , uncontrolled movements of the limbs ). if your doctor has diagnosed advanced parkinson ' s disease and you are also taking levodopa , your doctor may need to adjust your dose to manage dyskineia . talk to you doctor before using siffrol
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . sifrol is used to treat parkinson ' s disease in adults . the recommended dose is 3 tablets per day . during the first week , your doctor may increase your dose to 1 tablet of sIFrol 0 . 088 mg or 0. 264 mg once a day , starting at the lowest dose possible . after the first weeks , you will be treated with 1 tablet ( s ) of 0x8 mg ( corresponding to 0/ 0 = 0 + 264 ) every week until your symptoms are controlled ( maintenance dose ). your doctor will increase your dosage to a maximum of 1 tablet each day ; you will then start to take siffrol 0- 0 088 - 
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common may affect more than 1 in 10 people common may effect up to 1 in 100 people uncommon may affect up to1 in 1 , 000 people very rare may affect less than 1 10 ,000 people not known frequency cannot be estimated from the available data if you suffer from parkinson ' s disease , you may experience the following side effects as a result of treatment : - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) - dizziness - nausea ( sickness ) common : urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there ) confusion - tiredness , difficulty in sleeping 
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0. 18 mg / 0 debossed with " pfizer ", a thickness of 0
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye ( a group of allergic conditions that affect the light - sensitive surface of the human eye ). it is used when the allergic reaction is severe . allergic conjonctivits may occur due to the presence of some materials ( allergens ) in the eye . these can cause allergic reactions such as itching , redness and swelling of the surface of your eye if you feel worse or if the conditions are severe , contact your doctor immediately .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using ema . children and adolescents do not give this medicine to children under the age of 3 years because the active substance , benzalkonium chloride , may be present in very small amounts in some patients receiving ememadine ( listed under section 6 " contents of the pack and other medicinal products "). emanine has not been studied in clinical trials . therefore , the safety and efficacy of emagine have not been established . there have been no clinical trials with e madine in children and teenagers with kidney or liver problems . talk to the doctor or nurse if any of these apply to you . this medicine may not be suitable for you
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 3 mg for each eye . this medicine should only be used by your doctor and not by your eyes . see section 3 . use in children and adolescents 1 . do not use in adolescents 2 years of age and older . if your child is less than 1 year of age , use the emadine bottle as instructed by your physician . wash your hands . twist off the bottle , remove the cap . after cap is removed , if the tamper evident snap collar is loose , throw away the bottle and throw it away . hold the bottle up , with your thumb and middle finger pointing down . tilt your head back . pull down your eyelid with a clean finger , until there is a 
like all medicines , this medicine can cause side effects , although not everybody gets them . you should check with your doctor or pharmacist if you are not sure . when to use the drops : common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye , and eye redness . uncommon side effects( may affect more than 1 in 100 people ), effects in and around the eye: corneal disorder ( abnormal eye sensation ), increased tear production , tired eyes , eye irritation , blurred vision , corneal staining . reporting of side effects 25 if your doctor gets any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . they can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . keep out the reach of children to protect from infections .
what emadine contains - the active substance is edastine . each vial contains 0 . 5 mg difumarate . - other ingredients are benzalkonium chloride , trometamol , sodium chloride and hypromellose . the other ingredients include purified water , hydrochloric acid and sodium hydroxide to keep acidity levels ( ph levels ) normal . what amadine looks like and contents of the pack e madine is a liquid ( a solution ) for injection , supplied in a 5 ml or 10 mL plastic ( drop - container ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiragetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepipsy , to treat a certain form of epilema . epilepepsy is a condition where the patients have repeated fits ( seizures ). the type of epileptic is characterized by the way the patients fit in and surround their brain . levetirasetam works on its most important functions : the epileeptic fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the cerebral ( partial onset seizure with or without secondary generalisation ). Levetiracem actavic is also used in combination with other antieeptic medicines to treat partial initiation seizures ( myoclonic
do not take levetiracetam actavis if you are allergic to levetiragetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking levetirasetam actsavis and if any of your medical conditions apply to you : if your kidney problems are not well controlled , tell your doctor . if , for the first time , you notice any slow down in the growth or unexpected puberty development of your child , let your doctor know immediately . some patients being treated with anti - epileptics such as levetiractam reactavis have had thoughts of harming or killing themselves . you should tell your physician if at any time you have any symptoms of depression and / or suicidal ideation . tell your healthcare provider if
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take the number of tablets following your doctor' s instructions . levetiracetam actavis is usually taken twice a day , once in the morning and once inthe evening . monotherapy dose in adults and adolescents ( from 16 years of age ): general dose : between 1 , 000 mg and 3 , 500 mg each day . when you will first start taking levetiractam , your doctor will prescribe you a lower dose during 2 weeks before giving you the lowest general dose of 1  , 1000 mg . add - on therapy dose in adult ( 12 to 17 years ) weighing 50 kg or more : general dosage : Between 1 karma and 3 000 mg each week . example : if your daily dose
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction ; swelling of the face , lips , tongue and throat ( quincke ' s oedema ); flu - like symptoms and a rash on the face followed by an extended rash with a high temperature , increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell 56 ( eosinophilia ) and enlarged lymph nodes ( drug reaction with fever ). common side effects ( may affect up to 1 in 10 people ): - decreased appetite - di
what levetiracetam actavis contains the active substance is called levetiractam . one tablet of levetiragetam actsavis 250 mg contains 250 mg of levracetnam . two tablets of levatiracetham actaviS 500 mg contain 500 mg of the drug . three tablets of Levetiracem actavia 750 mg contain 750 g of leviracetan . four tablets of dulbecco ' s levetiretam actingavis 1 , 000 mg contains 1  ,000 mg of dutch . the other ingredients are crospovidon , povidone , silica colloidal anhydrous , magnesium stearate . what lev tam actionavis looks like and contents of the pack levetirasetam reactavis is a white , oval shaped ,
incruse ellipta contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . incrussé ellippa is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition in which the airways and air - sacs in the lungs gradually become blocked and blocked , leading to breathing difficulties that slowly get worse . difficulties in breathing is added to by tightening of the muscles around the airway , making it easier for air to get in and out of the arteries . this medicine blocks the tightener of these muscles , so that air passes more freely into the pulmonary airways . when used regularly , it can help control your breathing difficulties and reduce the effects of copd on your everyday life . elli
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately and do not take this medicine . warnings and precautions talk to your doctor or pharmacist before using incrue elpt : - you have asthma ( don ' t use in incrure ellippa to treat asthma ). talk to you doctor if : you have heart problems you have an eye problem called narrow - angle glaucoma . you have or have had an enlarged prostate , difficulty passing urine or a blockage in your bladder . your doctor may want to monitor you more closely . - severe liver problems . immediate breathing difficulties if your tightness of the chest , coughing , wh
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use incruse ellipta regularly it is very important that you use incluse inhaler every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . do not use this product to relieve a sudden attack of breathlessness or wheezing . if this is a serious attack you must use a quick - acting reliever inhalER ( such as salbutamol ). how to use the inhalers see 
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you have any of the following symptoms after taking incruse ellipta , stop using this medicine and tell your doctor immediately : itching skin rash ( hives ) or redness 29 other side effects common ( may effect up to1 in 10 people ) faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ) common cold infection of nose or throat cough feeling of pressure or pain in the cheeks and forehead ( may indicate a bladder infection ). common cold infections of nose and throat cough a feeling of tension or pain on the cheek and forehead . uncommon ( might affect upt . 4 in 100 users ): diarrhoea . reporting of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the inhaler inside the sealed tray in order to protect from light . after first opening , the inhaler can be used for up to 6 weeks , but within the maximum time the inhabitant can use the inher once opened , if kept at room temperature , or if carried as a spare . once the tray has been opened : do not store above 30 . for single use only . discard the inHALER that has been used for storing medicines away from direct heat or direct light , even when they are not needed . they will not be returned to the refrigerator .
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umecronium broMIDe ). - other ingredients are lactose monohydrate ( see section 2 under ' incruses ellippa contains lactoses ') and magnesium stearate . what increse incruta looks like and contents of the pack incrussant ellipata is an inhalations powder , pre - dispensed . the ellimpta inhaler consists of a grey plastic body , a light green mouthpiece cover and a dose counter . it is packaged in a foil laminate tray with a peelable
nucala contains the active substance mepolizumab , which is a monoclonal antibody , a type of protein that is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma is caused by the presence of many eosinophils , another white blood cell that helps to get air in and out of the lungs ( e . g ., esinolic asthma ). asthma nucalala is used : to help prevent asthma attacks and to reduce the number of medicines that you use to treat your asthma . it is not only used when you cannot use medicines called high dose inhalers to treat or prevent your asthma not working properly or if you cannot take these medicines alone . medicines called oral corticosteroids may not be suitable for you . nucalа can help control your asthma even when you are using
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine . tell your doctor if : you have worsening asthma 58 you have asthma - related side effects and tell your asthma doctor before you start nucalala . your doctor will monitor your asthma and will adjust your dose of nucalа as your condition gets worse . do not stop nucalum treatment if your asthma is not controlled with nucale treatment , because you may be allergic to certain substances or substances that may be present in the blood . injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions when they are injected into the body ( see section 4 , possible side effects ). if any of these apply to you , tell
nucala is given by injection under the skin ( subcutaneous injection ). the recommended dose is 12 micrograms . the dose may be increased or decreased by up to 100 microgram ( 1 ml ) per day . use the pre - filled pen at any time during treatment with nucal . if you have any further questions on the use of nucalа , ask your doctor , pharmacist or nurse . your doctor will decide how many injections you need . do not stop the treatment with no nucalala unless you have agreed this with your doctor or nurse and / or nurse who will be monitoring the treatment . you will be monitored while you are using nucalá , to check that the treatment is having the desired effect . nucalla may not be suitable for you if your asthma symptoms or attacks get worse or get worse . depending on your asthma problems , your doctor may decide
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions are common ( may affect up to 1 in 10 people ) and occur very rarely . they occur within the first weeks or months after the injection . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting , dizziness / feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash immediately if you notice any of the following : a reaction to , or to tamper evident signs of a similar reaction to nucalum : fever or chills bruising uncommon : may affect more than 1 in 100 people a sudden drop in the amount of blood particles in the
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the nucale pre - filled pen in the outer carton in order to protect from light . after first opening or if carried as a spare you can carry it with you and keep it at room temperature ( not above 25 ) for up to 7 days . once removed from the refrigerator , use within 7 days or discarded .
what nucala contains the active substance is mepolizumab . 1 ml solution contains 100 mg of mepolizuab in 1 0 . 5 mL solution . the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate . polysorbate 80 , edta disodium dihydrate e339 and water for injections . what nukala looks like and contents of the pack nucalala is presented as a solution for injection ( injection ) in a glass vial . it is available as : a pack containing 1 vial or a multipack containing 3 vials of 1 v . not all pack sizes may be marketed .
what ninlaro is nINlarro is not a cancer medicine and it contains the active substance ixazomib , also known as a ' proteasome inhibitor '. what iinlarao is used for nninnlar0 is used to treat adults with a type of cancer of the bone marrow called multiple myeloma . ixizomibu is used , for cell survival , to help prevent myelama cells from multiplying . it contains a lot of proteins called proteasoms that are involved in their development . what is ' nine myelosomo ' in patients with multiple myélomas . in patients who have received ninninglarô with lenalidomide and dexamethasone , among other medicines used
do not take ninlaro - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking nninlaaro and before starting treatment . warnings and precautions talk to your doctor or pharmacist before taking the medicine if any of these apply to you ( or you are not sure ): - patients taking a different type of medicine may develop bleeding , or develop persistent nausea or vomiting , diarrhoea . - suffer from nerve problems such as tingling , numbness , swelling or a persistent rash . tell your healthcare professional if your doctor notices any of those signs . your doctor may decide to reduce your dose . talk to you doctor or nurse if : you have liver or kidney problems
ninlaro must be given to you by a doctor with experience in treating multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . when to take nninlao : your doctor will prescribe nINlara together with lenalidomide , a medicine that your doctor prescribes in combination with dexamethasone , an anti - inflammatory medicine . how often to take lenalaro when taken together with deuxamethaone : on a 4 - week cycle . take  ninklars once a week on the same day of the week . the first 3 weeks of the cycle will consist of taking lenlaride and dexamine , which will then be increased to a maximum of 25 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds that can be easily bruise nausea , vomiting , diarrhoea , numbness , feeling of tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet( peripheral oedema ) skin rash or itchy anywhere on the body rare side effects may affect up to 1 in 1 , 000 people . if you notice any of the side effects above , contact your doctor immediately . reporting of side effects 25 if your doctor or pharmacist gets any side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister or carton after exp . the expiration date refers to the last day of that month . store below 30 . keep the capsule in the outer carton in order to protect from light and moisture . this medicine does not require any special temperature storage conditions . does not use if you notice any damage or signs of tampering to medicine packaging . please return ninlaro to your pharmacist .
what ninlaro contains - the active substance is ixazomib . each capsule contains 2 . 3 mg of ixazamia and 3 . 4 mg of it ( as ixozomibe citrate ). the other ingredients are microcrystalline cellulose , magnesium stearate and talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), and red iron oxide ( е172 ). printing ink contains shellac , propylene glycol , potassium hydroxide and black iron oxide . nninlao 3 mg hard capsules also contain ixizomid . they are supplied in packs containing 3 mg ixzomibid .
palforzia is not a treatment for people who are allergic to peanuts ( arachis hypogogaea ). palforizia is used in children and adolescents aged 4 months to 17 years in adults . it is used if you have not previously responded to treatment for peanut allergy because it contains soya - like particles derived from peanut ( sensitisation ) to peanut ( peanut ( desensitisation "). pal forzia has no other effect on allergic reactions . palforziea should not be used on food allergies . you should discuss with your doctor whether palfor zia is suitable for you .
do not take palforzia - if you are allergic to severe asthma or any of the ingredients of palforizia ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking palfor zia : - you have a problem swallowing it is very important to tell your doctor if this applies to you . there is a small chance that your asthma may get worse . you have long term problems with your digestive system . - your doctor will tell you if there is something you can take to prevent a severe mast cell disorder , such as severe or life - leading anaphylaxis , for at least 60 days after finishing treatment . your doctor may decide to stop your palforzazia temporarily or permanently . when you stop taking palfordzia you may experience the symptoms of peanut allergy . it is important to know that peanut allergy can occur
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine is not recommended for use under the supervision of a physician experienced in allergy . allergic reactions ( anaphylaxis ) may occur at least 3 days before you start treatment with palforzia . initial dose escalation : these treatment phases are called the initial dose elevation and up - dosing phases . you will be observed while you are taking palforzaa , and for at least two hours after the initial dosertion and up- dosesing phases of palforziea ; you will only be observed whilst you are being treated with palfordzia until desensitisation occurs . it may take some hours before you feel unwell . if your asthma is not controlled with initial dose elevation ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : severe allergic reactions . tell your doctor straight away if you get any of the following symptoms while you are taking palfor zia . they are usually mild to moderate and go away quickly after a few days . - the reaction may progress to trouble breathing , throat tightness , feeling of fulness , trouble swallowing or speaking - changes in voice - dizziness or fainting - severe stomach cramps or pain , vomiting , diarrhoea , severe flushing or itching of the skin palforizia may also cause problems with the stomach and digestive system , such as : - high blood sugar - low blood sugar ( hypoglycaemia ) - weight gain - muscle pain - joint
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . any hard lumps of powder should be thrown away . discard any unused solution appropriately .
what palforzia contains the active substances are : 0 . 5 mg , 1 mg / 10 mg and 20 mg . the other ingredients are cellulose , colloidal anhydrous silica and magnesium stearate palforizia 100 mg : oral powder in capsules opening microcrystalline cellulose ( e460 ) and colloidal anihydrous silicona and water for injections . magnesium STEarate papelforzian 300 mg - oral powderin sachet microcrystalline ( е460 ), colloidal and anhydrOUS silic , magnesium starate , beige oral powder for solution for initial dose escalation ( see section 2 ). available in packs of 3 , 13 and 5 single - dose blisters , each containing one or three single , dose blister . not all pack sizes may be marketed .
zerene belongs to a class of substances called benzodiazepine - related medicinal products . it has hypnotic actions and is used to help you sleep . zere will usually be given to you by a doctor or nurse . this kind of treatment is known as long as you continue treatment . the treatment is usually started when you have problems sleeping .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenede sleep apnoea syndrome ( a series of short periods of intense , sometimes severe kidney or liver problems ). if your doctor thinks you may have myasthenia gravis ( very weak or tired muscles , severe breathing or chest problems ) warnings and precautions talk to your doctor or pharmacist before taking zerente . the following undesirable effects may occur after taking any medicine , including any medicines that may induce physical dependence . in some cases , treatment may lead to withdrawal symptoms , such as headaches , muscle pain , extreme anxiety or tension . these effects usually resolve within a few days or weeks after stopping treatment . if they do not work well enough , you should contact your doctor .
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose for adults is 10 mg once a day , preferably with food , and you may be having difficulty falling asleep . do not exceed this recommended dose of 65 mg once daily , even if your doctor thinks you are 65 years or older . for people with mild to moderate liver problems , the usual starting dose is 5 mg once per day . if for mild to medium liver problems you will only be given 5 mg twice a week . after the capsule has been opened , contact your doctor . swallow the capsule whole with water . avoid contact with the capsule contents . contact your physician immediately if the contents of the capsule become cloudy or if there are particles in the liquid . an overdose may make you increasingly drowsy and
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor if you notice any of the following , or any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon ( affect 1 to 5 users in 1 , 000 ) rare ( affecting 1 to10 users in 10 to 10 Users in 10 000 ). very rare (affecting less than 1 patient in 10 and 10 users per 10 ,000 ) very rare : ( affect less than1 user in10 ,00 ,0000 ) not known ( frequency cannot be estimated from the available data ). as with all medicines it is possible that side effects could become serious if any of them become serious or if they become serious ( see section
what zerene contains - the active substance is zaleplon ( 5 mg / ml ). - consists of microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate . - contains lactose monohydrate , indigo carmine ( k25 ), titanium dioxide ( ink ). printing ink contains red iron oxide ( е172 ), yellow iron oxide and black iron oxide( e172 )), sodium leuryl sulfurate . the printing inken contains silicon dioxide (" s - 13350 ) and shellac , lecithin , simethicone , and yellow iron dioxide ( the ink is composed of iron oxide red ). what zeene looks like and contents of the pack
